摘要:

Natural Product Reports Editorial Board Professor T. J. Simpson (Chairman) University of Bristol Dr C. Abell University of Cambridge Dr J. R. Hanson University of Sussex Dr R. B. Herbert University of Leeds Professor J. Mann University of Reading Dr D. A. Whiting University of Nottingham Natural Product Reports is a bimonthly journal of critical reviews. It aims to foster progress in the study of bioorganic chemistry by providing regular and comprehensive reviews of the relevant literature published during well-defined periods. Topics include the isolation structure biosynthesis and chemistry of the major groups of natural products-alkaloids terpenoids and steroids aliphatic aromatic and 0-heterocyclic compounds. Many reviews provide details of biological activity and wider aspects of bioorganic chemistry including developments in enzymology genetics and structural spectroscopic and chromatographic methods of general interest to all workers in the area.Articles in Natural Product Reports are commissioned by members of the Editorial Board or accepted by the Chairman for consideration at meetings of the Board. Natural Product Reports (ISSN 0265-0568) is published bimonthly by The Royal Society of Chemistry Thomas Graham House Science Park Milton Road Cambridge CB4 4WF England. 1993 Annual Subscription Price E.C. f242.00 Overseas f266.00 U.S.A. $532.00 Canada f279.00. Change of address and orders with payment in advance to The Royal Society of Chemistry The Distribution Centre Blackhorse Road Letchworth Herts.SG6 1 HN England. Air Freight and mailing in the U.S. by Publications Expediting Service Inc. 200 Meacham Avenue Elmont NY 11003. US Postmaster send address changes to Natural Product Reports Publications Expediting Service Inc. 200 Meacham Avenue Elmont NY 11003. Second-Class postage paid at Jamaica NY 11431-9998. Afl other despatches outside the U.K. are by Bulk Airmail within Europe and Accelerated Surface Post outside Europe. Printed in the U.K. 0 The Royal Society of Chemistry 1993 All Rights Reserved No part of this publication may be reproduced stored in a retrieval system or transmitted in any form or by any means electronic mechanical photographic recording or otherwise without the prior permission of the publishers. Printed in Great Britain by the University Press Cambridge Subscription rates for 1993 E.C. f242.00 Overseas f266.00 U.S.A. US $532.00 Subscription rates for back issues are (1988) (1989) (1 990) (1991) (1 992) U.K. €1 59.00 f169.00 f177.00 f198.00 f222.00 Overseas f 183.00 f194.00 f204.00 f228.00 f250.00 U.S.A. US $342.00 US $388.00 US $398.00 US $467.00 US$474.00 Members of the Royal Society of Chemistry should order the journal from The Membership Manager The Royal Society of Chemistry Thomas Graham House Science Park Milton Road Cambridge CB4 4WF England

ISSN:0265-0568    

DOI:10.1039/NP99310FX001

出版商:RSC    

年代:1993

数据来源: RSC

ISSN:0265-0568    

DOI:10.1039/NP99310BX003

出版商:RSC    

年代:1993

数据来源: RSC

摘要:

Natural Product Reports Editorial Board Professor T. J. Simpson (Chairman) University of Bristol Dr C. Abell University of Cambridge Dr J. R. Hanson University of Sussex Dr R. 9.Herbert University of Leeds Professor J. Mann University of Reading Dr D. A. Whiting University of Nottingham Natural Product Reports is a bimonthly journal of critical reviews. It aims to foster progress in the study of bioorganic chemistry by providing regular and comprehensive reviews of the relevant literature published during well-defined periods. Topics include the isolation structure biosynthesis and chemistry of the major groups of natural products -alkaloids terpenoids and steroids aliphatic aromatic and 0-heterocyclic compounds. Many reviews provide details of biological activity and wider aspects of bioorganic chemistry including developments in enzymology genetics and structural spectroscopic and chromatographic methods of general interest to all workers in the area.Articles in Natural Product Reports are commissioned by members of the Editorial Board or accepted by the Chairman for consideration at meetings of the Board. Natural Product Reports (ISSN 0265-0568) is published bimonthly by The Royal Society of Chemistry Thomas Graham House Science Park Milton Road Cambridge CB4 4WF England. 1994 Annual Subscription Price E.C. f266.00 Overseas f286.00 U.S.A. $500.00 Canada f279.00. Change of address and orders with payment in advance to The Royal Society of Chemistry The Distribution Centre Blackhorse Road Letchworth Herts.SG6 1 HN England. Air Freight and mailing in the U.S. by Publications Expediting Service Inc. 200 Meacham Avenue Elmont NY 11003. US Postmaster send address changes to Natural Product Reports Publications Expediting Service Inc. 200 Meacham Avenue Elmont NY 11003. Second-Class postage paid at Jamaica NY 11431-9998. All other despatches outside the U.K. are by Bulk Airmail within Europe anti Accelerated Surface Post outside Europe. Printed in the U.K. 0 The Royal Society of Chemistry 1994 All Rights Reserved No part of this publication may be reproduced stored in a retrieval system or transmitted in any form or by any means electronic mechanical photographic recording or otherwise without the prior permission of the publishers. Printed in Great Britain by the University Press Cambridge Subscription rates for 1994 E.C. f266.00 Overseas f286.00 U.S.A. US $500.00 Subscription rates for back issues are (1 989) (1 990) (1991) (1992) (1993) E.C. f169.00 f 177.00 f198.00 f222.00 f242.00 Overseas f194.00 f204.00 f228.00 f250.00 f266.00 U.S.A. US $388.00 US $398.00 US $467.00 US$474.00 US$532.00 Members of the Royal Society of Chemistry should order the journal from The Membership Manager The Royal Society of Chemistry Thomas Graham House Science Park Milton Road Cambridge CB4 4WF England

ISSN:0265-0568    

DOI:10.1039/NP99310FX025

出版商:RSC    

年代:1993

数据来源: RSC

ISSN:0265-0568    

DOI:10.1039/NP99310BX027

出版商:RSC    

年代:1993

数据来源: RSC

摘要:

ISSN 0265-0568 NPRRDF 10 1-1-1-68 (1993) Natural Product Reports A journal of current developments in bio-organic chemistry Volume I0Indexes CONTENTS ... 111 Preliminary pages for Volume 10 1-1 Index of Authors Cited 1-39 Subject Index ISSN 0265-0568 Coden NPRRDF Natural Product Reports A journal of current developments in bio -organic chemistry Volume 10 1993 The Royal Society of Chemistry Cambridge Natural Product Reports (ISSN 0265-0568) @ The Royal Society of Chemistry 1994 All Rights Reserved No part of this publication may be reproduced stored in a retrieval system or transmitted in any form or by any means electronic mechanical photographic recording or otherwise without the prior permission of the publishers.Printed in Great Britain by the University Press Cambridge ISSN 0265-0568 NPRRDF 10 1-632 l-l-l-68(1993) Natural Product Reports A journal of current developments in bio -organic chemistry Volume 10 CONTENTS 1 Lignans Neolignans and Related Compounds R. S. Ward Reviewing the literature published between January 1989 and December 1991 29 Muscarine Oxazole Imidazole Thiazole and Peptide Alkaloids and Other Miscellaneous Alkaloids J. R. Lewis Reviewing the literature published between July 1990 and June 1991 51 Indolizidine and Quinolizidine Alkaloids J. P. Michael Reviewing the literature published between July 1990 and June 1991 71 Microbial Pyran-2-ones and Dihydropyran-2-ones J. M. Dickinson Reviewing the literature up to December 1991 99 Quinoline Quinazoline and Acridone Alkaloids J.P. Michael Reviewing the literature between July 1990 and June 1991 109 The Chemistry of Azadirachtin S. V. Ley A. A. Denholm and A. Wood 159 Diterpenoids J. R. Hanson Reviewing the literature published in 1991 175 Chemical and Biochemical Manipulations of Nucleic Acids 199 Tropane Alkaloids G. Fodor and R. Dharanipragada Reviewing the literature between January and December 1991 207 NMR of Proteins M. P. Williamson 233 The Biosynthesis of Shikimate Metabolites P. M. Dewick Reviewing the literature published during 1991 M. J. McPherson and J. H. Parish 265 Biological Variation of Microbial Metabolites by Precursor-directed Biosynthesis J. Rohr R. Thiericke and 29 1 Amaryllidaceae and Sceletium Alkaloids J.R. Lewis Reviewing the literature published during 1991 301 Stevioside and Related Sweet Diterpenoid Glycosides J. R. Hanson and B. H. De Oliveira Reviewing the literature published up to May 1992 311 Obituary David N. Kirk 1929-1992 313 Steroid Reactions and Partial Synthesis Reviewing the literature published in 1991 J. R. Hanson 327 Advances in Chemical Ecology J. B. Harborne Reviewing the literature published between January 1988 and June 1992 NATURAL PRODUCT REPORTS 1993 CONTENTS 349 Recent Progress in the Chemistry of Indole Alkaloids and Mould Metabolites J. E. Saxton Reviewing the literature published between July I991 and June I992 397 Natural Sesquiterpenoids B. M. Fraga Reviewing the literature published during 1991 421 Arsenic Compounds from Marine Organisms J.S. Edmonds K. A. Francesconi and R. V. Stick Reviewing the literature published up until October 1992 429 Macrocyclic Trichothecenes J. F. Grove Reviewing the literature published up to December 199I 449 P-Phenylethylamines and the Isoquinoline Alkaloids K. W. Bentley Reviewing the literature published between July 1991 and June 1992 471 Diterpenoid Alkaloids M. S. Yunusov Reviewing the literature published between December I989 and January 1992 487 Pyrrolizidine Alkaloids D. J. Robins Reviewing the literature published between July 1991 and June 1992 497 Marine Natural Products D. J. Faulkner Reviewing the literature published during 1991 541 HMG-CoA Reductase Inhibitors A.Endo and K. Hasumi Reviewing the literature published up to October 1992 551 A Survey of Natural Products which Abstract Hydrogen Atoms from Nucleic Acids J. A. Murphy and J. Griffiths 565 The Strobilurins Oudemansins and Myxothiazols Fungicidal Derivatives of P-Methoxyacrylic Acid J. M. Clough 575 The Biosynthesis of Plant Alkaloids and Nitrogenous Microbial Metabolites R. B. Herbert Reviewing the literature published between January and December 199I 593 Biosynthesis of Fatty Acid and Polyketide Metabolites D. O’Hagan Reviewing the literature published between mid- 1991 and mid- I992 625 Cumulative Contents Volumes 1-10 Natural Product Reports Editorial Board Professor T. J. Simpson (Chairman) University of’ Bristol Dr C.Abell University of’ Cambridge Dr J. R. Hanson University of’ Sussex Dr R.B. Herbert University 01 ’ Leeds Professor J. Mann University of’ Reading Dr D. A. Whiting University 01 ’ Nottingham ~ ~~ Natural Product Reports is a bimonthly journal of critical reviews. It aims to foster progress in the study of bio-organic chemistry by providing regular and comprehensive reviews of the relevant literature published during well-defined periods. Topics include the isolation structure biosynthesis and chemistry of the major groups of natural products -alkaloids terpenoids and steroids aliphatic aromatic and 0-heterocyclic compounds. Many reviews provide details of biological activity and wider aspects of bio-organic chemistry including developments in enzymology genetics and structural spectroscopic and chromatographic methods of general interest to all workers in the area.Articles in Natural Product Reports are commissioned by members of the Editorial Board or accepted by the Chairman for consideration at meetings of the Board. This journal includes reviews of books relating to natural products. Volumes for review should be sent to the editorial office for which the address is The Royal Society of Chemistry Thomas Graham House Science Park Milton Road Cambridge CB4 4WF and marked for the attention of the Senior Editor Reviews. Contributors to Volume 10 Bentley K. W. 449 Fraga B. M. 397 Murphy J. A. 551 Clough J. M. 565 Francesconi K. A. 421 O’Hagan D. 593 Denholm A. A. 109 Griffiths J. 551 Parish J.H. 175 De Oliveira B. H. 301 Grove J. F. 429 Robins D. J. 487 Dewick P. M. 233 Hanson J. R. 159 301 313 Rohr J. 265 Dharanipragada R. 199 Harborne J. B. 327 Saxton J. E. 349 Dickinson J. M. 71 Hasumi K. 541 Stick R. V. 421 Edmonds J. S. 421 Herbert R. B. 575 Thiericke R. 265 Endo A. 541 Lewis J. R. 29 291 Ward R. S. 1 Faulkner D. J. 497 Ley S. V. 109 Williamson M. P. 207 Fodor G. 199 McPherson M. J. 175 Wood A. 109 Michael J. P. 51 99 Yunusov M. S. 471 Nomenclature It is the policy of The Royal Society of Chemistry to en-courage the use of IUPAC and IUB Recommendations on nomenclature. Although many of the appropriate nomen-clature documents are included in the new edition of the IUB publication ‘Biochemical Nomenclature and Related Documents ’ (published by The Biochemical Society London 1992) a selection of recent Recommendations that will be of particular interest to those who investigate the chemistry occurrence or biosynthesis of natural products includes Extension of Rules A- 1.1 and A-2.5 concerning numerical terms used in organic nomenclature (Recommendations 1986) Pure Appl.Chem. 1986 58 1693-1696. [The original versions of these Rules are in ‘Nomenclature of Organic Chemistry Sections A B C D E F and H’ 1979 Edition] Nomenclature of tetrapyrroles (Recommendations 1986) Pure Appl. Chem. 1987 59 779-832. Nomenclature and symbols for folic acid and related compounds (Recommendations 1986) Pure Appl. Chem. 1987 59 833-836; Eur. J. Biochem. 1987 168 251-253.Nomenclature of prenols (Recommendations 1986) Pure Appl. Chem. 1987 59 683-689; Eur. J. Biochem. 1987 167 181-184. Nomenclature of retinoids (Recommendations 198 I) Pure Appl. Chem. 1983 55 721-726; Eur. J. Biochem. 1982 129 1-5. Nomenclature of vitamin D (Recommendations I98 I) Pure Appl. Chem. 1982 54 1511-1516; Eur. J. Biochem. 1982 124 223-227. Nomenclature of tocopherols and related compounds (Recommendations 1981) Pure Appf. Chem. 1982 54 1507-1510; Eur. J. Biochem. 1982 123 473-475. Recommendations for the presentation of thermodynamic and related data in biology (1985) Eur. J. Biochem. 1985 153 429434. ‘Enzyme Nomenclature (Recommendations 1984) ’ Supplement 1 Corrections and additions Eur. J. Biochem. 1986 157 1-26.‘Enzyme Nomenclature 1992’ (Recommendations of the Nomenclature Committee of the International Union of Biochemistry on the nomenclature and classification of enzyme- catalysed reactions) Academic Press Orlando Florida 1992. Nomenclature for multienzymes (Recommendations 1989) Eur. J. Biochem. 1989 185 485486. Symbolism and terminology in enzyme kinetics (Recommendations 1981) Eur. J. Biochem. 1982 128 281-291. Symbols for specifying the conformation of polysaccharide chains (Recommendations 1981) Pure Appl. Chem. 1983 55 1269-1272; Eur. J. Biochem. 1983 131 5-7. Polysaccharide nomenclature (Recommendations 1980) Pure Appl. Chem. 1982 54 1523-1526; Eur. J. Biochem. 1982 126 439441. Abbreviated terminology of oligosaccharide chains (Recommendations 1980) Pure Appf.Chem. 1982 54 1517-1522; Eur. J. Biochem. 1982 126 433437. Nomenclature of glycoproteins glycopeptides and peptidoglycans (Recommendations 1985) Eur. J. Biochem. 1986 159 1-6. Nomenclature and symbolism for amino acids and peptides (Recommendations 1983) Pure Appl. Chem. 1984 56 595-624; Eur. J. Biochem. 1984 138 9-37 (see also Eur. J. Biochem. 1985 152 1 and the Newsletter 1985 of NC-IUB and JCBN ibid. 1985 146,pp. 238 and 239 and the Newsletter 1986 ibid. 1986 154 pp. 485 and 486). Nomenclature for incompletely specified bases in nucleic acid sequences (Recommendations 1984) Eur. J. Biochem. 1985 150 1-5 (see also Eur. J. Biochem. 1986 157 1). Abbreviations and symbols for the description of conformations of polynucleotide chains (Recommendations 1982) Pure Appf.Chem. 1983 55 1273-1280; Eur. J. Biochem. 1983 131 9-15 (see also the Newsletter 1984 of NC-IUB and JCBN Eur. J. Biochem. 1984 138 p. 7). The most recent of the lists of restriction endonucleases and their isoschizomers (updated annually) is R. J. Roberts and D. Macelis Nucl. Acids Res. 1991 19 2077-2109. Recent codes of nomenclature for organisms include ‘International Code of Nomenclature of Bacteria and Statutes of the International Committee on Systematic Bacteriology (1 989 Revision)’ ed. P. H. A. Sneath V. B. D. Skerman and V. McGowan American Society for Microbiology Washington D.C. U.S.A. 1976. [Appendix 2 of this publication (Approved Lists of Bacterial Names) appeared in Int.J. Syst. Bucteriof. 1989 39.1 ‘International Code of Botanical Nomenclature (1988)’ ed. W. Greuter H. M. Burdett W. G. Chaloner V. Demoulin R. Grolle D. L. Hawksworth D. H. Nicholson P. C. Silva F. A. Stafleu E. G. Voss and J. McNeill Koeltz Scientific Books Konigstein Federal Republic of Germany 1988. ‘International Code of Zoological Nomenclature ’ 3rd edn. ed. W. D. L. Ride C. W. Sabrosky G. Bernardi R. V. Melville J. 0. Corliss J. Forest K. H. L. Key and C. W. Wright International Trust for Zoological Nomenclature in association with the British Museum (Natural History) London U.K. and the California Press Berkeley and Los Angeles U.S.A. 1985.

ISSN:0265-0568    

DOI:10.1039/NP99310FP029

出版商:RSC    

年代:1993

数据来源: RSC

ISSN:0265-0568    

DOI:10.1039/NP99310BP037

出版商:RSC    

年代:1993

数据来源: RSC

摘要:

lndol izid ine and Quino1kidine Alkaloids J. P.Michael Centre for Molecular Design Department of Chemistry University of the Witwatersrand Wits 2050 South Africa Reviewing the literature published between July 1990 and June 1991 (Continuing the coverage of literature in Natural Product Reports 1991 Vol. 8 p. 553) 1 Slaframine steps and 35 % yield from N-benzyl-L-glutamic acid was 2 Hydroxylated Indolizidine Alkaloids converted into (3) by a cis-stereoselective Wittig olefination. 2.1 Mono- and Dihydroxy-indolizidines The subsequent high-yielding epoxidation was disappointingly 2.2 Swainsonine and Related Compounds unselective (1 l) giving the HPLC-separable epoxides (4)and 2.3 Castanospermine and Related Compounds (5). Both were transformed by reduction and functional group 3 Monornoriurn Alkaloids manipulation into indolizidines the former leading to (-)-4 Indolizidine Alkaloids from Amphibians 178a-di-epi-slaframine(6) and the latter to the target alkaloid 5 Elaeocarpus Alkaloids (1) in an overall yield of 6% (12 steps) from N-benzyl-L- 6 Juliflorine glutamic acid.The optical rotation of (-)-slaframine hitherto 7 Phenanthroindolizidine Alkaloids and Seco Analogues unreported was measured as -33" (c 1.6 CHCl,). Separation 8 Nuphar Alkaloids of isomers could be accomplished more conveniently by column 9 Alkaloids of the Lupinine-Cytisine-Sparteine-chromatography if left until after indolizidine formation Matrine-Orrnosia Group though yields were then lower. An alternative attempt to 9.1 Occurrence and Detection produce the optically active alkaloid beginning with the same 9.2 Structural and Spectroscopic Studies derivative (2) and proceeding through thermal rearrangement 9.3 Synthesis of the cyclopropylimine (7) failed when oxidation of the 10 Alkaloids from Marine Sources indolizidine-enamine (8) gave only low yields of an appro-11 References priately substituted product of undefined stereochemistry.2 However reduction of (8) produced the optically active 8a- epimer of desacetoxy-slaframine (9) of potential value for studies on structure-activity relationships.1 Slaframine Cholinergic regulation by slaframine a parasympathomimetic The synthesis of the naturally occurring (-)-enantiomer of agent continues to find veterinary applications.In cattle the slaframine (1) by Pearson and Bergmeierl (Scheme 1) is alkaloid increased the rate of fluid flow from the rumen by important for two reasons it is the first asymmetric synthesis prolonging the dilation of the reticulo-omasal orifice a finding of the alkaloid and it establishes the absolute stereochemistry that has dietary implications. Slaframine proved ineffective in as IS 6S 8aS in line with previous predictions based on the enhancing nutrient digestibility in goats and sheep fed high indirect Horeau method. The azido-aldehyde (2) prepared in 6 fibre diets.4 PH PH PH ii 91% 1:l N3 80% CbzN CbzN CbzN CbzN I I I I Bn Bn Bn Bn (2) (3) (4) (5) iiiii (X = OAc) iii-vi vii-ix 35% 45% 59% HX xi xii (X = H) 48?&from (7) bn (6) X = OAC (1) (-)-Slaframine (7) (9) X= H Reagents i HO(CH,),PPh,+Br- KN(SiMe,), THF 0 "C then Me,SiCl then add (2) -78 "C to 23 "C; ii rn-CPBA CH,Cl, 23 "C then separate (preparative HPLC); iii p-TsC1 py DMAP (cat.) -10 "C; iv H (1 atm) 10 YOPd-C EtOH 23 "C then K,CO, reflux; v Ac,O py 23 "C; vi H (I atm) 10% Pd-C EtOH 23 "C;vii c-C,H,Li Et,O -78 "C viii (COCl), DMSO NEt, CH,Cl, -78 "C to 25 "C; ix Ph,P THF 25 "C;x xylene cat.NH,CI 145 "C; xi NaBH,CN AcOH 0 "C to 25 "C; xii H (1 atm) 10% Pd-C AcOH 25 "C Scheme 1 51 NATURAL PRODUCT REPORTS 1993 H? LNH NH + + NH 37% ’Cbz ’Cbz ’Cbz 33% 14% (s)-(1 1 ) 44% 78%1 HO - vi iv 61% HO OTBDMS HO Ho H .CHO viii-x xi 50% (14) OH Reagents :i ButOOH D-( -)-diisopropyl tartrate Ti(0-Pr’) ;ii Hg(OCOCF,) THF ;iii methyl acrylate NaBH(OMe), CH,CI,; iv H, Pd(OH), MeOH; v LiAIH, THF; vi Ph,P (=NCO,Et), PhCO,H THF; vii immobilized Baker’s yeast; viii H,/Pd (BOC),O; ix But(Me),SiC1; X DIBAL; xi Ph,P(CH,),OH+ C1- 2 LiN(SiMe,),; xii H,/Pd; xiii MsCI NEt,; xiv 3M HCI Scheme 2 2 Hydroxylated I ndoI kidine Al kaloids A short review article describing the discovery and sources of polyhydroxylated indolizidine and related alkaloids also provides useful information on their effect on the immune response and in cancer treatment their ability to inhibit virus replication effects on digestive enzymes and insect antifeedant proper tie^.^ Another general review on amino-sugars as glycosidase inhibitors also contains much relevant material.6 2.1 Mono- and Dihydroxy-indohidines Two syntheses of ( +)-(1S,8aS)-1-hydroxyindolizidine (10) still unknown as a natural product but postulated as a biosynthetic precursor of slaframine are of interest.In the first,’ optical activity was ensured by an interesting use of the Sharpless asymmetric epoxidation on the racemic pentenylamine derivative (1 1) in which the desired material was not the epoxide but rather the (S)-enantiomer of the starting material left behind during the kinetic resolution. The rest of the sequence used an amidomercuration cyclization strategy previously employed by the authorss and outlined in last year’s report (cf.Reference 9a). As shown in Scheme 2 both (+)-(lo) and the naturally occurring 1-epimer (-)-(12) were accessible by this route.Enantioselectivity in the second synthesis was a consequence of the reduction of proline derivative (13) with immobilized Baker’s yeast ;the optically active hydroxyproline (14) was formed in better than 95 O/O enantiomeric excess.l0 The standard transformations shown in Scheme 2 gave the target compound ( +)-(10) in a good overall yield of 19 YObased on (13). Husson and his co-workers have mooted the possibility of using their ‘CN(R,S) method ’ for the asymmetric synthesis of polyhydroxyindolizidine alkaloids.l1 The chiral cyano-piperidine derivative (1 5) previously used by this group in the synthesis of alkylindolizidine alkaloids (cf. Reference 12a) has now been used in making the chiral indolizidinediol (16) and applications to related alkaloids and their analogues are likely to follow.2.2 Swainsonine and Related Compounds Unambiguous proton and carbon NMR assignments for swainsonine (1 7) and swainsonine triacetate have been p~b1ished.l~ The Ehrlich spray reagent has been found useful for the thin-layer chromatographic detection of low levels of polyhydroxy indolizidine alkaloids and has led to the identification of swainsonine and its N-oxide in a number of hitherto uninvestigated Astragalus and Oxytropis species including some previously incriminated as ‘locoweeds ’ on the basis of their effects on range animals feeding on the plants.I4 A sensitive high-performance ion-exchange chromatographic method involving alkaloid detection by pulsed amperometry has been developed for the analysis of hydroxylated alkaloids including swainsonine and castanospermine.l5 The well-explored strategy of cationic cyclization via acyliminium ions has been given a new twist by Miller and Chamberlin who have used enantiomerically pure hydroxylated acyliminium ions as precursors for poly-hydroxylated indolizidine alkaloids.l6 Key steps in their synthesis of (-)-swainsonine (17) (Scheme 3) included con- version of the o-(-)-lyxose derivative (18) to the important ketene dithioacetal (19) followed by ring closure of the corresponding mesylate to (20). Because this compound had the wrong bridgehead stereochemistry it was converted into the vinylogous urethane (21) the plan being to reduce the 8,8a double bond from the less hindered convex face.However competitive scission of the allylic carbon-oxygen bond proved troublesome on attempted hydrogenation. When the lactam group of (2 1) was reduced first a fortuitous over-reduction NATURAL PRODUCT REPORTS 1993-5. P. MICHAEL a 51% 63% HO 0 0 0 (18) (19) (20) vii viii xv xi-xiv 0 ix x a -HO N 95% N 34% 86% (17) (-)-Swainsonine (22) 0 (211 Reagents i I-methoxycyclohexene BF .Et,O THF r.t. ; ii Ag,CO,-celite C,H, reflux; iii 2-(4-aminobutylidene)- 1,3-dithiane MeOH r.t. ; iv Pb(OAc), MeCN 0 "C; v MsC1 NEt, CH,Cl, 0 "C to r.t.; vi MeCN r.t.; vii NBS EtOH MeCN r.t. ; viii DBU THF reflux; ix Et,O' BF,- CH,Cl, 0 "C to r.t. ; x NaBH,CN MeOH 0 "C to r.t.; xi LDA THF O, -78 "C to r.t. ; xii LiAlH, THF 0 "C to r.t. ; xiii NaIO, H,O-MeOH; xiv Na NH, then H,O-THF; xv 6M HCI Scheme 3 ~ v viii 0 HO HO 85% (17) (-)-Swainsonine (25) Reagents i KN(SiMe,), Cl(CH,),PPh,+ Br- THF 0 "C then add (26) -78 "C to 23 "C; ii (PhO),P(O)N, PPh, (=NCO,Et), THF 23 "C; iii C,H, reflux; iv NaBH, MeOH 0 "C; v 6M HCl THF 23 "C; vi Bu'NH, then KN(SiMe,),; vii BH;THF 23 "C then NaOAc H,O, MeOH 23 "C; viii IRA-400 ion exchange resin Scheme 4 gave the advanced intermediate (22) with the correct stereochemistry at C-8a. After numerous attempts to find suitable conditions for the stereochemically selective oxidative replacement of the ester group the synthesis was completed as shown in the Scheme. The overall yield of (-)-swainsonine (17) was 3.8 YObased on D-( -)-lyxose.A short very efficient synthesis of (-)-swainsonine by Pearson and Lin exploited a string of sequential reactions (intramolecular 1,3-dipolar azide cycloaddition followed by rearrangement and alkylation) for the construction of the indolizidine nucleus from focal intermediate (23) (Scheme 4).17 The bicyclic iminium ion (24) could be intercepted in two ways either by reduction to give the dihydroxyindolizidine (25) which is effectively the 2,8a epimer of the recently reported18 alkaloid lentiginosine ; or by deprotonation followed by hydroboration/oxidation to give ( -)-swainsonine (1 7). The overall yield of the alkaloid was an impressive 39% based on the protected D-erythrose derivative (26).The method appears HO8 promising as a potentially general route to alkaloids with 1-azabicyclo[m.n.O]alkane skeletons. Other workers have performed an asymmetric allylation on (26) in order to make polyhydroxylated pyrrolizidines and this method also seems to hold promise for extension to hydroxylated indolizidines. l9 Syntheses of ( -)-swainsonine (17) and ( -)-8-epi-swainsonine (27) from (S)-and (R)-glutamic acid derivatives by Ikota and Hanaki previously reported in a communication20 (cf. Reference 9b),have now been published in Extensions NATURAL PRODUCT REPORTS 1993 PHO OH OH & RO RO RO "Bn "Bn \ "Bn \ (33) ii 100% 7:2 or iv-viii iii,95% 1:3 35% 1 T CO2Et NHBOC NHBOC (31) (+)-Castanospermine H' (34) (35) Reagents i LDA EtOAc THF -78 "C; ii H (45-50 psi) PtO, EtOAc; iii NaBH, EtOH 0 "C; iv HCO,H CH,Cl, 0-5 "C to 25 "C; v Dowex 1x2 (OH-) resin H,O; vi LiAlH, THF reflux; vii CF,CO,H 25 "C; viii H (50 psi) 5 % Pt-C H,O Scheme 5 include alternative enantioselective preparations of the key pyrrolidine-2-carboxaldehydes (28 R = benzyl or isopropylidene) and further investigations of the diastereo- selective allylation of (28) to give adducts (29) and (30).The intermediates were converted into the desired compounds by hydroboration cyclization and deprotection. The effects of swainsonine-inhibited glycoprotein processing on metastasis of various transfected murine cell lines,22 proliferation of human lymphocyte^,^^ and antibody effector function24 have been studied.Swainsonine does not inhibit HIV-1 reverse tran~criptase,~~ nor does it suppress the cytoadherence of erythrocytes infected with Plasmodium falciparum (the causative agent of cerebral malaria) to target host cells.26 The alkaloid stimulates proliferation and colony- forming activity of murine bone marrow a finding with possible implications for treatment of patients undergoing bone marrow transplantation or intensive chemoradio-the rap^.^' Furthermore a report describing swainsonine's ability to stimulate protein kinase C activity in murine peritoneal macrophages provides the first demonstration of the alkaloid's effect on a second messenger system known to be involved in tumour promotion and macrophage activation.'* Dosing of calves with swainsonine reproduces the effects of 'high mountain disease ' a congestive right-heart failure occurring in cattle grazing on certain locoweeds at high elevation.*' Behavioural and electrophysiological investigations have shown that swainsonine is a potent antifeedant towards larvae of the lepidopteran Spodoptera littoralis though it is unclear whether the alkaloid blocks the pyranose or the furanose receptor sites in the insect's taste ~ensilla.~~ 2.3 Castanospermine and Related Compounds As usual the chemistry of castanospermine (31) is dominated by reports of its synthesis.A short (10 step) efficient (13% overall yield) and highly stereoselective synthesis of (+)-castanospermine commences with the available glucuro-nolactone (32) which already includes four of the target alkaloid's five stereogenic centres with the correct c~nfiguration.~~ The fifth centre was introduced by stereoselective reduction of the disguised ketone group of hemiacetal (33).Catalytic hydrogenation of (33) gave a quantitative yield of the desired alcohol (34) and its diastereomer (35) in the ratio 7 :2 nicely complementing reduction with sodium borohydride which proceeded with the opposite diastereoselectivity (I :3). These easily separated products were converted into (+)-castanospermine (3 1) and (-)-I-epi-castanospermine (36) respectively by the simple transformations shown in Scheme 5 for the former product. The synthetic route has been patented.32 The manno azide (37) easily prepared from the readily available glucono-d-lactone (38) was the chiral educt used in complementary syntheses of ( +)-castanospermine (3 1) and (+)-6-epi-castanospermine (39) by Gerspacher and Rapoport (Scheme 6).33 Exploiting methodology based on 9-phenylfluoren-9-yl as a protecting group for nitrogen in configurationally stable a-amino carbonyl compounds the authors converted (37) in eight steps into the protected pyrrolidin-3-one (40).This versatile intermediate contains four of the five stereocentres of (+)-6-epi-castanospermine (39); also once inversion of configuration was accomplished at the site destined to become C-6 (40) served as an intermediate for ( +)-castanospermine as well. Syntheses were completed as shown in Scheme 6.The chief point of interest in another new synthesis of ( +)-castanospermine is the use of biocatalytic methodology to introduce the correct absolute configurations at C-1 and C-8a at an early stage (Scheme 7).34 The yeast Dipodascus sp. induced asymmetric reduction of the keto group of (41) giving the (+)-(2R,3S) alcohol (42) in greater than 99% optical yield. Alternatively a number of microbial lipases (especially Pseudomonas sp. (AK) and Candida cylindracea) preferentially NATURAL PRODUCT REPORTS 1993-5. P. MICHAEL 55 Ho\ I Pf = (37) J.steps CF3S0,0 AcO 0 0 v vii-x i ii iii,iv pz-70% from (40) bf OH OH 0 OH AcO 0 OH (39) (+)-6-epi -Castanosperm ine c- N 85% 60% HO.' (31) (+)-Castanospermine Reagents i Ac,O pyridine 0 "C; ii (CF,SO,),O pyridine CH,CI, -15 "C; iii Bu,N+ OAc- MeCN 40 "C; iv Ac,O DMAP pyridine r,t.; v NaBH, EtOH 0 "C; vi K,CO, MeOH 0 "C; vii N-tosylimidazolide/CF,SO,Me THF 0 "C then N-methylimidazole THF 0 "C; viii H (1 atm) 10YOPd-C NaOAc MeOH ; ix CF,CO,H dioxane-H,O r.t.;x Dowex 50W-X8 Scheme 6 OTBDMS TMSo OTBDMS Me02C iiiv Me02C 91% ___t TMso65 BOC' BOC' 75% I J.ook vi-viii OAc OAC OH xii Me02C~ Ma2C-.i9 TMs? OTBDMS BOC' BOC' BOC' + TMsoa rac-(43) (2R,3S)-(43) (2 S,3 R )-(44) (45) ix,x 24% + 32?k+ 15"/0 I sa O T MTMSoo OTBDMS TMso&TMS? OTBDMS H TMSo OTBDMS ~ xi -90% H S HO*' HO HO'= O (31) (46) (47) (48) Reagents i Dipoduscus sp. Vogel medium; ii TBDMS-C1 imidazole CH,CI, 24 "C; iii 20% CF,CO,H in CH,Cl,; iv NEt, H,C=CHCO,Me EtOH; v Na Me,SiCI toluene reflux; vi NaOAc HOAc 24 "C; vii DBU CH,CI, 24 "C; viii Me,SiCl Li(NSiMe,), THF -78 "C; ix BH,*Me,S THF -78 "C to 25 "C; x Me,NO toluene reflux; xi Bu,NF THF 0 "C to 25 "C; xii lipases (see text) Scheme 7 catalysed hydrolysis of the 3R-acetoxy group of racemic conventional chemical transformations though a poorly acetate (43) giving the (2S,3R) isomer of alcohol (44) in greater diastereoselective hydroboration of silyl enol ether (45) led to a than 99 Oh enantiomeric excess but leaving the acetate of separable mixture of silylated hydroxyindolizidines (46) (47) (2R,3S)-(43) untouched.The synthesis was completed by more and (48). Desilylation of these with fluoride ion yielded (+)- NATURAL PRODUCT REPORTS 1993 1 n n n BnO 'vS BnO I I J+ (50) 1:l (511 iv v viii vii 23% J B- n OBrio VOH HOW oH~OH vi vii 55% HHO'.' O S BnO'-* HO'** (31) (+)-Ca stanos permi 0ne (52) Reagents :i 2-(3-aminopropylidene)- 1,3-dithiane7 MeOH r.t.;ii Pb(OAc), MeCN then AcOH ;iii MsC1 NEt, CH,Cl, 0 "C to r.t. ;iv lo (from 0,,400-W sodium lamp) CC1,-MeOH rose bengal; v L-selectride THF -78 "C to r.t.; vi BH;DMS THF 0 "C to reflux; vii H (50 psi) 10% Pd-C MeOH-HCl r.t.; viii LiAlH, THF reflux Scheme 8 castanospermine (3 l) (+)-6,7-di-epi-castanospermine7and (+)-6-deoxycastanospermine respectively. Variations on two of the swainsonine syntheses described in section 2.2 have been devised or envisaged for castanospermine.In the acyliminium ion route of Miller and Chamberlin (Scheme 8),16 cyclization of (49) produced a separable mixture (1 I) of bridgehead epimers (50) and (51). The 8a-a-H isomer (50) was converted as shown into (+)-castanospermine (3 I) while the 8a-p-H isomer (51) could be taken by the same sequence to (+)-178a-di-epi-castanospermine (52). A projected synthesis by Pearson and co-workers is planned to incorporate a key intramolecular cycloaddition of azide to an electron-rich diene as shown by the conversion of (53) into (54) which occurred in 55% yield on heating in DMSO at 75 0C.35 A review36 by Vogel on the synthesis of biomolecules from furan-derived precursors contains details of a synthesis of (+)-castanospermine from the optically active (-)-7-oxabicyclo[2.2.l]hept-5-en-2-one (55).The route is essentially the same as that described in his previous synthesis3' of the ($)-alkaloid (cf. Reference 9c). A similar strategy also underlies recent syntheses of (+)-6-deoxycastanospermine(56) and (+)-6-deoxy-6-fluorocastanospermine (57) from the same The full paper describing all these results was also published during the review period.39 The past year has seen frenetic activity relating to the synthesis of castanospermine analogues mainly for biological testing. Fleet's syntheses of (+)-6-epi-castanospermine (39) and (-)-1,6-di-epi-castanospermine (58) from D-gulonolactone and of their enantiomers from L-gulonolactone previously reported as communications (cf. Reference 9d)have now been published will full experimental details.,O Richardson has prepared two further castanospermine analogues (-)-1-deoxy-6-epi-castanospermine (59) and (+)-I -deoxy-6,8a-di-epi-castanospermine (60) from a p-D-fructopyranoside deriva- ti~e.~~ In an attempt to identify the structural basis for inhibition of human glycosidases by castanospermine and its analogues the relative potencies of no fewer than seven castanospermine and deoxycastanospermine epimers prepared by both the Fleet and Richardson groups have been evaluated.42 The chief structural features affecting the specificity of inhibition were the number and configuration of the OH substituents on the piperidine ring the presence or absence of OH at C-1 in the pyrrolidine ring and the configuration at the bridgehead 0 (55) (56)X = H (57)X = F (64)X = NHCOMe carbon atom C-8a.Thus alteration at any of the alkaloid's five stereogenic centres markedly decreased inhibition of a-and p-D-glucosidases. ( +)-6-epi-Castanospermine and its 1-deoxy analogue both of which have the same relative configuration as a-D-mannopyranose were good inhibitors of various a-mannosidases while ( +)-1-deoxy-6,8a-di-epi-castanospermine (60) which closely resembles a-L-fucopyranose was a potent inhibitor of a-fucosidase. Castanospermine analogues prepared by other groups of workers include (-)-(6R77S,8R,8aS)-6,7,8-indolizidinetriol (6 l) which inhibits a-fucosidase ;43 0-benzyl derivatives of 1 -deoxycastanospermine and 1-deoxy-8a-epi-castanospermine (62) and (63) made from piperidine-2- NATURAL PRODUCT REPORTS 1993-5.P. MICHAEL Ho& H OH? H m BnO H HO HO BnO‘** (58) 8aa-H X=OH (62) 8aa-H (59)8aa-H X = H (63) 8aP-H (60) 8aP-H X= H iii iv 75% H’OyPr U U H (66) (+)-monomorineI (70) (71) Reagents :i 2,5-dimethoxytetrahydrofuran,NaOAc HOAc reflux; ii PrCOCl N-methylmorpholine Et,O r.t. then AlC1,; iii Me,CHCH,OCOCl N-methylmorpholine Et,O r.t.; iv CH,N, Et,O 0 “C to 25 “C; v AgOAc THF-H,O 25 “C; vi Rh,(OAc), CH,Cl, r.t.; vii H (10 bar) 10% Pd-C 6N HCI AcOH Scheme 9 propanols derived from D-glucose ;44 and the 6-acetamido analogue (64) of castanospermine which was prepared from the alkaloid itself and which has proved to be a very potent inhibitor of P-N-acetylglucosaminidases from a variety of sources.45 Castanospermine’s ability to inhibit lysosomal a-glucosidases has been related quantitatively to the accumulation of lysosomal glycogen in rat liver.46 Its ability to inhibit seminal a-glucosidase may be useful in assessing human epididymal f~nction.~’ The alkaloid’s effect on the alteration of membrane oligosaccharides resulted in the increased production of immunoglobin in human lymphocyte cultures4s and reduced metastasis in certain murine fibroblast cell lines.22 In a study of the inhibition of glycoprotein processing replication of human immunodeficiency virus (HIV) and replication of Moloney murine leukaemia virus by castanospermine and its esters the most potent compound was the 6-0-butanoyl ester of the alka10id.l~ Castanospermine did not reduce serum and spleen virus titres in mice affected with the Rauscher murine leukaemia virus though it did inhibit ~plenomegaly.~~ Other workers found that castanospermine and 6-0-butanoylcastanospermine had comparable relative toxicities and antiviral activities towards Rauscher murine leukaemia virus in vivo perhaps because both undergo conversion into the same active compound;51 both compounds were less active and more toxic than the commonly used 3’-azido-3’-deoxythymidine(AZT).Both compounds also disrupted the cytoadherence of Plas- modium faleiparum-infected erythrocytes to human C32 melanoma cells the ester again being the more active agent.26 Castanospermine induced an anaphylactoid response in rats raising the possibility that apparent food allergies might be produced by the ingestion of other plant alkaloids with similar proper tie^.^ Behavioural and electrophysiological studies have shown that castanospermine is a potent antifeedant towards the larvae of a number of lepidopterans especially Spodoptera littoralis and Heliothis vireseens apparently because it blocks the pyranose receptor site in the taste sen~illa.~O 3 Monomorium Alkaloids Jefford et al.used L-alanine (65) as the chiral foundation of a short synthesis of (+)-monomorine I (66) (Scheme 9)53that parallels their previously published synthesis of the racemic alkaloid (ef. Reference 9e). The key step decomposition of diazoketone (67) in the presence of rhodium(I1) acetate gave the desired bicyclic product (68) along with the unexpected carbene insertion-rearrangement product (69).Catalytic hydrogenation of the former yielded (+)-monomorine I (66) accompanied by the alcohols (70) and (71) which can in principle be defunctionalized to the desired product by way of the thiocarbonylimidazole derivatives as was shown in the earlier report. Momose’s route to the same optically active NATURAL PRODUCT REPORTS 1993 n Me-NwN-AH /-NH Ph (74) But OTMS ii iii d3-Me02CCH,GoH i 89% N F I I Cbz Cbz Cbz (73) 59% from (72) J *H&=CH(CH& aEt wEt -ix-xi H2C=CH(CH2)3&oMoM MeCO(CH2)3 .. I I I Cbz Cbz Cbz I xiii 70% I H (66) (+)-monomorine I Reagents i (74) Bu"Li TMS-CI HMPA -100 "C; ii 0, CH,Cl,-MeOH (10 11 -78 "C then NaBH,; iii CH,N,; iv MOM-C1 PriNEt; v super-hydride THF 0 "C to r.t.; vi TsCl pyridine; vii NaI acetone; viii H,C=CHCH,MgCl Cul THF -78 "C to -36 "C; ix conc.HC1 MeOH; x (COCl), DMSO NEt, -78 "C; xi CH,CH,CH=PPh, 0 "C to r.t.; xii 0, PdCl, CuCl; xiii H, 5% Pd-C MeOH Scheme 10 O0n Bn. Bn. CHCO,Me i N-0 ii-v 64% ,-&(CH2)3Me L ..N&(CH,),Me BnHN=O-+ 4(CH2),Me Me0,C' A H,C=CH(CH,); H' (75) (76) OBn OBn + 3,5-di-epi-isomer(3:l) vi-viii 73% OMS J H Cbz ix-xi N BnOCbz 40% MeCO(CH,) &(CH2)3Me OBn (66) (+)-monomorineI Reagents i toluene reflux; ii LiAlH, Et,O iii TsCl DMAP PriNEt CH,Cl,; iv NaI MeCOEt 75 "C; v H,C=CH (CH,),MgBr (2-thienyi)Cu(CN)Li THF -78 "C to r.t.; vi Zn AcOH-H,O-THF 60 "C; vii PhCH,OCOCl aq.Na,CO,; viii 0, PdCl, CuCl, DMF-H,O 80 "C; ix H, 10% Pd-C MeOH then H, 10% Pd-C 10% HCl-MeOH; x PhCH,Br Na,CO, DMF 70 "C; xi MsCl NEt, CH,Cl, -20 "C; xii H, 10% Pd-C MeOH-dioxane; xiii NEt, CH,Cl, reflux; xiv H, 10% Pd-C NEt, MeOH Scheme 11 alkaloid (Scheme is conceptually quite different using as a-iodoester (78). This cyclization produced a mixture of two key step the cleavage of the optically active silyl enol ether (72) indolizidines;the undesired epimer (79) could be isomerized to which was produced by asymmetric kinetic deprotonation of 8-(80) by iodination a to the ester followed by reduction of the azabicyclo[3.2.l]octan-3-one(73) in the presence of chiral iminium salt produced therefrom.The overall yield for this auxiliary (74). Kibayashi who has previously published a short sequence was 29% based on (77). synthesis of (+)-monomorine I (cf. Reference 9f) has now devised a second enantioselective synthesis (Scheme 1 1)55 that commences with the diastereoselective cycloaddition of nitrone 4 lndolizidine Alkaloids from Amphibians (75) to optically pure allylic ether (76) itself prepared from The past year has seen a record number of enantioselective diethyl L-tartrate. syntheses of 'frog indolizidines '. The first total synthesis of Key steps in a short synthesis of racemic monomorine I enantiomerically pure (-)-indolizidine 239CD shown in (Scheme 12)56include ethanolysis of the a-nitrocyclohexanone Scheme 13 is important because it confirms the gross structure A sequence of (77) reductive cyclization of the product to a 2,5-cis-and absolute stereochemistry of the alkal~id.~' disubstituted pyrrolidine and further cyclization by way of the stereospecific transformations from the optically active NATURAL PRODUCT REPORTS 1993-5.P. MICHAEL 59 H H Reagents i EtONa EtOH 0 "C; ii H (8-12 atm) 10% Pd-C EtOH then HCl; iii BOC-ON NEt, THF 20 "C; iv lithium cyclohexylisopropylamide THF -78 "C to 20 "C then I, THF -78 "C;v CF,CO,H 0 "C then NEt, THF; vi AcOH (pH ca. 4) NaBH,CN MeOH; vii LiAlH, THF; viii SOCl, reflux; ix Bu,SnH AIBN toluene reflux Scheme 12 OSiButMe2 iii-u -PhC02(CH2)4fl--(CH2)40Bn 0s.. I i ii (CH2)40Bn -PhC02(CH2)4 I 66% from (81) o.s/o I (81) OSi ButMe2 d"b (82) vi vii I %"/o (1:1) N3 ?" 71% PhC02(CH2) (CH2)40 Bn + phC02(c H2) 4y PhC02(CH2)4--a(CH2)40Bn viii-x (cH2)40Bn I C02Bn OH N3 (83) (84) (85) xi xii 71yo xiii xii xiv L f~% I I HCO(CH2J4-*-@(CH2),0Bn MeCH2CHOH(CH2)4--*(&(CH2)40Bn 77'10 -d? C02Bn C02Bn Me(CH2)i (CH2)40H (86) (-)-lndolizidine 239CD Reagents i Ref.58; ii PhCOCl DMAP CH,Cl,; iii Bu,NF THF; iv SOCl, Et,N CH,Cl, 0 "C; v RuCl;xH,O NaIO, CC1,-MeCN-H,O; vi LiN, DMF; vii aq. H,SO, THF r.t.; viii MsC1 Et,N CH,Cl, 0 "C; ix H, Pd-C MeOH; x PhCH,OCOCl 10% aq. K,CO, CH,Cl, 0 "C; xi 1YOKOH-MeOH r.t.; xii PDC CH,Cl,; xiii PrMgBr THF 0 "C;xiv H, Pd-C MeOH then H, Pd-C 2 % HCl-MeOH Scheme 13 diepoxide (81) via the cyclic sulfate (82) led to an inseparable structural simplicity.Mass spectrometry has generally pro- mixture of azide regioisomers (83) and (84) both of which gave vided the only evidence for their structure. Enantioselective the same trans-2,5-disubstituted pyrrolidine (85) after reduction total of both diastereoisomers of the putative and cyclization. From this the target alkaloid (86) was reached indolizidine alkaloids (-)-167B (87)/(88) and (-)-209D by conventional reactions in 20.7 YOoverall yield. Spectroscopic (89)/(90) shown in Scheme 14 have not cast any light on the data and the observed optical rotation agreed well with those problem since the mass spectra of the synthetic diastereomers reported for the natural product. were essentially identical. However the new work has led to Several indolizidine alkaloids occur in such minute quantities thorough characterization of all compounds a variety of NMR in the skins of neotropical frogs that there is still uncertainty techniques providing unambiguous evidence for the relative about their relative and absolute configurations despite their stereochemistry of the 5-alkyl and 8a-H substituents.Another NATURAL PRODUCT REPORTS 1993 i ii iii iv-vi ___F 89% 90% 58% OMe OQ '"AH 0 (5S):(5R) = 82~18 vii viii 93% ix 77% (R = C3H7) OPO(0Et)2 R 78% (R= C6H13) CN ci3 cs 84% (R = C3H7) 60% (1:l) 85% (R= C6H13) R = C3H7 1' CN XI 81% (R = C3H7) @ 87% (R = C6H13) d CN (88) R=C3H7 (go) R = C6H13 Reagents i LiBHEt, THF,-78 "C; ii H,C=CHCH,SiMe, SnCl, CH,Cl, -22 "C; iii LiAlH, THF reflux; iv Cp,ZrClH C,H, r.t.then CO (1 atm) then Na salt of EDTA; v excess (MeO),CH PPTS MeOH reflux; vi medium pressure LC separation; vii NH,+HCO,- 10% Pd-C MeOH 25 "C; viii KCN HCl-H,O CH,Cl, 25 "C; ix RMgBr Et,O 25 "C; x LDA THF -78 "C to 0 "C then RBr -78 "C to 0 "C; xi NaBH, EtOH 25 "C; xii K 18-crown-6 THF 20 "C Scheme 14 iv iii I%% lvi lvi Reagents i (R)-( -)-phenylglycinol Bu"OH reflux; ii Na,S,O, K,CO, H,O-Et,O 40 "C; iii filtration over alumina; iv n-C,H,,MgBr Et,O -78 "C ;v BrMgCH,CH,CH(OCH,CH,O) THF then chromatography on SO,; vi H,/catalyst H+ Scheme 15 NATURAL PRODUCT REPORTS 1993-5. P. MICHAEL 6-> (106) (1 04) lndolizidine205A (1 05) lndolizidine207A (1 07) lndolizidine2358 (108) lndolizidine2358' i,ii 40% ___t iii iv 93% ___t v vi 76% ___F 0w PhA Ph Ph (1 11) I Ivii 9570 H9C4 -HCI (1 12) I (1 15) (+)-Purniliotoxin251D (1 13) 3 isomers (€)-(114) 2*6:1 Reagents i 1 YOPdCl, CuCl, CO MeOH; ii separate diastereomers; iii DIBAL THF -78 "C to r.t.; iv (EtO),CMe Me,CCO,H (cat.) reflux; v NaOH MeOH reflux; vi Ac,O reflux; vii Hg(OAc), H,O THF r.t.then NaBH, aq. NaOH; viii LDA THF -78 "C then (R)-2-methylhexanal; ix DCC CuC1 toluene reflux; x MsC1 pyridine r.t. then KOH MeOH reflux; xi LiAlH,/AlCl (3 l) Et,O r.t.; xii HCl MeOH Scheme 16 new synthesis of both diastereomers of (-I-)-indolizidine 167B (*)-(87) and (-t)-(88) also shown in the Scheme has as key step the in situ formation of an a-aminomethyl carbanion by dissolving-metal cleavage of a-aminonitrile (9 I) followed by unselective cyclization.60 (-)-Indolizidine 167B formulated as (88) has been prepared by Jefford and co-workers from D-norvaline as chiral educt in 15% overall yield following essentially the same procedure (pyrrole formation Arndt- Eistert homologation diazoketone decomposition hydrogen- ation) as was shown in Scheme 9 for (+)-monomorine I (66).53 An asymmetric synthesis of (+)-indolizidine 209B proceeds by way of oxazolidines (Scheme 15).61 When heated with (R)-(-)-phenylglycinol the Zincke salt (92) produced pyrid- inium salt (93) that was reduced to 1,4-dihydropyridine (94) with sodium dithionite.On filtration over alumina this compound isomerized to a 9 :1 mixture of oxazolidines (95) and (96).Since these compounds are effectively masked iminium ions treatment of the mixture with n-pentylmagnesium bromide cleaved the heterocyclic ring replacing oxygen at C-2 with the alkyl group. Spontaneous recyclization of the products gave two further oxazolidines (97) and (98) (3 l) which were also cleaved stereoselectively with a Grignard reagent. The resulting mixture of piperidines (99) (1 00) and (101) (5 :2 :3) was separated by flash chromatography the only separation step necessary in the sequence. Further elaboration of (99) gave (+)-indolizidine 209B (+)-(102) in an overall yield of 8-10 YO. Similar treatment of (100) yielded (-)-indolizidine 209B while the diastereomer (103) was obtained from (101). Syntheses of (f)-indolizidines 167B (_+)-(88) 205A (104) 207A (105) and (-)-.indolizidine 209B (-)-(102) by Holmes and co-workers previously reported in a communication (cf.Reference 9g) have now been published in The basic synthetic approach in which the key step is the intramolecular dipolar cycloaddition of (2)-N-alkenylnitrones (106) has also been extended to (+)-indolizidines 235B (107) and 235B' (108).63 Enantioselective access to alkaloids of the pumiliotoxin class by means of palladium-mediated cyclization of the enantiomerically pure allenic amine (109) has been achieved by Gallagher and co-workers (Scheme 1 6).64 Diastereoselectivity in this cyclization-carbomethoxylation was negligible but the pure isomer (1 10) could be separated on a multi-gram scale.The chiral a-methylbenzylic residue thus acted as a resolving agent rather than as a chiral auxiliary. The important lactam intermediate (111) was hydrated to give the axial alcohol epimer of (1 12) in a selectivity of better than 10 1. Subsequent aldol condensation gave a mixture of three isomers of (1 13). One of these separated in 27% yield was subjected to syn elimination and gave the (Z)-enone (1 14) exclusively. The remaining two inseparable isomers of (1 13) under conditions of anti elimination gave a 73% yield of the (E) and (2) isomers of (I 14) in the ratio 2.6 1. X-Ray crystallographic analysis of the (E) isomer served to establish absolute and relative configurations. The synthesis was completed as shown in the scheme and afforded the hydrochloride salt of (+)-pumiliotoxin 251D (1 15) in nine steps and 6.3 YOoverall yield based on (109).A highly diastereoselective Lewis acid-mediated intramol- ecular ene reaction of an optically pure substrate derived from L-proline has yielded a methylene-substituted indolizidin-8-01 (1 16) reminiscent of the pumiliotoxin class of alkaloid^.^^ Pearson's azido-diene cycloaddition strategy for the synthesis of the tricyclic gephyrotoxin skeleton previously reported in a communication (cf. Reference 9h) has been elaborated in a full paper.35 NATURAL PRODUCT REPORTS 1993 0 0 v. vi 27% (OH viii-x 38% 0 (1 17) Elaeokanine A (119) Reagents:i Na EtOH then acrolein 30 "C ii trimethyl phosphonoacetate NaH THF -10 "C to r.t.;,iii NaBH, MeOH 0 "C; iv MeOH H+; v SnCl, (CH,Cl), 0 "C to 70 "C; vi DBU THF 60 "C; vii DIBAL THF 0 "C to r.t.; viii Swern oxidation; ix Pr"MgBr Et,O THF -10 "C; x PCC NaOAc CH,CI, r.t. Scheme 17 H Me0 (120) Juliflorine (121) Antofine 5 Elaeocarpus Alkaloids A short synthesis of (+)-elaeokanine A (1 17) by Taber and co- workers66 (Scheme 17) employed an acyliminium ion cyclization as exemplified by the conversion of (1 18) into (1 19). Though the overall yield of the alkaloid from succinimide was a modest 2.3% the procedure is simple enough for the preparation of gram quantities of the useful intermediate (1 19). 6 Juliflorine This alkaloid (120) isolated as the dihydrochloride from Prosopis julgora has antibacterial and antidermatophytic activity.Its dose-dependent toxicity in various animals and in a tissue culture system has now been determined and implications for its therapeutic use have been discussed. 67 7 Phenanthroindolizidine Alkaloids and Seco Analogues Bioactivity-guided fractionation of methanolic extracts of the leaves of Ficus septica a small tree from coastal provinces of Papua New Guinea traditionally used in the treatment of various disorders has led to the isolation of partially racemized antofine (121) and the interesting new indolizinium alkaloid ficuseptine (122).68 Electron-impact and FAB mass spectrometry UV and 1R spectroscopies and extremely comprehensive NM R spectroscopic experiments provided evidence for the unusual structure of ficuseptine the sub- stitution pattern of which is quite unlike that of the phenanthroindolizidines and seco-phenanthroindolizidines Me0 CI- MeO Me0 OM8 (122) Ficuseptine (123) (R)-(-)-Tylophorine previously isolated from this plant.MS and chemical evidence was adduced for chloride as the counter-ion. The biogenesis of this new type of indolizidine alkaloid is conceivably from ornithine and two p-hydroxyphenylpyruvate units. Both ficuseptine and antofine showed significant antifungal and an ti bacterial activities. Alternative syntheses of (R)-(-)-tylophorine (123) by intramolecular double Michael reaction previously reported in two communications (cf. Reference 99 have now been published with full experimental details.6g 8 Nuphar Alkaloids Ionization of sulfur-containing Nuphar alkaloids on electron impact leads to the formation of easily detectable doubly charged ions.As demonstrated in an ingenious study of the doubly charged molecular and fragment ions of thiobi-nupharidine (124) thionuphlutine B (129 and neothiobi- nupharidine (126) there is a relatively simple correlation between the kinetic energy released on fragmentation of these ions the charge separation and stereochemistry. 'O For each fragmentation process the kinetic energy (G)released deter- mined from the collisional activation mass-analysed ion kinetic cnergy (CA MIKE) spectrum was related to the distance R (in A) between the two charged centres in the transition state by the formula = e2/R.For the loss of fury1 ion from the doubly charged molecular ions where the charges were assumed to be localized on sulfur and a fury1 unit 3 values corrglated with charge separations of 6.5 A 7.4 A and 7.8 A for the three alkaloids respectively.Similarly the doubly charged NATURAL PRODUCT REPORTS 1993-5. P. MICHAEL n @ Me5 Me:Me "I Me Me . Me 00 (1 24) Thiobinupharidine (1 25) Thionuphlutine B (1 26) Neothiobinupharidine CO2Et CO2Et !H I a. "OCOPh OCOPh 0 0 0 0 (131) (132) llP-H R=COMe (135) R1 = OH R2 = H (133) lla-H R=H (136) R' = H R2 = OCO(CH2)4Me [M-C,H,,0]2+ ions having the putative localized structures acetylbaptifoline (132y but only the latter has received (127) also lose fury1 ion; 7;_ valup for this proces? translated additional exposure in the more accessible literatureg6 (cj into intercharge distances of 8.4 A 7.5 A and 9.6 A for (124) Reference 9j).13/3-Hydroxythermopsine (133) the structure of (125) and (126) respectively. The results are complementary which was deduced from one-and two-dimensional NMR and the distances are consistent with the structures of the spectra has been claimed as a new alkaloid from Thermopsis alkaloids. lice~tiana,'~but the structure given for it in Chemical Abstracts Quinolizidines (128) and (129) useful intermediates for the is identical to that of the known alkaloid argentamine. synthesis of Nuphar alkaloids have been prepared by reducing 12-Ethoxycarbonylcytisine (1 34) mentioned in last year's the quinolizinium salt precursor (130) itself made by Hantzch review as a putative new metabolite of Laburnum kvatereri (cf condensation of ethyl (5-benzoyloxy-2-pyridy1)acetateand the Reference 9k),has now been confirmed as a minor alkaloid of ethyl enol ether of 3-furoylacetaldehyde with sodium comparatively widespread occurrence in many different genera cyanoborohydride in ethanol-acetic acid.'l of the Leguminosae." Its spectroscopic characteristics have been recorded and its structure has been confirmed by synthesis from cytisine and ethyl chloroformate.The monotypic genus 9 Alkaloids of the Lupinine-Cytisine- Cytisophyllum containing the single species C. sessilifolium Sparteine-M at r ine-Orrnosia Group (previously classified as Cytisus sessilfolium) is clearly dis- A recent book contains chapters describing the teratogenicity tinguished from members of the genera Cjjtisus and The chemotaxonomic of rangeland Lupinus species and the implications for a birth Chamaecytisus by its alkaloid c~ntent.'~ defect known as 'crooked calf disease ';72 the teratogenic markers appear to be the dipiperidine alkaloid adenocarpine potential of the alkaloid anagyrine;73 and myopathy in cattle and several unusually hydroxylated lupanines amongst which caused by Thermopsis montana.'j Another short review also one new compound 7-hydroxylupanine (135) has been describes congenital effects of Lupinus species on cattle and the identified unambiguously on the basis of its NMR spectra.A potential hazard to the human population through ingested new but unidentified dihydroxylupanine was also present.The milk;7" while the problem of myopathy caused by various alkaloid content and pattern of Spartium junceum depend leguminaceous plants and their alkaloids has been investigated markedly upon the part of the plant investigated and on the in some depth.76 season of harvest but only to a minor extent on geographical origin.g2 Highest alkaloid concentrations with cytisine as the major component occurred in ripe seeds more complex 9.1. Occurrence and Detection alkaloid patterns characterizing leaves buds and twigs. New alkaloids belonging to this group and new sources of Seasonal variation was also marked ; N-methylcytisine known alkaloids are listed in Table 1.76-95 Claims concerning anagyrine and rhombifoline prominent in early spring two new alkaloids could not be checked owing to publication decreased in time while cytisine concentrations increased to a in obscure journals.Tetrahydrocytisine (1 3 1) has apparently maximum in summer. been isolated from Thermopsis chinensis along with 0-In view of the paucity of alkaloids previously reported from 5 NPR 10 NATURAL PRODUCT REPORTS 1993 Table 1 Isolation and detection of alkaloids of the lupinine<ytisine-sparteine-matrine-Orrnosia group Species Argyrocytisus battandieri Cytisophyllum sessilifolium Echinospartum horridum Genista lydia Genista sagittalis Genista tinctoria Laburnum anagyroides Laburnum alpinum Laburnocytisus adamii Lupinus albus Lupinus angustifolius Lupinus bicolor var.microphyllus Lupinus hirsutus Lupinus polyphyllus Lupinus subcarnosus Lupinus termis Lupinus texensis Maackia tashiroi Orthocarpus spp." (see text) Oxytropis glabra Petteria ramentacea Retama sphaerocarpa Sophora davidii Alkaloid 12-Ethoxycarbonylcytisine (I 34) 5,6-Dehydrolupanine 11,12-Dehydrosparteine *7-Hydroxylupanine (1 35) Isolupanine a-Isosparteine P-Isosparteine Lusitanine 12-Ethoxycarbonylcytisine 12-Ethoxycarbonylcytisine 12-Ethoxycarbonylcytisine 11-Allylcytisine Baptifoline 5,6-Dehydrolupanine a-Isolupanine Lupanine Rhombifoline Sparteine Tetrahydrorhombifoline I 2-Ethoxycarbonylcytisine 12-Ethoxycarbonylcytisine I2-Ethoxycarbonylcytisine Albine Anagyrine Ref.77 78 77 77 77 79 80 79 79 79 80 79 80 79 80 77 77 77 79 13-Cinnamoyloxylupanine (cis and trans) 5,6-Dehydrolupanine 11,12-Dehydrosparteine a-Isolupanine 17-Oxolupanine 17-Oxosparteine Tetrahydrorhombifoline * 13-Caproyloxylupanine (1 36) 81 N-Methy lcytisine 82 *(+)-(E)-(4-Acetoxycinnarnoyl)epilupinine (141) 83 *(-)-5,6-Dehydromultiflorine (152) Epilupinine acetate N-oxide (+)-(E)-(4-Hydroxycinnamoyl)epilupinine 84 ( +)-(Z)-(4-Hydroxycinnamoyl)epilupinine ( +)-(E)-(4-Hydroxy-3-methoxycinnamoyl)epilupinine (-)-Multiflorine (148) *(-)-Multiflorine N-oxide (15 1) 85 *( -)-(E)-(4-a-~-Rhamnosyloxycinnamoyl)epilupinine(137) 84 *( -)-(Z)-(4-a-~-Rhamnosyloxycinnamoyl)epilupin~ne (138) *(-)-13a-Tigloyloxymultiflorine (149) 83 Albine 79 a-Isolupanine N-Methylalbine Multiflorine 17-Oxosparteine Tetrahydrorhombifoline Anagyrine 86 5,6-Dehydrolupanine Lupanine Angusti foline 87 *(-)-5,6-Dehydromultiflorine (152) *( f)-Lupanine N-oxide (1 53) Multiflorine Anag yrine 86 5,6-Dehydrolupanine a-Isolupanine Lupanine (-)-Camoensidine (154) 88 *(-)-Camoensidine N-oxide (I 55) N-Methylcytisine 82 Tetrah ydrorhombi foline Thermopsine Anag yrine 89 Sparteine Thermopsine 12-Ethoxycarbonylcytisine 77 12-Ethoxycarbonylcytisine 77 Anagyrine 79 Aphylline Cytisine 5,6- Dehydrolupanine I3-Hydroxylupanine 5-2 NATURAL PRODUCT REPORTS.1993 0 HO OH &OR (139) R= H (1 (142)43)40) (137) €-isomer (138) Z-isomer (141) R = COMe (144) 0 Epilupinine R' = R2 = H (145) Virgilidone R' = CO-2-pyrroly1 R2 = OH R' = H R2= OCO-2-pyrrolyl R' = H R2= OH 0 (146) Sophorasine A R' (147) Sophorasine B R' = H R2 = OH (150) R=OH inconsiderable number of alkaloids not previously reported in the seven plant species studied have been detected amongst the 52 compounds screened by means of capillary GC and GC-MS.Not all of these alkaloids could be identified with certainty and it is probable that some will in time be shown to be new compounds. Secondly the aphids Macrosiphum albifrons (hosted by Lupinus albus L. angustifolius and L. polyphyllus) and Aphis genistae (hosted by Genista tinctoria Petteria ramentacea Sophora davidii and Spartium junceum) take up a remarkable number of the alkaloids which must presumably be transported in the phloem of the plants.The suggestion that the aphids exploit dietary alkaloids for their own defence was demonstrated for M. albifrons alkaloid-fed specimens of which proved lethal when fed in turn to aphid predators. In similar vein transfer of alkaloids from Genista monspessulana to larvae of the lepidopteran Uresiphita reversalis described last year (cf Reference 9k) has been investigated further with a view to exploring the localization of alkaloids in the insect and consequent feeding deterrency on predators. lol By contrast larvae of the moth species Syntomis mogadorensis and Creatonotos transiens excrete rather than sequester dietary quinolizidine alkaloids.lo2 9.2 Structural and Spectroscopic Studies Amongst several glycosidic derivatives of epilupinine isolated from the aerial parts of Lupinus hirsutus are the E and 2 isomers of (4'-a-~-rhamnosyloxycinnamoyl)epilupinine, (137) and (138);84both are claimed as new compounds but were in fact previously proposed as minor components of Lupinus co~entinii.''~The (-)-(E) isomer was characterized spectro-scopically and by hydrolysis to L-rhamnose the (9-p-coumaroyl ester of epilupinine (139) and (+)-epilupinine (140) itself.The structure of the (-)-cis isomer was assigned on spectroscopic grounds only and the compound may be an artefact. (+)-(E)-4'-Acetoxycinnamoylepilupinine (141) another new alkaloid found in young seedlingsof L.hirsutus was also characterized spectroscopically ;the trans configuration of the double bond was apparent from the large vicinal proton coupling constant of 15.9 Hz.~~ Mild acidic hydrolysis produced (E)-p-coumaroylepilupinine (139) and a small quantity of (+)-epilupinine. The new alkaloid could be regenerated by acetylation of (139). Hydroxylated epilupinines from the genus Virgilia mentioned in passing in an earlier publication (cf. Reference 9k) have now been identified conclusively for the first time.95 The new hydroxyepilupinine ester derivatives (142) and (143) (148) Multiflorine R = H (151) Multiflorine N-oxide = OH R2= H (149) R = (E)-OCOC(Me)=CHMe isolated from Virgilia divaricata and V.oroboides were characterized by proton and carbon NMR spectroscopy and mass spectrometry. The relative stereochemistries of the hydrogen atoms at C4,C-5 and C-6 were deduced from vicinal proton-proton coupling constants (34,,ca. 2 Hz and 3& ca. 10 Hz) to be gauche and trans respectively. Amongst other putative new bicyclic alkaloids in the extracts of these species the parent diol (144) was tentatively identified by mass spectrometry only. Virgilidone (149 the only new tricyclic alkaloid unambiguously identified in this study was likewise characterized with the aid of two-dimensional NMR experiments in which long-range effects were diagnostically important. Two new diastereomeric alkaloids of the cytisine class (-)-sophorasines A and B,(146) and (147) have been isolated from the leaves of Sophora grifithii and characterized by spec-troscopic techniques amongst which the HOHAHA NMR method was especially useful for determining long-range connecti~ities.~~ The stereochemistries of the hydroxy groups at C-16 in the two compounds were established as S and R respectively by means of the Horeau method.New tetracyclic alkaloids of the sparteine class include derivatives of multiflorine (148) from Lupinus species. Young seedlingsof L.hirsutuscontained (-)-13a-tigloyloxymultiflorine (149) the spectroscopic characterization of which included NOESY evidence for the (E)-geometry of the ester residue.83 Comparison of the hydrolysed product (150) with authentic (-)-1331-hydroxymultiflorine -not itself an alkaloid of L.hirsutus -provided further confirmation of the structure. (-)-Multiflorine N-oxide another constituent of L. hirsutus seedlings was also characterized by spectroscopic methods that included circular dichroism studies for the assignment of the absolute configuration shown in (151). The alkaloid could be reduced to (-)-multiflorine (148) with sulfur dioxide and regenerated from (148) by oxidation with m-chloroperoxy-benzoic Finally both L. hirsutus seedlingsg5 and L. termis seedss7 contained (-)-As-dehydromultiflorine (1 52) characterized mainly by NMR spectroscopy. The compound was previously known as a dehydrogenation product of m~ltiflorine.~~~ (L.termis is also the first natural source of (+)-lupanine N-oxide (153)87,the (+)-enantiomer (cf.Reference 9m) having previously been obtained from Thermopsis The l~pinoides.~~~) mass spectrometric characteristics of multiflorine and several of its hydroxy dehydro and seco derivatives have been investigated and fragmentation pathways have been elucidated with the aid of accurate mass measurements and metastable ion analysis.lo6 NATURAL PRODUCT REPORTS 1993-5. P. MICHAEL (1 53) Lupanine N-oxide (154) Camoensidine (1 55) Camoensidine N-oxide 15p-0 (1 57) 5a-Hydroxysophocarpine R = OH (156) 1501-0 (158) Sophocarpine R = H (1 59) Sophoranol (1 60) (-)-Templetine (161) X =2H (162) X =S Maackia tashiroi unusual in its ability to elaborate both indolizidine and quinolizidine alkaloids has been found to produce the known mixed quinolizidine-indolizidine alkaloid (-)-camoensidine (154) as well as the new compound (-)-camoensidine-N-oxide (1 55).** Structures were determined by a combination of spectroscopic and chemical methods.Catalytic hydrogenation of (1 55) over palladium-carbon gave (-)-camoensidine ; conversely treatment of (1 54) with hydrogen peroxide regenerated the N-oxide. While the relative stereochemistry of camoensidine was established with the aid of NOE experiments assignment of the stereochemistry of the C/D ring junction in camoensidine-N-oxide depended on analysis of the diastereomeric N-oxides (1 55) and (1 56) prepared from (-)-camoensidine in 60 ?LO and 26 O/O yields respectively by treatment with m-chloroperoxybenzoic acid.The through-space deshielding effect of the N-oxide oxygen atom of (156) caused an unusual downfield shift of the 8P-H signal that was not apparent in the spectrum of the natural N-oxide thereby allowing the assignment of the cis ring junction to the natural metabolite. In the review period only one new alkaloid of the matrine class has been isolated. (-)-5a-Hydroxysophocarpine which occurs with seven known bases in the seeds of SophoraJlavescens var. angustfolia was characterized spectroscopically and its absolute configuration was determined to be as shown in (157) by comparison of its CD spectrum with that of (-)-sophocarpine (1 %).go Confirmation of the structure was also provided by catalytic hydrogenation of (157) to the known compound ( +)-sophoranol (1 59).The absolute structure of (-)-templetine (160) isolated from Templetonia retusa has been established by means of X-ray crystallographic analysis of its trihydrochloride and trihydrobromide salts after degradative studies had revealed only limited aspects of the structure. lo' Several methiodide salts of (-)-templetine were also prepared; and homo-alkaloid derivatives (161) and (162) were made by condensing the alkaloid with formaldehyde and carbon disulfide respectively. The latter compound was converted into homotempletine (1 6 1) with W5 Raney nickel while treatment of both (161) and (162) with W1 Raney nickel followed by perchloric acid gave the diperchlorate salt (163) the structure of which was also determined crystallographically.Heating (-)-templetine with 10% palladium on carbon followed by treatment with perchloric acid yielded (-)-dehydropiptanthine perchlorate (164); chemical correlation of other Ormosia alkaloids with this focal intermediate or its enantiomer in turn led to the absolute configurations of (-)-ormosanine (+)-piptanthine and (-)-H (1 65) (-)-Ormosanine 6a-H (1 67) (-)-Panamhe (1 66) (+)-Piptanthine 6P-H panamine being defined as shown in (165) (166) and (167) respectively. The absorption and fluorescence properties of (-)-lupinhe (168) examined in dilute hexane solution have been interpreted in terms of intramolecular hydrogen bonding effects. lo8 Meta-stable ion analysis has given new insights into the fragmentation patterns of several new derivatives of lupinine.log Lupinine has been oxidized to its aldehyde under electrochemical conditions.9.3 Synthesis Lhommet and co-workers continue to refine their methodology for preparing fused 1 -azabicycloalkane skeletons from Meldrum's acid derivativesl'l (cf Reference 9n 0). Flash vacuum thermolysis of (1 69) and related compounds at 580 "C probably proceeding through cumulene intermediates (1 70) and (171) (Scheme 18) afforded the methyl esters (172 X = OMe) in fairly poor yields when the pyrolysate was trapped in methanol. With deuteriated chloroform as the trapping solvent the acid chloride intermediate (172 X = C1 n = 1) could be identified by NMR spectroscopy. The thermolysis procedure is less efficient but more versatile than the previously reported Lewis acid-induced alcoholysis of (169) (cf.Reference 90). Stereoselective reduction of the bicyclic vinylogous urethanes (172 X = OEt n = 1 or 2) to the diastereomeric esters (1 73) or (1 74) also described previously followed by further reduction with lithium aluminium hydride completed syntheses of (&)-epilupinine (1 40) (&)-lupinhe (168) and related pyrrolizidine and indolizidine systems. Indolizidine (175) though not recognized as such by the authors is actually the new alkaloid tashiromine (cf. Reference 9p). NATURAL PRODUCT REPORTS 1993 (140) Epilupinine n= 2 (168) Lupinine n = 2 (175) Tashirornine n = 1 Reagents i mm Hg 580 "C; ii NEt, MeOH for X = OMe or CDCl for X = C1; iii NaBH, EtOH r.t.; iv H, Raney Ni 100 "C; v H, Raney Ni 200 "C Scheme 18 cJ+'0-GI___ci ii 40% iii-v 83% __t H H H H OH OH HOHO' ;9 (1 78) + 1,12-regioisorner(1 :3) iii -(fpH ix - (180) vi-viii 37%1 ?H (176) a-lsosparteine Reagents i C,H, r.t.; ii nitrone (177) toluene reflux; iii H (3 atm) Pd(OH), MeOH r.t.; iv Ac,O pyridine 50 "C; v 1M NaOH in MeOH r.t.;vi Pb(OAc), pyridine r.t. ; vii NaBH, EtOH r.t. ;viii 2M NaOH in MeOH r.t.; ix PPh, CCl, NEt, MeCN r.t. ;x C,H, sealed tube 140 "C; xi nitrone (177) C,H, sealed tube 190 "C Scheme 19 Two complementary syntheses of a-isosparteine (176) the first simple indolizidine alkaloid to be found in a marine aspects of which have previously been published as a organism has been isolated from a sponge of the genus communication (cf.Reference 12b) exploit 1,3-dipolar Stelletta.'l3 The structure was established by means of a cycloaddition of nitrone (177) with either cyclopentadiene or comprehensive array of spectroscopic methods that included 4H-pyran (Scheme 19).lI2While the 2 1 cycloadducts (178) and two-dimensional NMR techniques. It is possible that chloride (179) were formed in a highly stereoselective manner the is the counter-ion in vivo and that the dihydrogen phosphate former dipolarophile proved less satisfactory because the ion in the isolated product may have been introduced during regioisomer of (178) was actually the major product. Reductive the HPLC isolation procedure. The alkaloid showed antifungal cleavage of the N-0 bonds of (178) and oxidative scission of and cytotoxic activity.the trans-diol (I 80) were key transformations in preparing diol The cytotoxic and antimicrobial alkaloids (-)-clavepictine (1 8l) which possesses the correct stereochemistry for con- A (183) and (+)-clavepictine B (184) the first simple version into the target alkaloid (176). Transformation of (1 79) quinolizidines isolated from a tunicate were obtained from into a-isosparteine was even more straightforward Bermudan specimens of Clavelina picta.'l4 The structure of the hydrogenolysis of its N-0 bonds presumably unveiled the former was deduced from spectroscopic data obtained on the bis(a1dehyde) analogue of (18 1) which underwent reductive natural product and its tetrahydro derivative. NOE effects amination to the desired alkaloid under the reaction conditions.indicated a cis-fused quinolizidine system an equatorial disposition of the alkadienyl side chain and axial methyl and acetoxy groups. Molecular modelling studies showed that this I0 Alkaloids from Marine Sources unusual configuration was energetically stable relative to ( +)-Stellettamide A (1 82 absolute configuration unknown) alternative possibilities. Moreover basic hydrolysis of NATURAL PRODUCT REPORTS 1993-J. P. MICHAEL H (182) Stellettamide A (183) Clavepictine A R = COCH3 n= 5 (186) Isosaraine-2 (184) Clavepictine B R = H n= 5 (185) Pictamine R = COCH3 n= 3 clavepictine A yielded clavepictine B which gave crystals 23 A. Myc P. DeAngelis P. Lassota M. R. Melamed and Z. suitable for X-ray diffraction analysis.The results confirmed Darzynkiewicz Clin. Exp. Immunol. 1991 84 406. 24 M. Nose and B. Heyman J. Immunol. 1990 145 910. the relative configuration deduced from the NOE studies but did not reveal the absolute configuration. (-)-Pictamhe (185) 25 G. T. Tan J. M. Pezzuto A. D. Kinghorn and S. H. Hughes J. Nut. Prod. 1991 54 143. a lower homologue of clavepictine A was obtained from a 26 P. S. Wright D. E. Cross-Doersen K. K. Schroeder T. L. Venezuelan specimen of Clavelina picta.'15 The cis ring junction Bowlin P. P. McCann and A. J. Bitonti Biochem. Pharmacol. and relative orientation of substituents were also demonstrated 1991 41 1855. by means of NOE experiments. 27 S. L. White T. Nagai S. K. Akiyama E. J. Reeves K. The complex suite of alkaloids isolated from the sponge Grzegorzewski and K.Olden Cancer Commun. 1991 3 83. Reniera sarai (cf. Reference 9q) has been augmented by a 28 P. Breton A. Asseffa K. Grzegorzewski S. K. Akiyama S. L. further new quinolizidine (-)-isosaraine-2 (1 86 absolute White J. K. Cha and K. Olden Cancer Commun. 1990 2 configuration unknown).l16 Structural characterization was 333. based on extensive one-and two-dimensional NMR 29 L. F. James K. E. Panter H. P. Broquist and W. J. Hartley Vet. Human Toxicol. 1991 33 217. experiments. 30 M. S. J. Simmonds W. M. Blaney and L. E. Fellows J. Chem. Ecol. 1990 16 3167. 31 P. B. Anzeveno P. T. Angell L. J. Creemer and M. R. Whalon 11 References Tetrahedron Lett. 1990 31 4321. 1 W. H. Pearson and S. C. Bergmeier J. Org. Chem.1991 56 32 P. B. Anzeveno L. J. Creemer and P. T. Angell Eur. Pat. Appl. 1976. EP 446,832 (Chem. Abstr. 1991 115 280349). 2 P. C. Heidt S. C. Bergmeier and W. H. Pearson Tetrahedron 33 M. Gerspacher and H. Rapoport J. Org. Chem. 1991 56 3700. Lett. 1990 31 5441. 34 R. Bhide R. Mortezaei A. Scilimati and C. J. Sih Tetrahedron 3 J. M. Kelly M. A. Froetschel W. J. Croom Jr. W. M. Hagler Lett. 1990 31 4827. Jr. and B. W. McBride Can. J. Anim. Sci. 1991 71 321. 35 W. H. Pearson S. C. Bergmeier S. Degan K.-C. Lin Y.-F. Poon 4 H. R. Gaskins W. J. Croom Jr. J. E. van Eys W. L. Johnson J. M. Schkeryantz and J. P. Williams J. Org. Chem. 1990 55 and W. M. Hagler Jr. Small Ruminant Res. 1990 3 561. 5719. 5 L. E. Fellows and R. J. Nash Sci. Progress (Oxford) 1990 74 36 P.Vogel Bull. Soc. Chirn. Belg. 1990 99,395. 245. 37 J.-L Reymond and P. Vogel Tetrahedron Lett. 1989 30,705. 6 G. W. J. Fleet L. E. Fellows and B. Winchester in 'Bioactive 38 J.-L. Reymond and P. Vogel J. Chem. Soc. Chem. Commun. Compounds from Plants' ed. D. J. Chadwick and J. Marsh John 1990 1070. Wiley and Sons Ltd. Chichester 1990 p. 1128. 39 J.-L. Reymond A. A. Pinkerton and P. Vogel J. Org. Chem. 7 H. Takahata Y. Banba and T. Momose Tetrahedron Asym- 1991 56 2128. metry 1990 1 763. 40 G. W. J. Fleet N. G. R. Ramsden R. J. Nash L. E. Fellows 8 H. Takahata M. Tajima Y. Banba and T. Momose Chem. G. S. Jacob R. J. Molyneux I. Cenci di Bello and B. Winchester Pharm. Bull. 1989 37 2550. Carbohydr. Res. 1990 205 269. 9 J. P. Michael Not. Prod. Rep. (a) 1991 8 554; (b) 1990 7 487; 41 K.H. Aamlid L. Hough and A. C. Richardson Carbohydr. Res. (c) 1990,7,489; (d) 1990,7,490; (e) 1991,8,557; cf) 1990,7,492; 1990 202 117. (g) 1990; 7,494; (h) 1991,8 559; (i)1990,7,498; (j)1991,8 567; 42 B. G. Winchester I. Cenci di Bello A. C. Richardson R. J. Nash (k)199 1,8,565 ;(I) 1990,7,504;(m) 1990,7,507;(n) 1990,7,509; L. E. Fellows N. G. Ramsden and G. Fleet Biochem. J. 1990 (0) 1991 8 569; (p) 1991 8 567; (4) 1990 7 510. 269 227. 10 M. P. Sibi and J. W. Christensen Tetrahedron Lett. 1990 31 43 H. Paulsen M. Matzke B. Orthen R. Nuck and W. Reutter 5689. Liebigs Ann. Chem. 1990 953. I1 V. Ratovelomanana L. Vidal J. Royer and H.-P. Husson 44 R. C. Bernotas and R. V. Cube Tetrahedron Lett. 1991 32 161. Heterocycles 1991 32 879.45 P. S. Liu M. S. Kang and P. S. Sunkara Tetrahedron Lett. 1991 12 M. F. Grundon Nut. Prod. Rep. (a) 1987,4,417; (b) 1984,1,351. 32 719. 13 L. B. S. Kardono A. D. Kinghorn and R. J. Molyneux 46 B. L. Rhinehart M. E. Begovic and K. M. Robinson Biochem. Phytochemical Analysis 1991 2 120. Pharmacol. 1991 41 223. 14 R. J. Molyneux L. F. James K. E. Panter and M. H. Ralphs 47 T. G. Cooper C. H. Yeung D. Nashan F. Jockenhovel and E. Phytochemical Analysis 1991 2 125. Nieschlag Int. J. Andrology 1990 13 297. 15 M. J. Donaldson H. Broby M. W. Adlard and C. Bucke 48 T. Karasuno Y. Kanayama T. Nishiura H. Nakao Y. Kurata Phytochemical Analysis 1990 1 18. T. Yonezawa and S. Tarui Scand. J. Immunol. 1990 32 529. 16 S. A. Miller and A. R. Chamberlin J.Am. Chem. Soc. 1990 112 49 P. S. Sunkara M. S. Kang T. L. Bowlin P. S. Liu A. S. Tyms 8100. and A. Sjoerdsma. Ann. N. Y. Acad. Sci. 1990 616 90. 17 W. H. Pearson and K.-C. Lin Tetrahedron Lett. 1990 31 7571. 50 M. H. Hollingshead L. Westbrook B. J. Toyer and L. B. Allen 18 I. Pastuszak R. J. Molyneux L. F. James and A. D. Elbein Antiviral Chem. 1991 2 119 (Chem. Abstr. 1991 115 197822). Biochemistry 1990 29 1886. 51 R. M. Ruprecht L. D. Bernard R. Bronson M. A. Gama Sosa 19 K. Burgess and I. Henderson Tetrahedron Lett. 1990 31 6949. and S. Mullaney J. Acq. Imm. Def. Syndromes 1991 4 48. 20 N. Ikota and A. Hanaki Chem. Pharm. Bull. 1987 35 2140. 52 N. S. Doherty and T. H. Beaver Int. Arch. Allergy Appl. 21 N. Ikota and A. Hanaki Chem. Pharm. Bull. 1990 38 2712. Immunol.1990 93 19. 22 M. A. Spearman J. E. Damen T. Kolodka A. H. Greenberg 53 C. W. Jefford Q. Tang and A. Zaslona J. Am. Chem. Soc. 1991 J. C. Jamieson and J. A. Wright Cancer Lett. 1991 57 7. 113 3513. 54 T. Momose N. Toyooka S. Seki and Y. Hirdi Chem. Pharm. Bull. 1990 38 2072. 55 M. Ito and C. Kibayashi Tetrahedron Lett. 1990 31 5065. 56 M. Vavrecka and M. Hesse Helv. Chim. Actu 1991 74 438. 57 N. Machinaga and C. Kibayashi J. Chem. SOC. Chem. Commun. 1991 405. 58 N. Machinaga and C. Kibayashi Tetrahedron Lett. 1990 31 3637. 59 R. P. Polniaszek and S. E. Belmont J. Org. Chem. 1990 55 4688. 60 E. Zeller H. Sajus and D. S. Grierson SYNLETT 1991 44. 61 D. Gnecco C. Marazano and B. C. Das J. Chem. SOC. Chem. Commun. 1991 625.62 A. B. Holmes A. L. Smith S. F.Williams L. R. Hughes Z. Lidert and C. Swithenbank J. Org. Chem. 1991 56 1393. 63 I. Collins M. E. Fox A. B. Holmes S. F. Williams R. Baker I. T. Forbes and M. Thompson J. Chem. Soc. Perkin Trans I 1991 175. 64 D. N. A. Fox D. Lathbury M. F. Mahon K. C.Molloy and T. Gallagher J. Am. Chem. Soc. 1991 113 2652. 65 S. Y. Dike M. Mahalingam and A. Kumar Tetrahedron Lett. 1990 31 4641. 66 D. F. Taber R. S. Hoerrner and M. D. Hagen J. Org. Chem. 1991 56 1287. 67 A. Aqeel A. K. Khursheed and A. Viqaruddin Arzneim.-Forsch. (Drug Res.) 1991 41 151. 68 B. Baumgartner C. A. J. Erdelmeier A. D. Wright T. Rali and 0.Sticher Phytochemistry 1990 29 3327. 69 M. Ihara Y. Takino M. Tomotake and K. Fukumoto J.Chem. Soc. Perkin Trans I 1990 2287. 70 0.Bortolini 0.Curcuruto P. Traldi A. Iwanow and J. T. Wrobel J. Chem. Soc. Perkin Trans. 2 1991 287. 71 W. M. Golebiewski and J. T. Wrobel Bull. Acad. Pol. Sci. Ser. Sci. Chim. 1990 38 17. 72 R. H. Finnell C. C. Gay and L. C. Abbott In ‘Handbook of Natural Toxins’ Vol. 6 ed. R. F. Keeler and A. T. Tu Marcel Dekker New York 1991 p. 27ff. 73 J. E. Meeker and W. W. Kilgore in ‘Handbook of Natural Toxins’ Vol. 6 ed. R. F. Keeler and A. T. Tu Marcel Dekker New York 1991 p.41ff. 74 D. C. Baker and R. F. Keeler in ‘Handbook of Natural Toxins’ Vol. 6 ed. R. F. Keeler and A. T. Tu Marcel Dekker New York 1991 p. 61ff 75 K. E. Panter and R. F. Keeler Vet. Human Toxicol. 1990 32 (Supplement) 89. 76 R.F. Keeler and D. C. Baker J. Comp. Pathol. 1990 103 169. 77 R. Greinwald P. Bachman L. Witte and F. C. Czygan Phy-tochemistry 1990 29 3553. 78 R. Greinwald L. Witte V. Wray and F.-C. Czygan Biochem. Syst. Ecol. 1991 19 253. 79 M. Wink and L. Witte Entomol. Gener. 1991 15 237. 80 F. Tosun M. Tanker A. Tosun and T. Ozden Pharmacia (Ankara) 1991 31 5 (Chem. Abstr. 1991 115 68442). 81 D. Strack A. Becher S. Brall and L. Witte Phytochemistry 1991 30 1493. 82 C. A. Boros D. R. Marshall C. R. Caterino and F. R. Stermitz J. Nut. Prod. 1991 54 506. 83 S. Takamatsu K. Saito I. Murakoshi and S. Ohmiya J. Nut. Prod. 1991 54 477. 84 S. Takamatsu K. Saito T. Sekine S. Ohmiya H. Kubo H. Otomasu and I. Murakoshi Phytochemistry 1990 29 3923.85 S. Takamatsu K. Saito S. Ohmiya and I. Murakoshi Heterocycles 1991 32 1167. 86 A. Chaudhuri and W. J. Keller Phytochemistry 1991 30 1833. NATURAL PRODUCT REPORTS 1993 87 M. H. Mohamed K. Saito I. Murakoshi €1.A. Kadry T. I. Khalifa and H. A. Ammar J. Nut. Prod. 1990 53 1578. 88 S. Ohmiya H. Kubo Y. Nakaaze K. Saito I. Murakoshi and H. Otomasu Chem. Pharm. Bull. 1991 39 1123. 89 R. Yu X. Li L. Song R. Zhang T. Zhu G. Yang Z. Li and B. Yang Zhonggtio Zhongyao Zazhi 1991 16 160 (Chem. Abstr. 1991 115 155030). 90 K. Saito N. Arai T. Sekine S. Ohmiya H. Kubo H. Otomasu and I. Murakoshi Planta Med. 1990 56 487. 91 Atta-ur-Rahman A. Pervin S. Perveen H. Nasir and N. Hasan Phytochemistry 1991 30 1001. 92 R. Greinwald G. Lurz L.Witte and F.-C. Czygan Z. Naturforsch. Teil C 1990 45 1085. 93 K. Saito S. Takamatsu M. Yamazaki S. Ohmiya and 1. Murakoshi Tennen Yuki Kagobutsu Toronkai Koen Yoshishu 1990 32 268 (Chem. Abstr. 1991 114 203603). 94 Z. Jia G. Song and Z. Li Gaodeng Xuexiuo Huaxue Xuebao 1990 11 1014 (Chem. Abstr. 1991 115 110591). 95 G. Veen R. Greinwald L. Witte V. Wray and F.-C. Czygan Phytochemistry 1991 30 1891. 96 K. Saito S. Takamatsu I. Murakoshi S. Ohmiya and H. Otomasu J. Nut. Prod. 1989 52 1032. 97 B.-E. van Wyk and G. H. Verdoorn Biochem. Sp. Ecol. 1990 18 503. 98 D.-G. Cai M.-J. Gu J.-D. Zhang G.-P. Zhu T.-Y. Zhang N. Li and Y. Ito J. Liq. Chromatogr. 1990 13 2399. 99 J. Pothier G. Petit-Paly M. Montagu N. Galand J. C. Chenieux M. Rideau and C.Viel J. Planar Chromatogr. ~ Mod. TLC 1990 3 356 (Chem. Abstr. 1991 114 202792). 100 K. Gander I. Szinai and A. Salgo J. Chromutogr. 1990 520 257. 101 C. B. Montllor E. A. Bernays. and M. L. Cornelius J. Chem. Ecol. 1991 17 391. 102 M. Wink and D. Schneider J. Comp. Physiol. B 1990 160 389. 103 A. B. Beck B. H. Goldspink and J. R. Knox J. Nut. Prod. 1979 42 385. 104 J. Wolinska-Mocydlarz and M. Wiewiorowski Bull. Acad. Pol. Sci. Ser. Sci. Chim. 1977 25 679. 105 K. Saito S. Takamatsu S. Ohmiya H. Otomasu M. Yasuda Y. Kano and 1. Murakoshi Phytochemistry 1988 27 3715. 106 E. Wyrzykiewicz and W. Wysocka Org. Mass Spectrom. 1990 25 453. 107 J. R. Cannon J. R. Williams D. Arbain A. Brossi J. F. Blount C. L. Raston B.W. Skelton and A. H. White Aust. J. Chem. 1991 44 509. 108 A. M. Halpern and M. W. Legenza J. Phys. Chem. 1990 94 8885. 109 U. A. Abdullaev R. T. Tlegenov A. A. Abduvakhabov and K. U. Uteniyazov,Khim. Prir.Soedin 1990,508(Chem.Abstr. 1991 114 102507). 110 A. M. Gazaliev M. Z. Zhurinov S. D. Fazylov S. A. Dyusambaev B. I. Tuleuov and S. N. Balitskii Khim. Prir Soedin 1991 251 (Chem. Abstr. 1992 116 129340). 111 M. Haddad J. P. CdCrier G. Haviari G. Lhommet H. Dhimane J. C. Pommelet and J. Chuche Heterocycles 1990 31 1251. 112 H. Oinuma S. Dan and H. Kakisawa J. Chem. Soc. Perkin Trans. 1 1990 2593. 113 H. Hirota S. Matsunaga and N. Fusetani Tetrahedron Lett. 1990 31 4163. 114 M. F. Raub J. H. Cardellina 11 M. I. Choudhary C.-Z.Ni J. Clardy and M. C. Alley J. Am. Chem. SOC. 1991 113 3178. 115 F. Kong and D. J. Faulkner Tetrahedron Letf. 1991 32 3667. 116 G. Cimino A. Fontana A. Madaio G Scognamiglio and E. Trivellone Magn. Reson. Chem. 1991 29 327.

ISSN:0265-0568    

DOI:10.1039/NP9931000051

出版商:RSC    

年代:1993

数据来源: RSC

摘要:

Microbial Pyran-2-ones and Dihydropyran-2-ones J. M. Dickinson Chemistry Department The University Stocker Road Exeter EX4 4QD" Selectively reviewing the literature published up until December 1991 1 2 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2.9.1 2.9.2 2.9.3 2.9.4 2.10 2.10.1 2.10.2 2.10.3 2.10.4 2.10.5 2.10.6 2.10.7 2.10.8 2.10.9 2.10.10 3 3.1 3.2 3.2.1 3.2.2 3.2.3 3.3 3.4 3.5 3.5.1 3.5.2 3.5.3 3.6 3.6.1 3.6.2 4 Introduction Microbial Pyran-2-ones Simple Pyran-2-ones 6-A1 kylpyran-2-ones Citreoviridin and Derivatives The Aurovertins Asteltoxin and Citreomontanin The Pyrenocines and Macommelins The Styryl-Pyrones and Related Compounds Pyran-2-ones from the Gliding Bacteria The Phytotoxic Pyran-2-ones Radicinin and Related Compounds The Solanopyrones Poaefusarin and Sporofusarin Colletopyrone Other Pyran-2-ones Phacidin Elasnin Nectriapyrone and Related Compounds Vulgamycin Luteoreticulin Aszonapyrone A Coarctatin Taiwapyrone Stizolobic Acid and Stizolobinic Acid Muscaurin I1 Microbial Dihydropyran-2-ones Pestalotin and Related Compounds Aspyrone and Related Compounds Asp yrone Asperline Phomalactone and their Derivatives Astepyrone The Leptomycins Kazusamycins and Anguinomycins The Phoslactomycins and Related Compounds Other Polyketide-derived Dihydropyran-2-ones Alternaric Acid The Rubratoxins Phomopsolides A and B Non-polyketide Derived Dihydropyran-2-ones Fomannosin 23-Deoxyantheridiol References I Introduction The pyran-2-one moiety is found in a large number of natural products and is responsible for a wide range of biological effects e.g.antibiotic antifungal cytotoxic neurotoxic phytotoxic etc. Pyrones thus constitute an important class of compounds. Although certain aspects of individual naturally- occurring pyrones have been discussed within various reviews,' there does not appear to have been a recent review devoted entirely to these compounds. It is therefore the aim of this article to go some way towards redressing the balance. * Present address School of Chemistry University of Bristol Cantocks Close Bristol BS8 ITS. 0 OCHS I HO H OH (3) Pyrones have been isolated from an extensive range of natural sources such as plants (e.g.kawain (1) from Piper methysticum2) animals (e.g. bufalin (2) from Bufa vulgaris (t~ad)~), and marine organisms (e.g. diemensin A (3) from Siphonaria diemensis4). However in order to keep this review to a sensible length the present discussion will be restricted to pyrones that have been isolated from microbial sources. Literature coverage is by necessity not exhaustive but will highlight articles published up until the end of 1991. This review will be divided into two main sections the first will focus on the fully unsaturated pyran-2-ones whilst the second will look at the partially saturated dihydropyran-2- ones. Aspects of the isolation sturcture elucidation synthesis biosynthesis biological activity and mode of action will be discussed where possible.Fully saturated pyrones (6-lactones) fall outside the scope of this review. 2 Microbial Pyran-2-ones 2.1 Simple Pyran-Zones The simplest pyran-2-ones from both a structural and a biosynthetic viewpoint are the 4-hydroxypyrones triacetic lactone methyl triacetic lactone tetraacetic lactone and de hydroace tic acid. Methyl triacetic lactone (5) was the first of these to be isolated from a natural source Penicillium stipitatum,' and was later isolated from another strain of P. stipitatum along with triacetic lactone (4) and tetraacetic lactone (6).6 Triacetic lactone (4) had also been isolated from two unstipulated Penicillium species.'Dehydroacetic acid had been known as a synthetic compound long before its isolation from Ramaria apiculata.8.It has also been isolated from Hypocrea sulphurea. lo 71 NATURAL PRODUCT REPORTS 1993 OH -HF Scheme 1 0 OH 0 Tetraacetic lactone (6) was first synthesized at the end of the last century,l’ and was shown to be converted to triacetic lactone (4) on treatment with sulfuric acid.l2.I3 Compound (4) has also been synthesized by treatment of the disodio-derivative of acetylacetone with carbon dioxide followed by cyclization of the resultant acid with hydrogen fluoride to give the pyrone (Scheme l).14 Another route through to triacetic lactone (4) involved condensation of malonic acid or malonyl chloride with ethyl acetoacetate.Use of methylmalonyl chloride allowed the synthesis of methyl triacetic lactone (5).I53l6 The first synthesis of dehydroacetic acid (7) was also reported at the end of the last century and was achieved by passing ethyl acetoacetate vapour through a heated iron tube.17 Other routes include treatment of diketene with sodium phenoxide in benzene to give (7) and 2,6-dimethylpyran-4-one,ls and also base (sodium bicarbonate)-catalyzed condensation of ethyl aceto- acetate.lg The biosynthetic origins of the 4-hydroxypyran-2-ones were of considerable interest particularly because of their apparent relationship to the proposed ,!$polyketomethylene inter-mediates on the acetate-methylmalonate pathway. The bio- synthesis of triacetic lactone (4) methyl triacetic lactone (5) and tetraacetic lactone (6)was studied in cultures of Peniciffium stipitatum.2o This organism normally produces the tropolones stipitatonic acid (8) and stipitatic acid (9). However addition of ethionine to the culture medium resulted in accumulation of the pyran-2-ones -these were not encountered under normal fermentation conditions. Small amounts of orsellinic acid (10) and orcinol (1 1) were also isolated. [1-14C]Acetate was administered to cultures of ethionine- inhibited Peniciflium stipitatum and the radioactively-labelled pyrones were isolated. Degradation of tetraacetic lactone (6) gave the expected polyketide-derived labelling pattern (Scheme 2).20Although triacetic lactone and methyl triacetic lactone OH OH were not degraded their labelling pattern was assumed to be as shown.It had been reported that triacetic lactone (4) stimulated the formation of aromatic compounds by Peniciffiumurticae,21and increased stipitatic acid (9) formation in P. sti~itatum.~ Coupled with the fact that the pyrones accumulated under fermentation conditions where normal tropolone biosynthesis was inhibited it was suggested that the pyrones could be precursors of stipitatonic and stipitatic acids and other aromatic metabolites e.g. orsellinic acid orcino1.20 However when radioactively labelled triacetic lactone was incubated with P. stipitatum under normal growth conditions evidence was obtained which indicated that (4) had been broken down into acetate before incorporation into the tropolones and was not therefore a direct precursor.2o This was in agreement with other results which showed that [2-14C]triacetic lactone and [2-14C]tetraacetic acid were degraded to acetate in Penicilfium sp.before being incorporated into acetate-derived metabolites such as 6-methylsalicylic acid.’ The degradation of dehydroacetic acid (7) to triacetic acid via triacetic lactone (4) by a Pseudomonas species has been reported,22 as has the breakdown of triacetic lactone to acetoacetic acid and acetic acid via triacetic acid by rat liver and kidney and beef and rabbit liver h~mogenates.~~. 24 The NATURAL PRODUCT REPORTS 1993-5. M. DICKINSON CH3(CH2)4CH0+ NaCECH CH3(CH2)44H CECH I-OH ..... 11 111 1 CH3(CH2)4 (12) CH3(CH2)4Br+ NaCrCH t CH3( CH2)4C=CH v-vii CH3( C H2)4CECC HO viii / ix -CH3(CH2)400 (13) Reagents i Liq. NH,; 11 CrO,; 11 1 H,C(CO,Et), NaOEt; iv NaOH; v EtMgBr; vi CH(OEt),; vii H+;viii CH,CO,H AcOH; ix A Scheme 3 iii iv -20 (15) Reagents i Ac,O AcOH ; ii Pd/C A; iii NBS hv;iv LiCl Li,CO, DMF A Scheme 4 metabolism of these pyrones therefore appears to be similar in both fungal and animal systems. The biological activity of (4) (5) and (6) does not appear to have been reported. On the other hand the use of dehydroacetic acid (7) as a plasticizer fungicide and bactericide (in toothpaste^),^^ has led to a detailed toxicological study of this compound.26 It has an LD, (oral) of 1000 mg/kg in rats whilst its sodium salt has an LD, (oral) of 570 mg/kg.At higher dosage levels toxic effects include loss of appetite loss of body weight vomiting ataxia and convulsions. 2.2 6-Alkylpyran-Zones Other simple pyran-2-ones to have been isolated from microbial sources are the 6-alkyl- and 6-alkenyl-pyrones. 6-Pentylpyran-2-one (1 3) was the first of these to be identified as a fungal product of Trichoderma viride,*' although it had previously been reported to be a component of peach essence.28 It has since been isolated from strains of Trichoderma harzianum,29 31 Trichoderma ~iride,~~, 33 and an unidentified Aspergillus species,34 from peach35 and ne~tarine~~-~' essence and as an aroma component of roasted beef.39 In a study on pyrone production by cultures of Trichoderma viride the formation of (13) was found to be affected by the carbon source in the fermentation medium.32 6-Pentylpyran-2-one possesses a characteristic coconut odour.Such an odour was noted to be produced by isolates of Trichoderma viride T. koningii and T. hamatum during a study on volatile antibiotic production carried out by Dennis and Web~ter.~ Although the component responsible was not isolated it seems probable in view of the production of 6-pentylpyran-2-one by so many Trichoderma species that (13) was indeed being formed in this case. 6- Pentylpyran-2-one (1 3) has been produced by a strain of Trichoderma kaningii which was also reported -to produce 6- heptylpyran-2-one and a 'dehydro ' derivative of the latter.41 The only evidence presented for the latter two compounds however was the presence of the corresponding molecular ion peaks in the mass spectrum of partially-purified fungal extracts.6-Pentylpyran-2-one (1 3) is a co-metabolite with 6-pentenyl- pyran-2-one (16) in strains of Trichoderma harzianum.4z Compound (16) has also been isolated from a strain of Trichoderma ~iride,~~ and has been identified as a component of the queen pheromone of the red fire ant Solenopsis invicta (B~ren),~~ and of male mandibular gland secretions of the carpenter ants Camponotus pennsylvanicus C. herculeanus and C. noveboracensi~.~~ 6-Propenylpyran-2-one (1 9) named sibirinone has been isolated from Hypomyces sernitransl~cens.~~ The distinctive coconut aroma of (13) has attracted interest in its use as a possible flavourant in the food industry.As a result of this its synthesis was developed in order to ascertain its organoleptic properties before its first isolation from a natural source. The routes developed4' are outlined in Scheme 3. In both cases the key intermediate is the pyrone-acid (12) which is reported to undergo decarboxylation at 200 "C giving the required product. A synthesis of (13) has also been described in which it was an intermediate in the production of the pentenyl derivative (1 6) (Scheme 4).45 The keto-acid (14) (formed via the reaction of dipentylcadmium with ethyl 4-(chloroformy1)butyrate cyclized to give the dihydropyrone (1 5) which on dehydrogen- ation gave (13).4s The conversion of (13) to (16) was achieved via allylic bromination followed by dehydrobromination.A second synthesis of (1 6) has been reported by Rocca et al. NATURAL PRODUCT REPORTS 1993 (17) (18) (16) Reagents i Et,N; ii conc. H,SO ;iii SOCl,; iv H, Pd/BaSO, xylenes; v Butyl(tripheny1)phosphonium bromide base; vi I, benzene Scheme 5 (Scheme 5)., [2+41-Cycloaddition between the ketene derived from crotonyl chloride and trichloroacetyl chloride gave 6- trichloromethylpyran-2-one (17) which was converted to the aldehyde (1 8). Wittig methodology gave trans-6-pentenylpyran- 2-one (16). Sibirinone (19) has been synthesized by dimerization of the crotonyl-derived ketene (Scheme 6).,’ The antifungal properties of 6-pentylpyran-2-one (1 3) have been demonstrated on a number of occasions.It has been shown to significantly inhibit growth of Verticillium dahiiae V. fungicola Pyranoechaeta lysopersici Phomopsis scler~tioides,~~ Gaeumannomyces graminis (Take-all),31*42Chaetomium coch- lioides and C. ~pinusurn.~~ It is also partially effective against Rhizoctonia cerealis Fusarium oxysporum Aspergillus niger,, A. Jlavu~,~~,~~ and Botrytis ~inerea,~”~~ Ceratocystis ~lmi.~’ Pythium ultimum Sclerotinia sclerotiorum and Trichoderma harzianum showed negligible inhibiti~n,,~ and Bacillus subtiiis was not affected.,O Although growth of Sclerotinia sclerotiorum was not inhibited it was found that sclerotial development was significantly affected.This was also noted with Rhizoctonia cerealis.42 High atmospheric concentrations of 6-pentylpyran-2-one (13) affected germination of lettuce seedlings and subsequent de~eloprnent.~~ Compound (13) is reported to be non-toxic to greenhouse grown bean plants (Phaseolus vulgaris) corn plants (Zea mays) or tobacco (Nicotiana tabacum) and significantly inhibits growth of etiolated wheat coleoptile~.~~ Crude extracts of Trichoderma koningii which were reported to contain both 6-pentylpyan-2-one (1 3) and 6-heptylpyran-2- one were shown to be active against Gaeumannomyces graminis Rhizoctonia solani Phytophthora cinnamoni Pythium middle- toni Fusarium oxysporum and Bipolaris sor~kiniana.~~ It seems likely that this biological activity was due mainly to the presence of the 6-pentyl derivative (13) particularly as the length of the alkyl chain in 6-alklylpyran-2-ones has been shown to be crucial to the antifungal activity exhibited.48 A comparison between 6-pentenylpyran-2-one (16) and the 6-pentyl derivative (1 3) has shown that the two pyrones display similar antifungal properties (16) being as effective as (13).48 It has been reported that (16) was partially responsible for the 0 (CH,CH=CHCO)20 i-iii (19) Reagents i 550 “C 0.1 Torr; ii [4 +21 dimerization ; iii NaHCO or P-TsOH Scheme 6 (20) R’=CH3 R2=H (21) R’ = CH3 R2= CH3 Ho induction of oospore formation in Phytophthora ~innamoni.~~ Its biological role in combination with other pheromonal components has been demonstrated with red fire ants Solenopsis invicta (Buren),, but its role with respect to Carpenter ants (Camponotus sp.) from which it has also been isolated has not been e~tablished.,~ Sibirinone (19) appears to be biologically inert and only its inactivity against Staphylococcus aureus has been noted.46 2.3 Citreoviridin and Derivatives In the early part of this century the occurrence of cardiac beriberi in East Asia reached epidemic-like proportions.Mouldy rice was found to be responsible for the observed symptoms the principal mould being identified as Peniciliium citreoviride (P. toxic~rium).~~ The mould was found to produce a toxic principle named citreoviridin (28) which exhibited the bio- logical effects attributed to the micro-organism itself.51 Since then citreoviridin (28) has been found to occur in culture filtrates of Penicillium o~hrosalmone~m,~~~ P.53 P. pul~illorum,~~ pedemont~num,~~ P. ~harlesii,~~ P. ~itreoviride,~~ and Aspergillus terre~s.~’ This latter organism also produced a number of very similar metabolites to citreoviridin referred to as citreoviridins B C D E and F. The structures of citreoviridins C (20) and D (21) were assigned on the basis of spectroscopic data. Isocitreoviridin which is isomeric about the C-13,C- 14 double bond as compared to citreoviridin has also been isolated from culture filtrates of Peniciilium pulvillor~m,~~ but was shown to be an artefact after pure citreoviridin was found to be converted to a mixture of citreoviridin and isocitreoviridin under simulated fermentation and extraction conditions.In addition to citreoviridin (28) the related metabolites citreoviridinol (22) isocitreoviridinol (23) secocitreoviridin (30) and citreo- viral (29) have also been isolated from Penicillium ~pecies.~~-~O The synthesis of citreoviridin (28) has been the subject of a NATURAL PRODUCT REPORTS 1993-5. M. DICKINSON .. Reagents i HNEt,; ii MeI; iii H,O; iv polyphosphoric acid Scheme 7 Reagents i NaNH, NH,; ii CO, Ether; iii HF; iv DMSO K,CO, 2-butanone; v NBS peroxide CCl,; vi (CH,O),P toluene; vii (+)-(A) LDA THF HMPA Scheme 8 i-iv v-vii 0-glucose steps -6Bn viii ix vii x J (29) Reagents i Ac,O-BF,. Et,O 0 "C; ii 0.4 M NaOMe MeOH r.t.; iii NaBH, H,O MeOH (1 :2) r.t.; iv p-TsOH-Drierite acetone r.t.;v H, Pd/C MeOH r.t.; vi NaIO, MeOH :H,O (1 l) r.t.; vii Ph,=C(Me)CO,Me benzene; viii DIBAL-H toluene -78 "C; ix PDC DMF 0 "C; x Amberlite MeOH:H,O (2 I) r.t.; xi mCPBA CH,Cl, 0 "C; xii CsOH CH,Cl, r.t.; xiii MnO, CH,Cl, r.t.; xiv Ph,P=CHCO,Et benzene r.t.; xv (31) benzene Scheme 9 OCH3 OCH H3C (30) (31) Reagents i DMSO K,CO,; ii SeO, dioxan A; iii Ph,=CH-CHO; iv DIBAL-H THF; v MsC1 pyridine CH,Cl,; vi Ph,P benzene; vii NaH THF Scheme 10 number of papers and considerable success has been achieved. was reported in 1985,68 and is outlined in Scheme 9. The The synthesis of the pyrone moiety from y,i?-acetylenic-/?-oxo- absolute configurations of both citreoviridin (28) and citreoviral ester (24) via the enaminoester (25) has been reported (Scheme (29) were established based on D-glucose.7).61A second approach towards the synthesis of the pyrone Pyrone-phosphorane (3 l) widely used in the synthesis of moiety is outlined in Scheme 8.62 Methylacetylacetone (26) was citreoviridin (28) the aurovertins and related compounds was converted to 6-bromomethylpyrone (27) in five steps. Wittig prepared from secocitreoviridin (30) the total synthesis of methodology gave (-)-citreoviridin (28). The tetrahydrofuran which had already been reported.69 The route devised and the portion of the molecule was prepared from ( +)-citreoviral(29) subsequent conversion of (30) into (3l) are outlined in Scheme The for which a number of syntheses have been rep~rted.~~-~' 10.This synthesis enabled the structure of (30) to be established first total synthesis of citreoviridin (28) starting with D-glucose unequivocally -previously two possible structures had been NATURAL PRODUCT REPORTS 1993 H36-& H +A A tA HsCS-(CH2)2CH( NH2)COZH L H3 C -C -' 80H 18' 02 Scheme 11 68 The total synthesis of citreoviridinol (22) has also been reported. 70 Initial studies into the biosynthetic origins of citreoviridin (28) in Penicillium pulvillorum suggested that the molecule was derived from nine molecules of acetic acid and five molecules of methi~nine,'~ although degradation of the [14C]-labelled meta- bolite did not enable confirmation of all the positions of incorporation. Subsequent studies with [1-13C]- and [2-13C] acetate in Aspergillus terreus demonstrated the incorporation of nine acetate units as shown (Scheme 11).5i Oleic acid was suggested as a possible biosynthetic precursor of citreoviridin however feeding with [l-14C]oleic acid resulted in a low incorporation the distribution being consistent with degrada- tion of the acid to acetic acid.Labelling studies with [1-13C]- and [2-13C]acetate in PenicilZium puZvilZorum showed a similar incorporation pattern to that demonstrated in A. terre~s.~~ In addition to this the remaining methyl groups were shown to be methionine-derived and an acetate-starter unit was demonstrated by feeding experiments with [l-13C,2-2H,]acetate. Feeding experiments with [1-13C,180z]a~etate (P. pulvillorum) led to upfield isotope shifts for the C-2 C-4 and C- 6 resonances in the 13C NMR spectrum of (28) indicating that the corresponding carbon-oxygen bonds had remained intact throughout the biosynthetic pathway.Fermentation of cultures under an 1802 atmosphere and simultaneous addition of [l- 13C]acetate demonstrated the origin of the tetrahydrofuran ring oxygens from oxidative processes. i3 The discovery of citreoviridin (28) was as a result of the search for the cause of acute cardiac beriberi which was prevalent in rice-eating countries at the beginning of the century.50 Citreoviridin induced acute poisoning in cats and dogs (intraperitoneally (i.p.) subcutaneously (s.c.)) early symptoms of which were progressive paralysis of the hind legs vomiting and convulsions.Respiratory distress appeared gradually whilst cardiovascular disturbance and hypothermia were marked in the advanced stages. The final stage of toxicity was characterized by dyspnoea gasping and Cheyne-Sto kes respiration followed by respiratory arrest. Subacute ad-ministration in cats led to induced damage of the central nervous system. The LD, in male mice has been determined as 11 (s.c.) and 7.5 (i.p.) mg/kg whilst in female rats it is 3.6 mg/kg (s.c.). Pretreatment of test animals with vitamin B reduced acute intoxication whilst vitamin C led to an increase in the life-span of poisoned mice. Because of the similarity of the clinical manifestations of acute cardiac beriberi in humans with the toxicological effects of citreoviridin in poisoned animals the mycotoxin was presumed to be the cause of the cardiac beriberi that swept East Asia.The toxicity of citreoviridin (28) had been reported pre- vio~sly,~~ where it was noted that a single dose of 100 mg/kg (s.c.) was sufficient to kill all the experimental animals within two hours. Isocitreoviridin on the other hand had no effect at all. Citreoviridin monoacetate (32) is less potent than citreo- viridin (28) whilst the diacetate (33) is virtually ineffecti~e.~~. 75 Hydrogenation of the monoacetate reduced its potency considerably.75 The phytotoxic activity of citreoviridin (28) has been examined to a lesser degree. The compound was found to inhibit growth of wheat coleoptiles at concentrations of M OCH :5& ,.-CH 0 / / / /*--H3C H3C H (32)R' = Ac R2 = H (33) R' = R2 = Ac 3 (34) R1=H R2=CH3 R =R4 =COMe (35)R' = R2 = R4= H R3 = COMe (36) R'=OH R2=CH3 R3=COMe R4= H (37) R' = R3= R4= H R2 = CH3 and of corn seedlings with the inhibitory effects on the latter still in evidence two months after treatment at concentrations of lop2 M.On the other hand tobacco seedlings were not visibly affected by citreoviridin (28) indicating a degree of selectivity in its phytotoxic activity. 2.4 The Aurovertins The aurovertins are a group of mycotoxins related to citreoviridin (28). To date the structures of five aurovertins A (34) B (38) C (35) D (36) and E (37) have been reported. The first isolation of an aurovertin was from Calcarisporium arbu~cula'~-later evidence showed this to be aurovertin D (36).Aurovertin B (38) was also isolated from C.arb~sc~la," and its structure determined.78 At least nine aurovertins were reported in the mycelial extracts of this organism,77 although as mentioned structures have only been proposed for auro- vertins A through to E.i4 The total synthesis of aurovertin (38) has been rep~rted,'~ and the route is outlined in Scheme 12. As with citreoviridin D-glucose was used as starting material and so the absolute configuration of aurovertin B (38) was established on the basis of its derivation from this sugar. The biosynthetic origins of the aurovertins have been determined. Feeding experiments with [1-l3C]acetate in C.arbuscula demonstrated the incorporation of acetate units into aurovertin B (38) as shown in Scheme 13.80 Five units of [Me- 13C]methionine were also incorporated. Incorporation of [1,2-13C]acetate indicated that C(2) and C(3) of the ethyl side chain were derived from an intact acetate unit. These results thus NATURAL PRODUCT REPORTS 1993-5. M. DICKINSON OMe H OCOCH3 Me (38) Reagents i 80 % aq. AcOH; ii NaIO, MeOH-H,O; iii Ph,P=C(Me)CO,Me benzene; iv K,CO, MeOH; v CH,(OMe),-P,O, CHC1,; vi DIBAL-H THF; vii mCPBA CH,Cl,; viii (COCI), DMSO Et,N CH,Cl,; ix Ph,P=CHCO,Et benzene; x CF,CO,H CHC,; xi DIBAL- H THF; xii Trityl chloride pyridine CH,Cl,; xiii Ac,O pyridine r.t. ;xiv p-TsOH MeOH; xv BUtOOH Ti(OPtl), D-( -)-DET CH,Cl,; xvi H,/Pd black MeOH; xvii (COCI), DMSO Et,N CH,Cl,; xviii Ph,P=CHCHO benzene; xix CSA CH,Cl,; xx (31) THF Scheme 12 H&=EO,H +A A OMe t.r ~ H3CS-( CH&CH( NH,)C02H l 0a * H,CCH,CO,H ____t + + A '3 Medium derived Scheme 13 suggested that aurovertin B was derived from a C,,-polyketide precursor with the introduction of a methyl group from the C,- pool onto the methyl carbon atom of the chain-initiating acetate unit.However feeding experiments with [1-13C]pro-pionate demonstrated that this ethyl side chain could also be propionate-derived. Similar results were found for aurovertin D (36).,l Further labelling studies confirmed that aurovertins B (38) and D (36) were in fact derived from a C,,-polyketide which was methylated at C, of this precursor followed by the loss of the starter acetate unit through a retro-Claisen cleavage.*' This was shown by the incorporation of [2-13C]malonate with high enhancement at the positions also labelled by [2-13C]acetate -all atoms were labelled to a similar extent.The previous results with [l-13C]propionate still held and so the question was raised as to whether both pathways operated simultaneously. This was shown to be the case. It appeared that aurovertin C (35) was derived only via the single pathway using the acetate-polymalonateethionine route. Addition of [1-13C,1s02]acetate to cultures of C. arbuscula demonstrated that as in the case of citreoviridin (28) the pyrone oxygens of aurovertins B (38) and D (36) were acetate- derived.82 Fermentation of cultures under an "0 atmosphere and simultaneous addition of [1 -13C]acetate established the derivation of all the remaining oxygens by oxidative processes with the exception of the C(4)-oxygen atom which was presumably derived from the medium.With the above results in hand a detailed mechanism was proposed for the formation of the 2,6-dioxabicyclo[3.2. lloctane moiety from the postulated polyene precursor (39) (Scheme 14).82 The polyene is postulated to undergo monooxygenase- mediated epoxidation using molecular oxygen to give the (3R 4R 5R 6R 7R 8S)-triepoxide (40). Nucleophilic attack by water at C-4 leads to a series of ring closures to generate eventually the 2,6-dioxabicyclo[3.2. lloctane moiety of auro- vertin B (38).The biological activity and particularly the mode of action of the aurovertins has been studied in considerable detail. Whilst there is no apparent antibiotic activity against bacteria or pathogenic fungi toxicity against a number of animals has been noted. i4. i6 Pharmacological effects include brief stimu- lation followed by depression. Hypotension has also been noted along with a marked diuretic effect and enhanced secretion of Na' ions. The LD, for mice is 1.65 mg/kg. Intravenous injection of 1 mg/kg caused death in rabbits in less than 15 minutes and in dogs in less than 50 minutes.i6 Aurovertin does not appear to be significantly metabolized in the body.' Aurovertins B (38) and D (36) have been shown to inhibit oxidative phosphorylation 32Pi-ATP exchange and exchange of l80between PI and water in rat liver mitochondria.They also enhanced ATP hydrolysis induced by selenite selenate and deoxycholate. The hydrolysis of ATP induced by DNP and NATURAL PRODUCT REPORTS 1993 Me I Scheme 14 agents that uncouple oxidative phosphorylation were partially inhibited. It was ~onc1uded~~~~~ that aurovertin inhibited at a site located on the coupling factor F of ATPase. Enzymatic activity of highly purified mitochondrial ATPase from rat liver was found to be dependent on the anion of the buffer used. However aurovertins decreased enzymic activity to the same level regardless of the anion Aurovertins B (38) C (35) and D (36) were reported to have similar levels of activity whilst aurovertin E (37) was only a weak inhibitor of enzyme activity.Aurovertin A (34) was anomalous in its effects in that it was a powerful inhibitor of ADP-stimulated respiration but was impotent as an inhibitor of ATPase The inhibition of ATPase activity of soluble Escherichia coli coupling factor isolated from wild-type E. coli K-12 by aurovertin D (36) was found to be totally lost on acetylation or saponification of this metabolite.86 Aurovertin-resistant mutants of E. coli generated by nitroso- guanidine rnutagene~is,~’ were shown to be altered in the p-subunit suggesting that this was the position of the aurovertin binding site. Further evidence indicated that aurovertin B (38) and citreoviridin (28) bound to nonidentical subunits on the p-subunit of yeast F,-ATPase.88 The binding of citreoviridin was noncompetitive with respect to aurovertin and F,-ATPase obtained from aurovertin-resistant mutants was partly inhibited by citreoviridin.The ATPase activity and ATP-induced energization of photosynthetic membranes from Rhodopseudomonas capsulata a facultative photosynthetic bacterium were reported to be stimulated by phosphate -aurovertins completely inhibited the activity elicited by this anion.89 They also inhibited the energy transfer reactions of R. rubrum and the membrane-bound and soluble ATPases of this organism.go The R.rubrum coupling factor was suggested to be the site of action. Inhibitory action by aurovertins on chloroplast functions has not been found. 74 91 The aurovertins fluoresce weakly in solutions of methanol ethanol or alcohol-water mixtures when irradiated with light at 370 nm with an emission maximum at 470 nm.At lower temperatures or in glycerol solution an enhanced fluorescent intensity is ob~erved.’~ Aurovertin has found use as a fluorescent probe in following structural changes of membrane com-ponent~.~~ Thus when aurovertin was added to fragmented rat liver mitochondria the fluorescence was found to decrease on the addition of ADP. These changes were interpreted in terms of environmental constraints of the probe binding site. The formation of a complex between aurovertin and soluble mitochondrial ATPase (F,) was accompanied by a 55-fold enhancement of fluorescence. 93 This was partially quenched by ATP as previously noted for mitochondrial fragments and by Mg2+.Two binding sites were found on F in the presence of ATP and one site in the presence of ADP Mg2+ and dilute buffer. It was thus proposed that of the two binding sites for ;F1 -ATP ADP ATP Pi ADP Scheme 15 aurovertins only one participated in inhibition of ATPase activity. The fluorescence maxima was found to be during State-3 respiration and was partially quenched on anaerobiosis or on addition of respiratory inhibitor oligomycin or uncoupler suggesting that aurovertin bound cooperatively to State-3 mitoch~ndria.~~ Aurovertin thus induced conformational change in F binding sites in two ways firstly by directly acting as an allosteric effector of an oligomeric system ; and secondly indirectly by inhibiting State-3 respiration which changes the allosteric constant of the oligomeric system.Of the two binding sites for aurovertin one had high affinity binding and the other low affinity. A model was presented (Scheme 15) in which changes of the aurovertin fluorescence reflected conformational changes of the ATPase induced by its ligandsg5 The two conformations termed F and *F1 are in equilibrium. F contained one binding site per mole of enzyme which had a high affinity whilst *F exposed two binding sites one of high affinity and one of low affinity. Changes in the fluorescent properties of aurovertins were explained by a shift in equilibrium between the two conformations induced by binding of ligands to the enzyme.ATP and phosphate induce conformation *F, whilst ADP stabilizes conformation F,. Further evidence has been obtained in support of these conformational changes.96 ’’ The rate of change of fluorescence on addition of the various ligands was found to be pH dependent.98 2.5 Asteltoxin and Citreomontanin Asteltoxin (44) a mycotoxin structurally related to both citreoviridin (28) and the aurovertins was first isolated from toxic maize meal cultures of Aspergillus stellatus and its structure confirmed by single crystal X-ray cry~tallography.~~ NATURAL PRODUCT REPORTS 1993-5. M. DICKINSON Me. 0LeO MeOM' MewBz' PI BzlOwCHO i ii-iii 'c OH O B z H iViX I 1 xii -x xi Me H H Me (43) Reagents i hv;ii mCPBA NaHCO, CH,Cl,; iii THF; 3N HCl (3:1); iv Me,NNH, CH2Cl2 MgSO,; v EtMgBr THF; vi CSA acetone CuSO,; vii Li NH, Et,O; viii o-NO,C,H,SeCN Bu,P THF; ix H,O, THF; x 0,,CH,Cl, MeOH; xi CH,=CHMgBr THF; xii Ac,O Et,N DMAP Scheme 16 H3&-&2H t A H3CS-( CHp)BCH( NH2)C02H 16 II + H3C -C -I 'OH 18' 02 0 + Scheme 17 The polyene-pyrone citreomontanin (41) has been isolated the case of the aurovertins two biosynthetic pathways were in from Penicillium pedemontanum and also from a ci treoviridin- operation -the first in which C-14-3 was derived from producing strain of P.pulviIlorurn.lOO The structure of this methionine-malonate and the second in which these atoms compound has also been determined by means of X-ray were propionate-derived.crystallography and confirmed that the double bonds possessed In order to investigate the mechanism of the proposed 1,2-an all-E configuration. lol shift labelling studies with [I-13C,180,]acetate and with l80 The synthesis of the bistetrahydrofuran moiety of asteltoxin were carried Again as with both citreoviridin (28) and (44) has been reported and the route is illustrated in Scheme the aurovertins the pyrone ring oxygen atoms were found to be 16.1°2 Rearrangement of alcohol (42) gave the bistetra-acetate-derived. The remaining oxygen atoms with the ex-hydrofuran moiety of asteltoxin (43) with the correct relative ception of that attached to C(4) of the bistetrahydrofuran stereochemistry. system are 0 derived suggesting that this latter oxygen is Biosynthetic studies of the origin of asteltoxin in Aspergillus derived from the medium (Scheme 17).stellatus have demonstrated the incorporation of acetate with The mechanism proposed for the formation of asteltoxin (44) the position of label as shown in Scheme 17.1°3Feeding with in A. stellatus is outlined in Scheme 18.1°4 Thus the polyene [1,2-13C2]acetate proved the presence of eight intact acetate (45) was postulated to undergo monooxygenase-mediated units and also indicated the cleavage of a ninth unit via a 1,2-epoxidation to give the (3R 4R 5R 6R 7S 8S)-triepoxide bond migration. It was suggested that this cleavage occurred (46). Nucleophilic attack at C-4 by water would then initiate a via a pinacol or epoxide rearrangement to generate a branched series of reactions including the 1,2-shift resulting in the aldehyde which was subsequently utilized in the formation of formation of the bistetrahydrofuran moiety as shown.the tetrahydrofuran moiety. Both asteltoxin (44) and citreomontanin (41) were both led to incorporation tested for their effect on ATPase activity in Escherichia coli Feeding of (2S)-[methyl-13C]methionine of label at the C-4 and C-5 methyl groups and C-1 of the BF1.105 Whilst citreomontanin (41) was found to be completely bistetrahydrofuran moiety and at the two methyl groups of the inactive asteltoxin (44) was found to inhibit enzyme activity pyrone ring. [1-13C]Propionate was also incorporated with the with a potency intermediate between citreoviridin (28) and signal assigned to C-3 of the bistetrahydrofuran moiety in the aurovertin B (38).Asteltoxin (44) showed a large enhancement 13CNMR spectrum being enhanced. This suggested that as in of fluorescence upon interaction with BF, analogous to the NPR 10 NATURAL PRODUCT REPORTS 1993 1.2-ShiftI Me H Scheme 18 0 aurovertins and showed similar increase in intensity on treatment with ADP and was quenched on addition of Mg2+. However unlike the aurovertins asteltoxin did not enhance the binding affinity of BF for inorganic phosphate. 2.6 The Pyrenocines and Macommelins As well as citreoviridin Penicillium citreoviride has been the source of citreopyrone (58),lo6 and the novel dihydrothio- pyrone citreothiolactone (56).Io7 From a biogenetic point of view these may be derived from a common intermediate as will be discussed later.Citreopyrone (58) has also been isolated from Pyrenochaeta terrestris the causal agent of onion pink root disease and was named pyrenocine A. This latter name will be used in reference to structure (58) in the remainder of this review. The structurally-related pyrenocine B (55) was a co-metabolite.108~ log Pyrenocines A and B were originally erroneously assigned furan structures (47) and (48),loS re- spectively but were reassigned as (58) and (55) on the basis of an X-ray crystal structure determination of pyrenocine A.109 Pyrenocine C (49) has also been isolated from P. terrestris."' The macomellins (64) (59)-(61) which differ from the pyrenocines only with respect to the structure of the side chain at C-5 have been isolated from Macrophoma commelinae (fruit rot disease of apple and other plants)."' Rosellisin (1 14) was a co-metabolite of the macommelins ''I but had also previously been isolated from Hypomyces rosellus.112Its structure was originally misassigned as (50),but was later revised to (68) on the basis of biogenetic Rosellisin aldehyde (51) has also been isolated from Hypomyces ro~ellus."~ Compounds related to rosellisin have been reported.Macro- phin (53) has been obtained from Macrophoma commelinae along with macrophic acid (52).'14 Islandic acid (54) was isolated from Penicillium isiandicum.1'5 The biogenesis of pyrenocine A (58) and citreothiolactone (56) has been investigated in cultures of Penicillium citreo- H3CO OH CH20H p 0 CH3 / C02CH3 (49) (50) 0 (53)R= &CH3 0 OH (54) R = CH3 viride.l16 On addition of cysteine or methionine to the fermentation medium yields of the two metabolites decreased significantly.However addition of [1,2-13C,]acetate led to the isolation of enriched (58) and (56) as well as pyrenocine B (55) a metabolite not normally isolated from this organism. A possible biogenetic route was proposed (Scheme 19) in which all three intermediates were formed via a common intermediate (57). It was suggested that the sulfur atom in citreothiolactone was derived from enzyme-bound thiocrotonate although there is no evidence to support this. Feeding experiments with [1-13C]- and [1,2-13C2]acetate in Macrophoma commelinae resulted in formation of macom-melins (61) and (60) with a labelling pattern as shown (Scheme 20).l14Cultivation of the organism with diethyl [2-13C]malonate gave high enrichment at positions C-3 C-5 and C-7 of macommelinol (61) but only low incorporation at C-9.This result precluded the possibility that the macommelins were derived from a branched tetraketide chain,l16 but supported the 81 NATURAL PRODUCT REPORTS 1993-5. M. DICKINSON (55) 0 (57) Scheme 19 PH3CO HO H H * &OH+ OCH3 0 H3CmC02H -0 *o* o*o* Scheme 20 H3C0 H3C0 HO,H H3C0 OH * -hoH+ flH+ D&-COEH DD #CD3 0 * 0 * CH3 0 0 CH3 0 0 CH3 (59) (60) Scheme 21 theory proposed by Turner and Aldridgell' that an aromatic Compound (61) was only formed from (63) suggesting that this intermediate was formed with subsequent oxidative cleavage compound was at an early stage of the biosynthetic pathway.of the benzene ring followed by rearrangement. When [l-13C,2- [Methoxy-l4C] (59) was converted to radioactively-labelled 2H3]acetate was administered to M.commelinae deuterium was postulated intermediates (64) (67) (65) and (66). All were incorporated into the C-5 side chain of (59) (60) and (61) as transformed into (59) with the aldehyde (67) showing an shown in Scheme 21.'14 extremely high incorporation (91.7 Yo),suggesting that it is an A biogenetic pathway on the basis of the above results was immediate precursor. The incorporation of epoxide (66) into suggested to be as shown in Scheme 22.The epoxide (66) was (59) was low (2.5 %) with most of the radioactivity being taken postulated as intermediate in which a 1,2-hydride shift could into (60). The reduction of the alkene (65) to macommelin (64) occur thus accounting for the presence of a deuterium atom a was not detected by these experiments. Compound (64) to the pyrone ring in (59). [Methoxy-14C] (63) was prepared,l14 however was incorporated into (55). It was suggested that and shown to be incorporated into (59) (60) and (61). conversion of (65) to (64) was reversible. 6-2 OH HO HO*OH 'OH (70) The biosynthesis of rosellisin (68) a co-metabolite of the macommelins has been investigated in Hypomyces r0seZ1us.l~~ It was found that incorporation of [1-l3C]acetate and [2-I3C]acetate was as shown in Scheme 23.The branch carbons of the hydroxymethylene groups did not show any incorporation of label and so it was assumed that these were derived from the c pool. Both rosellisin (68) and rosellisin aldehyde (51) have been shown to be active against Staphyloccoccus aureus at low 113 The structurally related islandic acid (54) has exhibited cytotoxicity against Yoshida sarcoma cells in tissue culture and inhibited the transfection of BaciZZus phage M2.'15 Pyrenocines A (58) and B (55) were phytotoxic preventing germination of lettuce seeds and inhibiting root elongation in seedlings.lo8 Inhibition of root elongation was also demonstrated in rice and onion seedlings. Compound (58) showed the greater activity.Pyrenocine C (49) was reported to be only weakly phytotoxic.ll0 2.7 The Styryl-Pyrones and Related Compounds A number of conjugated arylpyrones e.g. yangonin (69) have been isolated from plant sources such as Piper Aniba Alpinia and Ranunculus. The first report of a styrylpyrone from a micro-organism however concerned the isolation of hispidin (79) from Polyporus hispidus,118. 119 a lignin-attacking white rot parasitic chiefly on ash (Fraxinus excelsior). Hispidin has since been isolated from a number of other species including Polyporus schweinitzii 12' Phellinus pomaceus where it is a co- metabolite with 3,14'-bishispidinyl (70),12' Phellinus igniarius,122 NATURAL PRODUCT REPORTS 1993 OH OH (72) X = H (73)X =OH 0 OH (74) X = H (75)X = OH OHI OH I and Gymnopilus species.123 Bisnoryangonin (7 1) was a co-metabolite in this latter organism and has also been reported to occur in Pholiota squarroso-adiposa 124 Gymnopilus spectabZis,'25 and G.decurrens.126A systematic study of the distribution of styrylpyrones and derivatives has been carried out among the Strophariuceue and related genera.12' Hispidin (79) and bisnoryangonin (71) were found to occur in Hypholoma Flammula Philiota and Gymnopilus species. Hypholomines A (72) and B (73) and fasciculines A (74) and B (75) were also found to be distributed amongst these same species. These compounds were also isolated from the fruiting bodies of Hypholoma fasciculare (Agaricales) (' Sulfur Tuft ').128 Other related compounds to have been isolated from micro-organisms were hymenoquinone (76) and leucohymeno- quinone (77) both metabolites of the fruiting bodies of Hyrnenochaete mougestii (Poriales).129 The synthesis of hispidin (79) has been reported on occasions and involves condensation of an aromatic aldehyde with the NATURAL PRODUCT REPORTS 1993-5.M. DICKINSON MOMO + MOMO OH i ii 1 OH OH - iii iv Reagents i EtOH KOH; ii H+; iii Ac,O; iv aq. H,SO, EtOH A Scheme 24 (80)R = n-C4Hg methyl ether of dehydroacetic acid to give a protected hispidin analogue (78). Deprotection followed by recyclization of the pyrone ring gave hispidin (79) (Scheme 24).l19* 130 Biosynthetic studies on the styrylpyrones have concentrated on the formation of hispidin (79) in cultures of Polyporus hispidus.Early studies demonstrated the incorporation of [U-14C]phenylalanine and [1-l*C]acetate and so suggested that hispidin was formed by condensation of a phenylpropanoid moiety with two acetate Conversion of phenylalanine to cinnamic acid in cultures of P.hispidus was also demonstrated and the presence of an enzyme capable of effecting hy- droxylation of cinnamic p-coumaric and benzoic acids was indicated. 132 p-Coumaric acid and caffeic acid were incor-porated efficiently into hispidin (79).133 The hydroxylase enzyme from P.hispidus was isolated and shown to catalyse hydroxylation of p-coumaric acid and even more readily hydroxylation of bisnoryangonin (7 1) to yield hispidin (79).NADH NADPH and ascorbate were found to serve as electron donor~.'~~,~~~ It was also noted that blue light (43k530 nm) stimulated pigment formation. The effect of light on growth pigmentation and enzymic activity in the biosynthesis of hispidin (79) was studied in more detail. It was found that conversion of cinnamic acid to p-coumaric acid was (81) R=H (82)R=CH3 enhanced whilst p-coumaric acid was converted to caffeic acid only in cultures exposed to light.134 Action spectrum studies showed that the system responded to light of 380 and 440 nm. Cycloheximide was found to block light-induced activity. 135 As the fruiting bodies of P. hispidus matured the amount of hispidin present decreased. Simultaneously the fruit- bodies became tougher and their fibrous 'woody' structure more pronounced.Oxidase enzymes isolated from cultures of P. hispidus were found to act on hispidin in vitro to bring about rapid oxidative polymerization,ll* and so a role for hispidin as a precursor of toughening polymers in Basidiomycetes had been suggested. No firm evidence either for or against this hypothesis has been reported although the presence of hispidin in other non-woody Basidiomycetes suggested that this might not be the case.133 2.8 Pyran-Zones from the Gliding Bacteria Gliding bacterium Myxococcus fulvus Mx f50 has been the source of the novel N-alkenylcarbamate pyrones myxo-pyronins A (84) and B (80),136whilst the structurally related corallopyronins A @I) B (82) and C (83) have been isolated from Corallococcus coralloides Cc c 127.13' NATURAL PRODUCT REPORTS 1993 s I 0 OH H36-C02H ___t A H3CS-( CH2)2CH( NH2)COZH Scheme 25 0 R' OyyR2 H 3H** C m H R20 (85) R' = CHO R2 = OCH3 (88)R' = CHO R2 = xylose (86) R' = CH20H R2 = OCH3 (89)R' = CH3 R2 = (glucose)eibose (87) R' = CHO R2 = -NHCH&H20H Biosynthetic studies on myxopyronin A have shown it to be derived from two polyketide chains with glycine being incorporated as a starter unit in one of the chains.138 Two of the remaining methyl groups and the carbamate methyl ester are incorporated from methionine with the third methyl group being derived from the C-2 of acetate (Scheme 25).Myxopyronins A (84) and B (80) were found to be active against a range of bacteria i.e.Corynebacterium mediolanum Arthrobacter simplex Bacillus megaterium B. subtilis Brevi- bacterium ammoniagenes Staphylococcus uureus Micrococcus luteus Acinetobacter calcoaceticus and Agrobacterium tume-faciens. Activity was marked for Gram-positive bacteria. However Gram-negative bacteria were hardly affected and yeasts and moulds were totally re~istant.'~~ Incorporation with Staphylococcus aureus sug-gested that the myxopyronins inhibited RNA synthesis and thus with a certain delay protein synthesis. This was confirmed when DNA-dependent RNA polymerase isolated from Escherichia coli was found to be strongly inhibited by the myxopyronins. Inhibition with both whole cells (S. aureus) or isolated enzyme (E.coli) was not however inhibited com- pletely. The inhibitory effect was not seen for wheat germ RNA polymerase 11 and so the biological activity appeared to be restricted to prokaryotic RNA polymerases. Myxopyronins had no acute toxicity for mice up to 100 mg/kg (s.c.). In general myxopyronin B (80) appeared to be more active than myxopyronin A (84). The corallopyronins (81)-(83) were found to exhibit similar biological activity to the myxopyronins,140 with the mechanism of action also being similar i.e. inhibition of bacterial RNA polymerases. However whereas the myxopyronins only par- tially inhibited RNA synthesis corallopyronin A (81) gave total inhibition both in whole cells and with the isolated enzyme. RNA synthesis was inhibited even after chain elongation had started.Once again eukaryotic cells were completely resistant. 2.9 The Phytotoxic Pyran-2-ones A number of pyran-2-ones have been isolated from micro- organisms which were pathogenic on plants and the pyrones themselves were found to exhibit some of the phytotoxic (92) (93) activity attributed to the organism. Such compounds include radicinin (94) the solanopyrones A (85) B (86) and C (87) poaefusarin (88) sporofusarin (89) and colletopyrone (90). These will be discussed in this section. 2.9.1 Radicinin and Related Compounds Radicinin (94) also named stemphylone was first reported in culture filtrates of Alternaria r~dicina,'~~ and has been isolated from Stemphylium radicinum. 142-'45 This latter organism has been shown to be identical with A.radi~ina.'*~ Radicinin (94) has also been found in culture filtrates of Curvularia lunata C. inequalis C. coisis and C. trij~lii,"~ and as a co-metabolite with the structurally related radicinol (91) in culture filtrates of Cochliobolus l~nata,~~' and Alternaria chrysanthemi.148 The X-ray crystal structure of radicinin (94) has been reported whilst the absolute configuration of the 4-O-p-bromobenzoyl ester of radicinin and by analogy of radicinin itself has been determined.138 Two other closely related metabolites deoxy- radicinin (92) and 3-epideoxyradicinol (93) have been isolated from Alternaria helianthi.'". lj0 NATURAL PRODUCT REPORTS 1993-5. M. DICKINSON Scheme 26 * H&-CO,H dH2(COZEt) (94) Scheme 27 The syntheses of (-t )-radicinin (94) and the dihydro analogue have been re~0rted.l~l-l~~ The route through to radicinin is outlined in Scheme 26.15' Construction of the second ring of radicinin was achieved via the Lewis acid-mediated con-densation of crotonyl chloride with the hydroxy-pyrone.Biosynthetic studies on radicinin have been carried out and its derivation from acetate established. Labelling studies with [ 1-'*C]acetate and [2-14C]malonate led to distribution of label as shown in Scheme 27 with evidence suggesting that radicinin (94) was formed by the condensation of two acetate-malonate- derived chains.'j4 Feeding studies with [ 1,2-13C,]acetate confirmed these results. Incorporation of [ 1-l3C]- and [2-l3C]acetate into deoxyradicinin (92) was shown to give a similar labelling pattern to that demonstrated for radicinin.150 Two pathways are biosynthetically possible for the formation of radicinin.The first would require the condensation of a C,-unit with a C,-unit whilst the second would require the condensation of two C,- units. Although the former is biosynthetically preferable no evidence has been obtained that favours one pathway over the other. Radicinol (91) was produced some time after the first production of radicinin (94) in cultures of Alternaria chrysanthemi and with concomitant decrease in concentration of the latter thus suggesting that radicinin was converted to radicinol by this Radicinin (94) has been shown to inhibit the germination of seeds of Lepidum sativum (cress) at concentrations of 5 x lop5M.At concentrations which permitted seed germi- nation considerable damage to root development was noted in that the roots were shorter than normal discoloured and devoid of root hairs. 142 Stems and seed-leaves were not affected. Radicinin has been found to be a constituent of necrotic lesions on chrysanthemum leaves that were artificially infected with Alternaria chrysanthemi. This suggested a causal role for the metabolite in foliar disease caused by this organism. Radicinol (91) has been shown to exhibit similar phytotoxic effects to that demonstrated for radicinin (94) and caused interveinal necrosis of cuttings of Canada thistle.lg8 3-Epideoxyradicinol (93) when applied over needle punctures on sunflower leaves caused small necrotic spots in less than 24 hours.These were enlarged after 24 hours and surrounded by chlorotic halos. These symptoms were also typical of the leaf spot phase of the disease caused by Alternaria helianthi. Although this suggested a causal role for 3-epideoxyradicinol in disease produced by the organism it has not been identified as a constituent of A. helianthi-induced sunflower leaf lesions. Deoxyradicinin (9 I) has been identified however. I5O (95) Radicinin has been reported to be inhibitory towards the growth of several Gram-positive bacteria such as Staphy-lococcus aureus Bacillus cereus and Clostridium species,142 146,148 and antagonistic towards Phytophthora erythroseptica.l'l In general however its antifungal properties are negligible.Experiments to determine the mode of action of radicinin (94) showed that it increased the rate of dehydrogenation of isopropyl alcohol by Fusarium lini. However there was no effect on the quantity or degree of desaturation of fatty acid synthesized.144 2.9.2 The Solanopyrones The solanopyrones A (85) B (86) and C (87) have been isolated from Alternaria solani the causal organism of early blight disease of tomato and potato. Solanopyrone A (85) induced a necrotic lesion on the leaf of potato at concentrations of 100 ,ug/,ul (rnethanol).'j6 2.9.3 Poaefusarin and Sporofusarin Poaefusarin (88) has been isolated from Fusarium poae and sporofusarin (89) from Fusariurn sporotrichiella.15' These Fusarium species have been identified as the causal organism of alimentary toxic aleukia. The toxins themselves have marked phytotoxic effects as well as exhibiting mammalian toxi~ity.'~' Phytotoxic symptoms include the death of branches of peas beans and tomatoes accompanied by extreme loss of turgor. The germination of pea beans and barley seeds was completely inhibited. In mammals the toxins caused temporary inflammation of the skin and oedematous haemorrhagic or leukocytorric reactions. The final stages of toxicity resulted in leucopenia and agranulocytosis necrotic angina haemorrhagic diathesis sepsis and necrosis of various parts of the alimentary tract especially the throat and exhaustion of the bone marrow.2.9.4 Colletopyrone Colletopyrone (90) has been isolated from Colletotrichum nicotianae a pathogenic fungus causative of tobacco anthra~n0se.l~~ It is related in structure to helipyrone (95) a dipyran-2-one that has been isolated from a higher plant Helichrysum italicurn. When solutions of colletopyrone (90) were placed on young tobacco leaves that had been pricked with a needle brown necrotic spots appeared within three days; the symptoms were analogous to those caused by the pathogenic fungus.lj8 NATURAL PRODUCT REPORTS 1993 0 00 0 (97) (99) (100) iii (CH,),SO, K,CO,; iv MeOCH,Cl TiCl,; v SeO Scheme 28 A Scheme 29 (98) Reagents i 2 BuLi; ii H,C(CH,),Br; 2.10 Other Pyran-Zones 2.10.1 Phacidin Phacidin (101) has been isolated from the canker fungus Potebniamyces balsamicola causal organism of bark disease in Abies grandis.160 161 Phacidin was originally assigned the pyran- 4-one structure (96),161 which was revised to that of structure (97) on the basis of spectroscopic evidence.162 However the actual structure was finally confirmed as the pyran-2-one (lOl) by an unambiguous total synthesis the route for which is outlined in Scheme 28.163 Thus pyrone (98) was 0-methylated under conditions that had been shown to produce only 4- methoxy-2H-pyran-2-ones to give methyl ether (99) which was then converted into phacidin via the formyl derivative (100). Labelling studies with [1-13C]-and [1 ,2-13C,]acetate demonstrated that phacidin (101) was derived from seven acetate units with two carbons derived from the C p00l.l~~ The distribution of label is shown in Scheme 29.Phacidin (101) showed potent antifungal properties and inhibited the growth of fungi in all the major groups. Fungi that were particularly affected were Phytophthora cactorum Xenomeris abietis Acremonium tsugae Sirococcus strobilinus Conisphora puteana Lenzites saepiariu Polyporus schweinitzii P. sulphureus Poria placenta P. subacida P. weirii and Serpula himuntioides.160 Although in most cases inhibition by the control antibiotic nystatin was greater phacidin was con- siderably more inhibitory against species of Pythium Phycomycetes and Phytophthora. The effect of phacidin (101) on fungi and yeasts that cause superficial and deep mycoses in man was also investigated.l'j4 It was found that amongst yeasts species of Cundida Sac- charomyces Trichosporon and Torulopsis were inhibited.Phacidin was also inhibitory against dermatophytes such as Epidermophyton floccosum Trichophyton mentagrophytes and T. rubrum its in vitro effectiveness being similar to that reported for griseofulvin. Its activity against systemic dimorphic fungi e.g. Histoplasma capsulatum Sporothrix schenckii Blastomyces dermatitidis and Coccidioides immitis was in general greater than that of the known antifungal agent 5-fluorocytosine. By comparison phacidin (101) was compara- tively ineffective against opportunistic fungi such as Aspergillus species. 2.10.2 Elasnin Elasnin (1 04) was isolated from Streptomyces norboritoensis.165 The synthesis of elasnin has been reported and the route followed is outlined in Scheme 30.166 Treatment of diketone (102) with a catalytic amount of acid and simultaneous azeotropic removal of water gave pyrone (103 R = H) which was then converted into elasnin (104). Original biosynthetic studies using [1 ,2-13C,]acetate as the labelled precursor suggested that elasnin (104) was derived from twelve molecules of acetate.167 This was confirmed in subsequent studies with the distribution of label as shown in SchemC 31.168 Elasnin (104) was originally isolated because of its inhibitory effect on human sputum (leukocyte) elastase an enzyme that has been implicated in many inflammatory disease states such as pulmonary emphysema acute arthritis and destruction of connective tissue.50 YOinhibition of this enzyme was achieved by elasnin at concentrations of 1.3 ,~g/ml.~~~* 169The compound appeared to be specific in its activity with considerably higher concentrations required in order to achieve 50 YOinhibition of pancreatic elastase. Chymotrypsin trypsin thermolysin and papain were unaffected. A number of analogues of elasnin have been prepared with the aim of developing more specific inhibitors of greater potency. The phenyl derivative (105) was as active as elasnin against human sputum elastase 170 and more effective against porcine pancreatic elastase or chymotrypsin whilst the octyl derivative (106) was thirty times more active than elasnir~.~'~ NATURAL PRODUCT REPORTS 1993-5.M. DICKINSON 0 CO2Me ... TCHO i ii 111 iv ___F C02Me -7 -1 (102) (103) v-viii J 0 (104) Reagents i Base condensation; ii DDQ dioxan; iii TsOH (cat.) toluene; iv Ac,O pyridine; v mCPBA ArSAr; vi 10% Pd-C EtOH; vii Jones reagent; viii conc. H,SO, 0 “C Scheme 30 0 ___t H3C -C02Na (104) Scheme 31 Scheme 32 Studies on the effects of substituents on biological activity have 2-10-3NectriaPYrone and Related Compounds also been carried 0~t.l’~ Nectriapyrone (107) has been isolated from Gyrostroma Elasnin (104) was reported to be of low toxicity with an missouriense the imperfect stage of Thyronectria rnissouri-and more recently from Gliocladium ~ermoesenii.”~ LD, in mice 290 mg/kg (i.p.) and > 1000 mg/kg rally).'^^ ensi~,~’~ Elasnin has no antibacterial or antifungal a~tivity.’~’ Vermopyrone (108) was a co-metabolite in this latter organism.NPR 10 D@-( C H&CH( NH2)COzH Scheme 33 A I IVI H3CS-( CH2)2CH( NH,)( (110) X=H (111) X=F Scheme 34 A closely related compound fusalanipyrone (109) has been isolated from Fusarium solani. li4 A route through to substituted 2-pyrones7 which involves the condensation of two molecules of @unsaturated acid chlorides with loss of two molecules of hydrogen chloride has been developed. Fusalanipyrone (109) was one of the pyrones synthesized by this method.175 When nectriapyrone (107) was first isolated it was reported to incorporate [2-14C]mevalonic acid and the conclusion was drawn that nectriapyrone was in fact a monoterpene.’i2 However there was no evidence from degradation studies to support this claim.Recent studies using [1,2-13C2]acetate and [Me-13C]methionine have demonstrated that this metabolite is acetate-derived with the extra methyl groups being introduced from methionine (Scheme 32).173 The labelling pattern for vermopyrone (108) suggested that the latter may have arisen through cleavage of nectriapyrone. The fact that vermopyrone was not isolated from shorter fermentations provided some support for this hypothesis. Fusalanipyrone (109) also appeared to follow the isoprene rule and the question was raised as to whether this might be a monoterpene. However feeding studies with [2H3C]methionine demonstrated that the C-3 and the C-l’methyl groups were methionine-derived and that presumably fusalanipyrone (1 09) was biosynthesized via a polyketide which was subsequently methylated (Scheme 33).176 Nectriapyrone (107) has been reported to display anti-bacterial activity against Staphylococcus aureus at a con-centration of 30 ppm.172 Fusalanipyrone was in contrast inactive against Staphylococcus and Escherichia coli although it displayed weak antibiotic activity against Candida albicans Mucor and Trichoderma k~ningii.l~~ 2.10.4 Vulgamycin Vulgamycin (1 lo) also named enterocin has been isolated from Streptomyces candidus var. enterostaticus S. virido-chromogenes,17i and S. hygroscopicus.178 An X-ray crystal structure determination of the m-bromobenzoyl ester of vulgamycin has been carried out.179 Biosynthetic feeding studies with [1-13C]- [2-13C]- and [1,2-13C2]acetate demonstrated that vulgamycin was derived from NATURAL PRODUCT REPORTS 1993 OCH3 I (113) R=H (114) R=CHs 0 0 Scheme 35 seven acetate units with the distribution of label as shown in Scheme 34.17* The methoxyl carbon of the pyrone ring was derived from methionine. [U-14C]Benzoate was incorporated specifically into the benzoyl portion of vulgamycin. It was thus proposed that vulgamycin was biosynthesized from methionine and seven acetate units with benzoate as the starter unit. Vulgamycin (1 10) was bacteriostatic against both Gram- positive and Gram-negative bacteria such as Escherichia coli and species of Proteus Sarcina Staphylococcus and Coryne- bacterium.Derivatives of vulgamycin were prepared in which the aromatic moiety was substituted with fluorine at various positions -these derivatives were formed by addition of the fluorinated benzoic acid to fermentations of Streptomyces hygroscopicus.180 Although p-fluorovulgamycin (1 11) showed stronger activity than the parent compound against Micro- coccus luteus the fluorinated derivatives displayed very little difference in their antimicrobial spectrum compared to vulgamycin itself. Vulgamycin had no activity against fungi and yeasts and its mammalian toxicity was 10w.l~’ 2.10.5 Luteoreticulin Luteoreticulin (1 12) has been isolated as a toxic metabolite of Streptomyces luteoreticuli.lsl NATURAL PRODUCT REPORTS 1993-5.M. DICKINSON HO t.r 0 Ho2C+co2H NHp l!, 0' -uu H CH2Br 7;O2H i ii iii __.F ___F -I Et02C00 H02C Reagents i NBS CCI, hv or peroxide; ii Na+ C(NHCOCH,)(CO,Et),; iii HCl/CH,CO,H 100 "C sealed tube Scheme 36 CO2H I 2.10.6 Aszonapyrone A Aszonapyrone A (1 13) has been isolated from Aspergillus zonatus,1s2and the crystal structure of the monomethyl ether (1 14) determined by X-ray analysis.183 It has been suggested that aszonapyrone A is biosynthesized by a combination of both the mevalonate-geranylgeranyl-pyrophosphate route and the acetate-polyketide route.lsz Aszonapyrone A showed antibacterial activity with an MIC of 6.3 ,ug/ml against Staphylococcus aureus.182 2.10.7 Coarctutin Coarctatin (1 16) has been isolated as an inactive metabolite of the fungus Chaetomium ~ourctatum'~~ and its structure was determined by spectroscopic means.Confirmation of the structure was obtained by X-ray crystallography studies on the dibromo-derivative (1 15).ls5 A number of possible biosynthetic pathways have been proposed for the formation of coarctatin. However feeding studies with [1,2-13C,]acetate demonstrated the incorporation of four intact acetate units into the structure (Scheme 35). The methyl carbon of [2-13C]acetate was also incorporated into the three remaining carbons as shown indicating that these were derived from the C 2.10.8 Tuiwapyrone Taiwapyrone (117) has been isolated from the fungus Cercospora taiwanensis a plant pathogen and its structure determined by spectroscopic means.lsi 2.10.9 Stizolobic Acid and Stizolobinic Acid Stizolobic acid (123) was first isolated from the cut surface of the epicotyl tips of etiolated seedlings of Stizolobium hassjoo (Velvet bean) and its structure reported to be that of the pyran- 4-one (1 18) on the basis of chemical degradations.ls8 It was also found to be present in other Stizolobium species and in Mucuna irukanda (Leguminoseae).The structure of stizolobic acid was later reassigned to that of the pyran-2-one (123) whilst the structure of a co-metabolite in S. hassjoo named stizolobinic acid was shown to be the related pyran-2-one (1 19).189 Both of these metabolites have since been isolated from the fungus Amanita pantherina a frequent cause of non-fatal mushroom poisoning in the Pacific Northwest.lgo The syntheses of stizolobic acid (123) and stizolobinic acid (1 19) have been re~0rted.l~~ The synthesis of the former is illustrated in Scheme 36. Thus ethyl 4-methylpyran-2-one-6- carboxylate (120) is treated with N-bromosuccinimide to give the bromomethyl derivative (12 I) which condenses with sodio diethyl acetamidomalonate to give pyrone (1 22). Hydrolysis of this compound gave the target diacid (123). Stizolobinic acid (1 19) was synthesized in an analogous manner taking ethyl 3-methylpyran-2-one-6-carboxylateas the starting pyran-2-one. Biosynthetic studies utilizing the plants S. hassjoo and Mucuna deeringiana demonstrated the derivation of both stizolobic acid (1 23) and stizolobinic acid (1 19) from tyrosine via DOPA with extradiol cleavage of the aromatic ring of DOPA being invoked in order to explain the formation of the heterocyclic rings of the pyrone-acid~.~~~-'~~ Th e enzymes responsible for this conversion have been isolated and purified.lg3.lg5 Feeding studies with [U-14C]DOPA utilizing Amanita pantherina demonstrated the incorporation of this amino acid into stizolobic acid thus indicating that a similar biosynthetic pathway was acting in the fungus as had been demonstrated for higher plants.lg6 2.10.10 Muscaurin II Muscaurin I1 (124) is one of a group of orange pigments to have been isolated from the caps of Amanita muscaria (Fly Agaric).lgi It is structurally related to stizolobic acid (123) and its synthesis from the latter has been reported.lg7 3 Microbial Dihydropyran-2-ones 3.1 Pestalotin and Related Compounds Pestalotin (also designated LL-P880a) (129) was originally isolated from the culture broth of Pestalotia cryptomeriaecola NATURAL PRODUCT REPORTS 1993 OCH OCH, I I OCH OCH, I I OH OH a fungus pathogen of Cryptomeriajaponica(Japanese Cedar).lg8 It has since been isolated from an unidentified Penicillium species,lg9 and an unidentified fungus which was believed to be neither a Pestalotia nor a Penicillium species. The keto- analogue (125) was a co-metabolite in this latter organism. Both pestalotin (129) and the keto analogue (125) have been isolated from another unidentified Penicillium species along with the fully unsaturated pyran-2-one dehydropestalotin (1 26).201 The dihydroxy analogues LL-P88Op (127) and LL-P880y (128) have also been isolated from an unidentified Penicillium species.2o2 The absolute configuration of pestalotin (129) at C-6 and C-1’ has been determined as (S).lg9 The structure of pestalotin (129) established by spectroscopic means,*03 has been confirmed by total synthesis,204 the route for which is illustrated in Scheme 37.The pyrone ring was constructed from ethyl acetoacetate whilst the side chain was synthesized from acrolein and butylmagnesium bromide. Reformatsky methodology yielded pestalotin (1 29) though in poor yield.The polyketide origin of pestalotin (129) has been determined from biosynthetic studies with labelled acetate. Thus addition of [1,2-13C,]acetate to fungal cultures led to isolation of pestalotin with the distribution of label as shown in Scheme 38.,05 Related metabolites are also presumably polyketide derived. Pestalotin (129) was originally isolated because of its role as a gibberellin synergist. Thus it was found that when pestalotin alone was applied to rice seedlings no effect was observed. However when it was applied in combination with gibberellic acid (GA,) the stimulative effect of this plant growth hormone was considerably enhanced. It was demonstrated that this enhancement was due to an increase in the promotive effect of GA on a-amylase synthesis.lg8 Pestalotin alone was also found to be capable of inducing sugar release although its activity was much lower than that of GA,.3.2 Aspyrone and Related Compounds 3.2.1 Aspyrone Aspyrone (1 30) was originally isolated from Aspergillus melleus,206and has since been isolated from A. elegans,”’ A. ochraceuS,208and another unidentified Aspergillus species.2o9 Its structure has been determined by spectroscopic means and by X-ray crystallographic studies.210 Considerable work has been carried out in elucidating the biosynthetic origins of aspyrone (130). Feeding studies with [I- 13C]- [2-13C]- and [1,2-13C,]acetate established the labelling pattern to be as shown in Scheme 39.211 It was proposed that the pyrone was formed via a pentaketide precursor which underwent a Favorskii-type rearrangement.Cleavage of an originally intact acetate unit would account for loss of 1,2-coupling in the 13C NMR spectrum as observed for the C-6 C H3COC H2C02E t i ii iii-v J J BrCH+=CHCO,Et CH,(CH2)3C?-CHO OCH OTHP vi vii I OCH, I OH ( 129) Reagents i CH(OCH,), H,SO (cat.); ii NBS CCl, A; iii acrolein; iv 0,;v Dihydropyran H+; vi Zn; vii H+ Scheme 37 OCH, I* ~~6-50,~ (1 29) Scheme 38 (130) Scheme 39 methyl group of [1 ,2-13C,]acetate enriched aspyrone.212-21* When a 13CNMR spectrum was obtained at 500 MHz a small coupling of 6.2 Hz between C-1 and C-8 was observed thus demonstrating that these carbons were originally derived from the same acetate unit.212 Incorporation of [2-14C]malonate into aspyrone demonstrated lower levels of label at C-10 thus identifying C-9-C-10 as the starter unit.Any possibility that aspyrone may have been derived from an aromatic intermediate such as mellein (1 3 1) (a co-metabolite) was discounted on the basis of feeding studies with [2-3H,]a~etate.215 Tritium was retained at C-7 whereas in the formation of mellein or other aromatic metabolites all three hydrogens would be removed in the formation of the aryl ring. Asperlactone (136) a co-metabolite of aspyrone (130) showed a similar incorporation pattern to that observed for the latter. This could be accounted for if both metabolites were derived from a common (post-Favorskii rearrangement) in- termediate.216 Feeding studies using 180-labelled precursors NATURAL PRODUCT REPORTS 1993-5.M. DICKINSON HOdMe t t +Me NAH’ -H20* Me t Scheme 40 HOh H3C4oAo \ H have allowed further elaboration of the biosynthetic pathway to aspyrone. When [l-13C,1s02]acetate was investigated as a precursor it was found that there were no 180-isotope induced shifts3n the 13C NMR spectrum indicating that none of the oxygen atoms of aspyrone were acetate derived. Growth of organisms under an atmosphere of 1802 gas and simultaneous addition of 13C-labelled acetate demonstrated that the epoxide and C-5-hydroxy oxygen atoms were derived from the atmosphere. In addition to this the C-2 and C-6 signals were also shifted but the intensity of their signals was approximately half that of the carbons attached to the hydroxyl and epoxide oxygen atoms.It was suggested that l80had been introduced onto C-2 from the atmosphere and that this was incorporated equally into both the carbonyl and ether oxygen of the pyrone ring. The remaining oxygen at C-2 would therefore be derived from the medium. Similar results were observed for asperlactone (I 36). A proposed biosynthetic pathway that takes into account all the above results has been postulated,216-220 and is illustrated in Scheme 40. Thus the epoxide (133) derived from the trienone intermediate (1 32) would undergo rearrangement to give the aldehyde (134). Further epoxidation and NAD+- mediated oxidation would then give the epoxycarboxylic acid (135).Ring closure to either end of the epoxide moiety would finally yield either aspyrone (130) or asperlactone (1 36). 3.2.2 Asperline Phomaluctone and their Derivatives Asperline (U-13,933) (140) was originally isolated from Aspergillus nidulans,221* 222 and has since been isolated from A. H36 -C02H (140) Scheme 41 * H,C-CO,H -H 0 3c~ (141) Scheme 42 carneus20i and A. caespito~u~.~~~ The epimer of asperline (1 37) was a co-metabolite in this latter organism as was the propenyl- derivative (1 38). Phomalactone (1 39) has been isolated from an unidentified Nigrospora species,224 and from an unidentified Phoma species.207 Feeding studies with [2-13C]acetate have demonstrated that asperline was polyketide-derived with the distribution of label as shown in Scheme 41.225 Asperline (140) displayed antibiotic activity against Staphy-lococcus aureus Proteus vulgaris Salmonella gallinarum Ba- cillus cereus Sarcina lutea Mycobacterium avium Salmonella pullorum Rhodopseudomonas spheroides and Chromobacterium violaceurn in vitro although it was inactive in P.vulgaris- infected mice when they were treated subcutaneously at the maximum tolerated dose.221,226 Asperline was also found to exhibit antifungal activity against Trichophyton violaceurn T. rubrum Homodendrum compactum Coccidioides immitis Blastomyces dermatitidis and Nocardia asteroides,226 but was inactive against Fusarium inoculijorm and Verticillium albo- ~trurn.~~~ Activity against Candida albicans was also noted.The related metabolites have been reported to exhibit a similar antimicrobial spectr~m.~~~~ 223 3.2.3 Astepyrone Astepyrone (141) has been isolated from cultures of Aspergillus terreus and has been shown to be a polyketide.22i The distribution of label derived from [1-l3C]acetate was as shown in Scheme 42. NATURAL PRODUCT REPORTS 1993 (142) R = CH3 R' = CH2CH3 R2 = CH20H (143) R = R' = CH3 R2 = CH20H (144) R = H R' = R2 = CH3 (145) R = H R' = CH2CH3 R2 = CH3 H3C-CO2H 0 OH HC ____t -C02H C02H (147) Scheme 43 Astepyrone was reported to exhibit antiulcerogenic activity in rat but also showed considerable toxicity. 3.3 The Leptomycins Kazusamycins and Anguinomycins A group of structurally-related cytotoxic dihydropyran-2-ones isolated from Streptomyces species are leptomycins A (146) and B (147) kazusamycins A (142) and B (143) and anguino- mycins A (144) and B (145).Leptomycin A (146) (also named PD 118,607) was isolated from Streptomyces 229 and from another Streptomyces species,23n with leptomycin B (147) as a co-metabolite. The latter compound which is identical to PD 114,720 and (3-940 has also been isolated from an unidentified Actinomycete. 231-232 Leptomycins A and B differ only in the nature of the alkyl group at C-3' of the polyene side chain. The kazusamycins are analogous to the leptomycins but bear a hydroxymethyl substituent at C-11' of the same side chain. Kazusamycin A (142) (identical to PD 114,721) has been isolated from the same unidentified Actinomycete as a co-metabolite of leptomycin and from a Streptomyces sp.233*234 B,231,232 Ka zusamycin B (143) (PD 124,895) was also isolated from this latter or-gani~m,~~~ as well as from another unspecified Streptomyces sp.236 Anguinomycins A (144) and B (145) isolated from a Streptomyces SP.,~~' differ from the leptomycins only with respect to the methyl substituent at C-5 of the dihydropyrone ring this group being absent in the former.Incorporation studies with labelled precursors ([1-13C]-acetate [1-13C]propionate and [1 -13C]butyrate) demonstrated that leptomycin A (146) was derived from four acetate units and eight propionate units with the distribution of label as shown in Scheme 43.Leptomycin B however was derived from four acetate units and seven propionate units with C-2' C-3' and the C-3' ethyl substituent being butyrate The biosynthetic origins of the kazusamycins and anguino- mycins have not been determined but are presumably analogous to the leptomycins As already mentioned all these compounds have been shown to be cytotoxic and as such their biological activity has been explored on a number of occasions. The leptomycins (146 and 147) have been shown to cause hyphal curling of Mucor racemosus M. rouxianus and Trichophyton mentagrophytes and to cause cell elongation of Schizosaccharornyces pombe.229.230 Their activity against other micro-organisms is however less well pronounced. They showed weak activity against Rhizopus and Rhodotorul~,~~~ whilst leptomycin B (147) was also active against Alcaligenes viscolactis Microcnccus luteus Staphylococcus aureus Streptococcus pj'ogenes S.pneumoniae and Bacillus With these exceptions most other fungi or yeasts were insensitive as were Gram-positive and Gram-negative bacteria e.g. species of Aerobacter Bacillus Mycobacterium Corynebacterium Staphylococcus Pseudo-monas Aspergillus Penicillium Paecilomyces and Candida."" Kazusamycin A (142) was active against fungi and some yeasts but was inactive against Gram-positive and Gram-negative bacteria.234 The antimicrobial spectrum of kazusamycin B (143) is similar to that of kazusamycin A.235 The mode of action of leptomycin B (147) with Schizo-saccharomyces pombe was examined.228 Low concentrations caused inhibition of cell division leading to the production of elongated cells with morphologically altered nuclei.High concentrations of leptomycin B inhibited nucleic acid synthesis. It appeared from the evidence obtained that the antibiotic inhibited a specific step possibly in the M phase just prior to nuclear division. Leptomycin A (146) was highly active against murine B16 melanoma in vivo and showed anticancer activity at very low dosages.239 Leptomycin B (147) was active in vitro against a number of human and mouse tumour lines and in vivo against murine experimental tumour systems such as P388 leukaemia L12 I0 leukaemia (IC50= 3 x M) Ridgeway osteogenic and M 5076 sarcomas and mammary adenocarcinoma 16/C.231.239 Growth of HeLa cells was also inhibited and the life-span of mice bearing Ehrlich ascite carcinoma or Lewis lung carcinoma was increased."O Kazusamycin A (142) was also strongly active against murine tumours in vi~o,~~~.241 as were the anguin~mycins.'~~ Anguinomycin B (145) was found to be more potent than anguinomycin A (144).237 NATURAL PRODUCT REPORTS 1993-5. M. DICKINSON HO CH (148) R’ = H R2 = OH (149) R’ = R2= H (150) R’ = R2 =OH (151) R = OC(O)CH(CH3)2 (152) R = H (1 53) R = OC(O)CH2CH(CH& (154) R = OC(O)CH2CH&H(CH& (155) R = OC(0)-(cyclohexyl) (1 56) R = OC(O)CH2CH2CH( CH3)CH2CH3 (157) R = OC(O)CH(CH3)CH2CH3 OH 0 Scheme 44 3.4 The Phoslactomycins and Related Compounds The phoslactomycins are a group of biologically active dihydropyran-2-ones containing a phosphate ester moiety.A number of structurally related compounds have also been isolated and these will be discussed together in this section. CI-920 (PD 110,161) (148) PD 113,270 (149) and PD 113,271 (150) were the first of this group of metabolites to be isolated in 1983 from Streptomyces pulveraceus subsp. fostreus.242 Their structures were determined by a combination of spectral and chemical The phoslactomycins A (151) B (152) C (153) D (154) E (155) and F (156) were isolated as a complex from culture broth of Streptomyces nigrescens.243Their structures have been shown to differ only with respect to the nature of the substituent on the cyclohexane ring.245 Phoslactomycin B (1 52) is identical to phospholine which has been isolated from Streptomyces hygroscopi~us,~~~- 247 whilst phoslactomycin C (153) is identical to phosphazomycin C, isolated from Streptomyces sp.248 Phosphazomycin C (1 57) was a co-metabolite in this latter organism,248 as was phosphazomycin A.249A structure has not been assigned to this metabolite although it appears to belong to the phoslactomycin class of antitumour antibiotics.CI-920 (148) has been shown to exhibit cytotoxic activity against murine P388 lymphocytic and L1210 lymphoid leu- kaemia as have PD 113,270 (149) and PD 113,271 (150) with the former being the most active.242 When CI-920 (148) was administered to mice (25 mg/kg i.p.) bearing approximately lo7 L1210 leukaemic cells it was found to be curative in about 10 % of the mice whilst the lifespan of mice that eventually died was increased typically in excess of 150%.The lactone and phosphate moieties were shown to be essential for anti-tumour activity whereas ring hydroxylation or removal of the terminal hydroxyl group had little effect. CI-920 (148) was inactive when given orally or subcutaneously and also failed to show activity against murine M5076 sarcoma B 16 melanoma or Ridgeway osteogenic CI-920 (148) PD 113,270 (149) and PD 113,271 (150) were all devoid of antimicrobial activity when tested against a range of micro-organisms including Bacillus subtilis Escherichia coli Penicillium avellaneum and Staphy-lococcus au~eus.~~~ The phoslactomycins (1 5 1)-( 156) showed strong antifungal activity against a range of organisms including Botrytis cinerea Alternaria sp.Chaetomium globosum Verticillium albo-atrum and Pseudocercosporella herpotrichoides.244 Antibacterial ac-tivity was weak although there was a slight inhibitory effect against some Gram-positive bacteria. A comparison of activity between phoslactomycins A to F showed that they had almost the same antimicrobial spectrum and so it was thought that the substituent on the cyclohexane ring was unimportant for On the other hand (21-920 (148) although struc- turally similar was devoid of antifungal activity suggesting that the aminomethyl and cyclohexadienyl moieties may be required for expression of antifungal activities of the phoslacto- mycins.Although the phoslactomycins have not been tested as a group for cytotoxic activity phoslactomycin B (1 52) has been shown to be active against L1210 P388 and EL-4 le~kaemias.,~~ Phosphazomycin C (1 57) along with phoslactomycin C (phosphazomycin C,) (153) has been shown to exhibit strong antifungal activity against Aspergillus sp. Trichophyton menta- grophytes Colletotrichum lagenarium Glomerella cingulata and Alternaria mali amongst others.248 Phosphazomycin A has also been shown to inhibit fungal growth being effective against the above named organisms and against yeasts (Saccharomyces cerevisiae Candida albi~ans).~~’ The inhibition of fungal growth by phosphazomycin A was found to be accompanied by swelling of the mycelia and in Saccharomyces cerevisiae p-1,3-glucan synthetase was inhibited at concen-trations of 100 ,ug/ml.Pot tests demonstrated that the metabolite prevented infection by cucumber grey mould disease and cucumber anthracnose at concentrations of 25 ppm. The LD, in mice was 19 mg/kg when administered orally. 3.5 Other Polyketide-derived Dihydropyran-Zones 3.5.1 Alternaric Acid Alternaric acid (158) has been isolated from the plant pathogen 252 Alternaria ~olani,~~’.and its structure elucidated by a combination of chemical degradation and spectroscopic studie~.~~~-~~’ Biosynthetic studies using [1-14C]-and [2-14C]acetate demonstrated the incorporation of nine acetate units into the molecule and thus established alternaric acid as a polyketide.258 The remaining carbons were derived from the C,-pool (Scheme 44).The possibility that alternaric acid may have been NATURAL PRODUCT REPORTS 1993 TOH 0 propionate-derived was precluded due to the low incorporation of [l-14C]propionate into the molecule. Alternaric acid did not display antibacterial activity but was shown to inhibit spore germination in a number of fungi (e.g. Absidia glauca Myrothecium verrucaria Mucor mucedo Thamnidium elegans) at concentrations of 1 ,ug/ml or less. Spore germination of other fungi was unaffected. However at high concentrations (100 ,ug/ml) the extension of germ-tubes after germination was retarded markedly in Botrytis allii Aspergillus tamari and Stemphylium species. 251 252 3.5.2 The Rubratoxins Rubratoxins A (159) and B (160) have been isolated from cultures of Penicillium rubrum and P.purpurogenum moulds responsible for diseases induced by infected corn. The isolation biosynthesis and biological activity of these metabolites has been reviewed,259 and so these aspects will only be summarized here. The effect of medium on toxin production has since been studied in P. rubrum.260s 261 Biosynthetic studies using 14C-labelled precursors have established that [l-14C]acetate [2-14C]malonate [l -14C]glucose [1,5-14C2]citrate,[l-14C]hexanoate and [U-14C]glucose were all incorporated into the rubratoxins although the position of label has not been established. The incorporation of both acetate and malonate provided evidence for the theory that these metabolites were polyketides.262 26‘3 The biological activity of the rubratoxins has been examined in Rats treated with these compounds developed within a short period anorexia diarrhoea and a porphyrin ‘OR (163) R = pBrC6H4CONHC0 (1 64) R = (-)-Camphanyl Scheme 45 discharge from the eyes ears and nose.Post-mortem exam- ination of these animals revealed extensive liver damage which consisted mainly of massive haemorrhagic necrosis with entire sections of the organ destroyed. The toxicity of the rubratoxins decreased when administered orally and rubratoxin B (160) displayed greater activity than any of its derivatives. The LD, of rubratoxin B in rats was 0.36 mg/kg (i.p.). Rubratoxin B was also found to exhibit antiprotozoal activity inhibiting growth of Tetrahymena pyrformis in vitro at concentrations of 25,4m1.264 3.5.3 Phomopsolides A and B The fungus Phomopsis oblonga has been shown to act as a biocontrol agent for the control of Scolytus scolytus the insect vector of Dutch elm disease.265 Phomopsolides A (161) and B (162) were isolated from this organism,266 and shown to act as boring/feeding deterrents against adult Scolytid beetles in vitr~.~~~ The structures of these metabolites were assigned on the basis of chemical and spectroscopic studies.3.6 Non-polyketide Derived Dihydropyran-Zones 3.6.1 Fomannosin Fomannosin (165) has been isolated from the wood-rotting fungus Fomes annosus and its structure determined on the basis of chemical and spectral data.268 An X-ray crystal structure of the p-bromobenzoylurethane derivative of dihydro- fomannosin (163) has been determined,269 as has that of the camphanate ester (1 6$).270 In direct contrast to other fungal pyrones fomannosin (165) has been shown to be a sesquiterpene derived from mevalona- lactone via trans,trans-farnesyl pyrophosphate and humulene.Feeding studies with [1,2-13C2]acetate have demonstrated the incorporation of label to be as shown (Scheme 45).2719272 The possibility that 1,2-hydride shifts may be occurring in the conversion of humulene to fomannosin was discounted on the basis of evidence obtained from feeding studies with [5,5-2H2]mevalonate.273 Fomannosin has been shown to be phytotoxic affecting seedlings of Pinus tadea and Chlorella pyrenoidosa thus NATURAL PRODUCT REPORTS 1993-J.M. DICKINSON 95 31 E. L. Ghisalberti M. J. Narbey M. M. Dewan and K. Sivasithamparam Plant Soil 1990 121 287 32 F. M. Yong and G. Lim MIRCEN J. Appl. Microbiol. Biotechnol. 1986 2 483 33 K. S. M. Sastry C. V. P. Rao and R. Manavalan Indian Perfum. 1985 29 193 (Chem. Abs. 1986 105 297840 34 T. Kikuchi T. Mimura K. Hariyama H. Yano T. Arimoto Y. Masada and T. Inoue Chem. Pharm. Bull. 1974 22 1946 35 A. J. Harvat G. W. Chapman Jr. J. A. Robertson F. I. Meredith R. Scorza A. M. Callahan and P. Morgens J. Agric. Food Chem. 1990 38 234 36 G. R. Takeoka R. A. Flath M. Guentert and W. Jennings J. Agric. Food Chem. 1988 36 553 37 K. H. Engel R.A. Flath R. G. Buttery T. R. Mon D. W. Ramming and R. Teranishi J. Agric. Food Chem. 1988 36 549 38 K. H. Engel D. W. Ramming R. A. Flath and R. Teranishi J. Agric. Food Chem. 1988 36 1003 39 C. M. Hsu R. J. Peterson Q. Z. Jin C. T. Ho and S. S. Chang, suggesting a role for this metabolite in diseases caused by J. Food Sci. 1982 47 2068 Fomes annosus. Antibacterial activity has also been 40 C. Dennis and J. Webster Trans. Br. Mycol. SOC.,1971 57 41 1 demonstrated.268 41 A. Simon R. W. Dunlop E. L. Ghisalberti and K. Sivasithamparam Soil Biol. Biochem. 1988 20 263 42 N. Claydon M. Allan J. R. Hanson and A. G. Avent Trans. Br. 3.6.2 23-Deoxyan theridiol Mycol. SOC.,1987 88 503 23-Deoxyantheridiol (166) has been isolated from culture 43 M. 0.Moss R.M. Jackson and D. Rogers Phytochemistry 1975 14 2706 filtrates of the water moulds Achyla bisexualis and A. 44 J. R. Rocca J. H. Tumlinson B. L. Glancey and C. S. Lofgren, amb isex ualis. Tetrahedron Lett. 1983 24 1889 45 T. H. Jones and H. M. Fales Tetrahedron Lett. 1983 24 5439 46 M. S. R. Nair and S. T. Carey Phytochemistry 1977 16 1613 4 References 47 A. Nobuhara Agric. Biol. Chem. 1969 33 1264 1 e.g. J. D. Hepworth in ‘Comprehensive Heterocyclic Chemistry’ 48 J. M. Dickinson D. Phil. Thesis University of Sussex 1988 Vol. 3 ed. A. J. Boulton A. McKillop Pergamon Press 1984 49 W. S. Trahanovsky B. W. Surber M. C. Wilkes and M. M. pp. 737; W. B. Turner and D. C. Aldridge ‘Fungal Metabolites Preckel J. Am. Chem. Soc. 1982 104 6779 11’ Academic Press London 1983 50 Y.Ueno in ‘Mycotoxins’ ed. I. F. H. Purchase Elsevier New 2 C. P. Dutta L. P. K. Ray A. Chatterjee and D. N. Roy Phyto-York 1974 p. 283 chemistry 1972 11 2891 51 Y. Hirata J. Chem. Soc. Japan 1947 68 63 74 104 3 J. P. Ruckstuhl and K. Meyer Helv. Chim. Acta 1957 40 1270 52 N. Sakabe T. Goto and Y. Hirata Tetrahedron Lett. 1964 1825 4 J. E. Hochlowski and D. J. Faulkner Tetrahedron Lett. 1983,24 53 D. W. Nagel P. S. Steyn and D. B. Scott Phytochemistry 1972 1917 11 627 5 P. E. Brenneisen T. E. Acker and S. W. Tanenbaum J. Am. 54 G. M. Nan0 and M. Bellando Allionia 1976 21 73 (Chem. Chem. Soc. 1964 86 1264 Abstr. 1978 89 176023m) 6 R. Bentley and P. M. Zwitkowits J. Am. Chem. Soc. 1967 89 55 N. Sakabe T. Goto and Y. Hirata Tetrahedron 1977 33 3077 676 56 R.J. Cole J. W. Dorner R. H. Cox R. A. Hill. H. G. Cutler 7 R. J. Light T. M. Harris and C. M. Harris Biochemistry 1966 and J. M. Wells Appl. Environ. Microbiol. 1981 42 677 5 4037 57 B. FranckandH. P. Gehrken Angew. Chem. Int. Ed. Engl. 1980 8 K. Miyazaki M. Sakaguchi T. Shibamoto Y. Saeki and 46 1 N. Hashimoto Nippon Nogei Kaishi 1971,45 317 (Chem. Abstr. 58 M. Niwa T. Endo S. Ogiso H. Furukawa and S. Yamamura 1972 76 69829~) Chem. Lett. 1981 1285 9 K. Miyazaki Japan Kokai 72 16,691 (Chem. Abstr. 1973 78 59 S. Nishiyama Y. Shizuri D. Imai and S. Yamamura Tetra-41 562p) hedron Lett. 1985 26 3243 10 M. S. R. Nair and S. T. Carey Mycologia 1979 71 1089 60 H. Shizuri S. Nishiyama D. Imai S. Yamamura H. Furukawa 11 J. N. Collie J. Chem. Soc. 1891 607 K.Kawai and N. Okada Tetrahedron Lett. 1984 25 4771 12 J. N. Collie J. Chem. SOC. 1907 1806 61 E. Suzuki H. Sekizaki and S. Inoue J. Chem. Res. (S) 1977 200 13 R. F. Witter and E. Stotz J. Biol. Chem. 1948 176 485 62 H. Suh and C. S. Wilcox J. Am. Chem. SOC 1988 110 470 14 T. M. Harris and C. M. Harris J. Org. Chem. 1966 31 1032 63 Y. Shizuri S. Nishiyama H. Shigemori and S. Yamamura J. 15 K. Boltze and K. Heidenbluth Chem. Ber. 1958 91 2849 Chem. Soc. Chem. Commun. 1985 292 16 T. E. Acker P. E. Brenneisen and S. W. Tanenbaum J. Am. 64 D. R. Williams and F. H. White Tetrahedron Lett. 1985 26 Chem. Soc. 1966 88 834 2529 17 J. N. Collie J. Chem. Soc. 1891 617 65 M. C. Bowden D. Patel and G. Pattenden Tetrahedron Lett. 18 A. B. Steele A. B. Boese and M. F.Dull J. Org. Chem. 1949,14 1985 26 4793 460 66 B. M. Trost J. K. Lynch and S. R. Angle Tetrahedron Lett. 19 F. Arndt Org. Synth. CON. Vol. IZI 1955 231 1987 28 375 20 R. Bentley and P. M. Zwitkowits J. Am. Chem. Soc. 1967,89,681 67 S. Hatakeyama Y. Matsui M. Suzuki K. Sakurai and 21 G. Ehrensvard Exptl. Cell Res. Suppl. 1955 3 102 S. Takano Tetrahedron Lett. 1985 26 6485 22 T. Kotani S. Nonomura and C. Tatsumi Nippon Nogeikagaku 68 S. Nishiyama Y. Shizuri and S. Yamamura Tetrahedron Lett. Kaishi 1964 38 585 (Chem. Abstr. 1965 63 12021d) 1985 26 231 23 R. F. Witter and E. Stotz J. Biol. Chem. 1948 176 501 69 E. Suzuki B. Katsuragawa and S. Inoue J. Chem. Res. (S),1982 24 A. Meister J. Biol. Chem. 1949 178 577 224 25 ‘Merck Index’ 9th Edn. 1976 Merck & Co.Rahway N. J. 70 S. Nishiyama H. Toshima and S. Yamamura Chem. Lett. 1986 Entry 2840 375 1973 26 H. C. Spencer V. K. Rowe and D. D. McCollister J. Pharmacol. 71 D. W. Nagel P. S. Steyn and D. B. Scott Phytochemistry 1972 Exp. Ther. 1950 99 57 11 3215 27 R. P. Collins and A. F. Halim J. Agric. Food Chem. 1972,20,437 72 P. S. Steyn R. Vleggaar P. L. Wessels and M. Woudenberg J. 28 M. R. Sevenants and W. G. Jennings J. Food Sci. 1971 36 536 Chem. SOC.,Perkin Trans. I 1982 2175 29 0.A. M. Merlier M. J. Boirie B. J. Poris and C. M. Renaud 73 P. S. Steyn and R. Vleggaar J. Chem. Soc. Chem. Commun. Eur. Pat. Appl. 1984 EP 124,388 (Chem. Ah. 1984 102 1985 1531 183 747r) 74 P. E. Linnett and R. B. Beechey Methods Enzymol. 1979 55,472 30 H. G. Cutler R. H. Cox F.G. Crumley and P. D. Cole Agric. 75 P. E. Linnett A D. Mitchel M. D. Osselton L. J. Mulheirn and Biol. Chem. 1986 50 2943 R. B. Beechey Biochem. J. 1978 170 503 76 C. L. Baldwin L. C. Weaver R. M. Brooker T. N. Jacobsen C. E. Osborne Jr. and H. A. Nash Lloydia 1964 27 88 77 M. D. Osselton H. Baum and R. B. Beechey Biochem. Soc. Trans. 1974 2 200 78 L. J. Mulheirn R. B. Beechey D. P. Leworthy and M. D. Osselton J. Chem. Soc. Chem. Commun. 1974 874 79 S. Nishiyama H. Toshima H. Kanai and S. Yamamura Tetra-hedron Lett. 1986 27 3643 80 P. S. Steyn R. Vleggaar and P. L. Wessels J. Chem. Soc. Chem. Commun. 1979 1041 81 P. S. Steyn R. Vleggaar and P. L. Wessels J. Chem. Soc. Perkin Trans. 1 1981 1298 82 P. S. Steyn and R. Vleggaar J. Chem.Soc. Chem. Commun. 1985 1796 83 A. M. Robertson R. B. Beechey C. T. Holloway and I. G. Knight Biochem. J. 1967 104 54C 84 J. L. Connelly and H. A. Lardy Biochemistry 1964 3 1969 85 D. 0.Lambeth and H. A. Lardy Eur. J. Biochem. 1971 22 355 86 M. Satre M. Bof and P. V. Vignais J. Bacteriol. 1980 142 768 87 M. Satre G. Klein and P. V. Vignais J. Bacteriol. 1978 134 17 88 E. M. Gause M. A. Buck and M. G. Douglas J. Biol. Chem. 1981 256 557 89 A. B. Melandri E. Fabbri and B. A. Melandri Biochim. Biophys. Acta 1975 376 82 90 R. A. Ravizzini W. I. M. Lescano and R. H. Vallejos FEBS Lett. 1975 58 285 91 M. Avron and N. Shavit Biochem. Biophys. Acta 1965 109 317 92 D. Layton A. Azzi and P. Graziotti FEBS Lett. 1973 34 87 93 T.-M. Chang and H.S. Penefsky J. Biol. Chem. 1973 248 2746 94 R. M. Bertina P. J. Schrier and E. C. Slater Biochim. Biophys. Acta 1973 305 503 95 R. J. Van de Stadt K. Van Dam and E. C. Slater Biochim. Biophys. Acta 1974 347 224 96 T.-M. Chang and H. F. Penefsky J. Biol. Chem. 1974 249 1090 97 J. L. M. Muller J. Rosing and E. C. Slater Biochim. Biophys. Acta 1977 462 422 98 R. J. Van de Stadt and K. van Dam Biochim. Biophys. Acta 1974 347 253 99 G. J. Kruger P. S. Steyn R. Vleggaar and C. J. Rabie J. Chem. SOC.,Chem. Commun. 1979 441 100 S. Rebuffat D. Davoust L. Molho and D. Molho Phyto-chemistry 1980 19 427 101 C. Brassy B. Bachel C. Guidi-Morosini S. Rebuffat and ’ D. Molho Acta Crystallogr. Sect. B 1982 38 1624 102 S. L. Schreiber and K. Satake J. Am.Chem. SOC.,1983,105,6723 103 P. S. Steyn and R. Vleggaar J. Chem. Soc. Chem. Commun. 1984 977 104 A. E. de Jesus P. S. Steyn and R. Vleggaar J. Chem. Soc. Chem. Commun. 1985 1633 105 M. Satre Biochem. Biophys. Res. Commun. 1981 100 267 106 M. Niwa S. Ogiso T. Endo H. Furukawa and S. Yamamura Tetrahedron Lett. 1980 21 4481 107 Y. Shizuri M. Niwa H. Furukawa and S. Yamamura Tetra-hedron Lett. 1983 24 1053 108 H. Sato K. Konoma and S. Sakamura Agric. Biol. Chem. 1979 43 2409 109 H. Sato K. Konoma S. Sakamura A. Furusaki T. Matsumoto and T. Matsuzaki Agric. Biol. Chem. 1981 45 795 110 S. A. Sparace J. B. Mudd B. A. Burke and A. J. Aasen Phyto-chemistry 1984 23 2693 11 1 S. Shimizu I. Sakurai and Y. Yamamoto Chem. Pharm. Bull. 1983 31 3781 112 M.S. R. Nair and S. T. Carey Tetrahedron Lett. 1975 3517 113 M. S. R. Nair Phytochemistry 1976 15 1090 114 I. Sakurai S. Shimizu and Y. Yamamoto Chem. Pharm. Bull. 1988 36 1328 115 Y. Fujimoto H. Tsunoda J. Uzawa and T Tatsuno J. Chem. Soc. Chem. Commun. 1982 83 116 Y. Shizuri S. Kosemura S. Yamamura H. Furukawa K. Kawai and N. Okada Tetrahedron Lett. 1984 25 1583 117 W. B. Turner and D. C. Aldridge ‘Fungal Metabolites II’ Aca-demic Press London 1983 p. 199 118 J. D. Bu’Lock and H. G. Smith Experientia 1961 17 553 119 R. L. Edwards D. G. Lewis and D. V. Wilson J. Chem. Soc. 1961 4995 120 A. Ueno S. Fukushima Y. Saiki and T. Harada Chem. Pharm. Bull. 1964 12 376 121 M. Klaar and W. Steglich Chem. Ber. 1977 110 1058 122 T. K.Kirk L. F. Lorenz and M. J. Larsen Phytochemistry 1975 14 281 NATURAL PRODUCT REPORTS 1993 123 G. M. Hatfield and L. R. Brady Lloydia 1971 34 260 124 L. R. Brady and R. G. Benedict J. Pharm. Sci. 1972 61 318 125 G. M. Hatfield and L. R. Brady J. Pharm. Sci. 1969 58 1298 126 G. M. Hatfield and L. R. Brady Lloydia 1968 31 225 I27 K. Gluchoff-Fiasson and R. Kiihner C. R. Acad. Sci. Ser. D 1977 284 1667 128 J.-L. Fiasson K. Gluchoff-Fiasson and W. Steglich Chem. Ber. 1977 110 1047 129 M. Klaar and W. Steglich Chem. Ber. 1977 110 1063 130 R. L. Edwards and D. V. Wilson J. Chem. Soc. 1961 5003 131 G. M. Hatfield and L. R. Brady Lloydia 1973 36 59 132 P. W. Perrin and G. H. N. Towers Phytochemistry 1973 12 583 133 P. W. Perrin and G. H. N. Towers Phytochemistry 1973 12 589 134 A.M. D. Nambudiri C. P. Vance and G. H. N. Towers Biochem. J. 1973 134 891 135 C. P. Vance E. B. Tregunna A. M. D. Nambudiri and G. H. N. Towers Biochim. Biophys. Acta 1974 343 138 136 W. Kohl H. Irschik H. Reichenbach and G. Hofle Liebigs Ann. Chem. 1983 1656 137 R. Jansen H. Irschik H. Reichenbach and G. Hofle Liebigs Ann. Chem. 1985 822 138 W. Kohl H. Irschik H. Reichenbach and G. Hofle Liebigs Ann. Chem. 1984 1088 139 H. Irschik K. Gerth G. Hofle W. Kohl and H. Reichenbach J. Antibiot. 1983 36 1651 140 H. Irschik R. Jansen G. Hofle K. Gerth and H. Reichenbach J. Antibiot. 1985 38 145 141 W. Newton Can. J. Bot. 1953 31 423 142 0.R. Hansen Acta Chem. Scand. 1954 8 1332 143 D. D. Clarke and F. F. Nord Arch.Biochem. Biophys. 1953 45 469 144 D. D. Clarke and F. F. Nord Arch. Biochem. Biophys. 1955 59 269 279 145 J. F. Grove J. Chem. Soc. 1964 3234 146 A. Ozaki T. Ishikura and T. Yokota Jap. Patent 1967 11997 (Chem. Abstr. 1967 67 89818b) 147 M. Nukina and S. Manimo Tetrahedron Lett. 1977 3271 148 D. J. Robeson G. R. Gray and G. A. Strobel Phytochemistry 1982 21 2359 149 D. J. Robeson G. R. Gray and G. A. Strobel Phytochemistry 1982 21 1821 150 D. J. Robeson and G. A. Strobel Phytochemistry 1984 23 767 I51 K. Kato Y. Hirata and S. Yamamura J. Chem. Soc. (0, 1969 1997 152 K. Kato Y. Hirata and S. Yamamura J. Chem. Soc. Chem. Commun. 1969 95 153 K. Kato Y. Hirata and S. Yamamura J. Chem. Soc. Chem. Commun. 1968 319 154 J.F. Grove J. Chem. Soc. (C) 1970 1860 155 H. Set0 and S. Urano Agric. Biol. Chem. 1975 39 915 156 A. Ichihara H. Tazaki and S. Sakamura Tetrahedron Lett. 1983 24 5373 157 A. Z. Joffe J. Stored Prod. Res. 1969 5 21 1 158 M. Gohbara S.-B. Hyeon A. Suzuki and S. Tamura Agric. Biol. Chem. 1976,40 1453 159 L. Opitz and R. Hansel Tetrahedron Lett. 1970 3369 160 A. Funk and E. E. McMullan Can. J. Microbiol. 1974 20 422 161 G. A. Poulton M. E. Williams and E. E. McMullan Tetrahedron Lett. 1974 2611 162 G. A. Poulton T. D. Cyr and E. E. McMullan Can. J. Chem. 1979 57 1451 163 T. D. Cyr and G. A. Poulton Can. J. Chern. 1982 60 133 164 A. S. Sekhon and A. Funk J. Antimicrobial Chemother. 1977 3 95 165 S. Omura H. Ohno T. Saheki M. Yoshida and A.Nakagawa Biochem. Biophys. Res. Commun. 1978 83 704 166 J. R. Pfister Tetrahedron Lett. 1980 21 1281 167 S. Omura A. Nakagawa and H. Ohno J. Am. Chem. Soc. 1979 101 4386 168 A. Nakagawa H. Ohno K. Miyano and S. Omura J. Org. Chem. 1980 45 3268 169 H. Ohno T. Saheki J. Awaya A. Nakagawa and S. Omura J. Antibiot. 1978 31 1116 170 A. W. Spencer L. J. Copp and J. R. Pfister J. Med. Chem. 1985 28 1828 171 L. Cook B. Ternai and P. Ghosh J. Med. Chem. 1987 30 1017 172 M. S. R. Nair and S. T. Carey Tetrahedron Lett. 1975 1655 173 A. G. Avent J. R. Hanson and A. Truneh Phytochemistry 1992 accepted for publication NATURAL PRODUCT REPORTS 1993-J. M. DICKINSON 174 W.-R. Abraham and H.-A. Arfman Phytochemistry 1988 27 3310 175 M.Rey E. Dunkelblum R. Allain and A. S. Dreiding Helv. Chim. Acta 1970 53 2159 176 W.-R. Abraham I. Knoch and L. Witte Phytochemistry 1990 29 2877 177 N. Miyairi H. Sakai T. Konomi and H. Imanaka J. Antibiot. 1976 29 227 178 H. Seto T. Sato S. Urano J. Uzawa and H. Yonehara Tetra-hedron Lett. 1976 4367 179 Y. Tokuma N. Miyairi and Y. Morimoto J. Antibiot. 1976 29 1114 180 A. Kawashima H. Seto M. Kato K. Uchida and N. Otake J. Antibiot. 1985 38 1499 181 Y. Koyama Y. Fukakusa N. Kyomura S. Yamagishi and T. Arai Tetrahedron Lett. 1969 355 182 Y. Kimura T. Hamasaki A. Isogai and H. Nakajima Agric. Biol. Chem. 1982 46 1963 183 Y. Katsube Y. Kimura T. Hamasaki H. Nakajima and A. Isogai. Agric. Biol. Chem. 1985 49 551 184 B. F. Burrows W.B. Turner and E. R. H. Walker J. Chem. Soc. Perkin Trans. I 1975 999 185 A. J. Geddes and B. Sheldrick Acta Crystallogr. Sect. B 1975 31 2124 186 H. Seto M. Shibamiya and H. Yonehara J. Antibiot. 1978 31 926 187 L. Camarda L. Merlini and G. Nasini Phytochemistry 1976 15 537 188 S. Hattori and A. Komamine Nature 1959 183 1116 189 S. Senoh. S. Imamoto Y. Maeno T. Tokuyama T. Sakan A. Komamine and S. Hattori Tetrahedron Lett. 1964 3431 190 W. S. Chilton C. P. Hsu and W. T. Zdybak Phytochemistry 1974 13. I179 191 K. Saito A. Komamine and S. Senoh Z. Naturforsch. Teil C 1975 30 659 192 K. Saito A. Komamine and S. Senoh Z. Naturforsch. Teil C 1976 31. I5 193 K. Saito and A. Komamine Eur. J. Biochem. 1976 68 237 194 B. E. Ellis Phytochemistry 1976 15 489 195 K.Saito and A. Komamine Eur. J. Biochem. 1978 82 385 196 K. Saito and A. Komamine 2.Naturforsch. Teil C 1978,33 793 197 H. Musso. Tetrahedron 1979 35 2843 198 Y. Kimura K. Katagiri T. Inoue and S. Tamura Agric. Biol. Chem. 1971 35 1313 199 G. A. Ellestad W. J. McGahren and M. P. Kunstmann J. Org. Chem. 1972 37 2045 200 G. M. Strunz C. J. Heissner M. Kakushima and M. A. Stillwell Can. J. Chem. 1974 52 825 201 Y. Kimura W. J. McGahren A. Suzuki and S. Tamura Agric. Biol. Chem. 1978 42 1625 202 W. J. McGahren G. A. Ellestad G. 0.Morton M. P. Kunstmann and P. Mullen J. Org. Chem. 1973 38 3542 203 Y. Kimura K. Katagiri and S. Tamura Tetrahedron Lett. 1971 3137 204 Y.Kimura and S. Tamura Agric. Biol. Chem. 1972 36 1925 205 Y.Kimura A. Suzuki and S. Tamura Agric. Biol. Chem. 1980 44,451 206 S. D. Mills and W. B. Turner J. Chem. Soc. (C) 1967 2242 207 I. Yamamoto H. Suide T. Henmi and T. Yamano Takeda Kenkyusho Ho 1970 29 1 (Chem. Abstr. 1971 73 52347~) 208 J. H. Moore T. P. Murray and M. E. Marks J. Agric. Food Chem. 1974 22 697 209 W. Rosenbrook Jr. and R. E. Carney Tetrahedron Lett. 1970 1867 210 M. J. Garson J. Staunton and P. G. Jones J. Chem. Soc. Perkin Trans. I 1984 1021 21 1 T. J. Simpson Tetrahedron Lett. 1975 175 212 T. J. Simpson and J. S. E. Holker Tetrahedron Lett. 1975 4693 213 J. S. E. Holker and T. J. Simpson J. Chem. Soc. Perkin Trans. I 1981 1397 214 M. Tanabe M. Uramoto. T. Hamasaki and L. Cary Hetero-cycles 1976 5 355 215 R.J. Copeland R. A. Hill D. J. Hinchcliffe and J. Staunton J. Chem. Soc. Perkin Trans. I 1984 1013 216 R. G. Brereton M. J. Garson and J. Staunton J. Chem. Soc. Perkin Tranp. I 1984 1027 217 J. Staunton and A. C. Sutkowski J. Chem. Soc. Chem. Commun. 1991 1106 218 J. Stauntonand A. C.Sutkowski J. Chem. Soc. Chem. Commun. 1991 1108 219 J. Staunton and A. C. Sutkowski J. Chem. Soc. Chem. Commun. 1991 1110 220 A. Jacobs J. Staunton and A. C. Sutkowski J. Chem. Soc. Chem. Commun. 1991 1113 221 A. D. Argoudelis J. H. Coats and R. R. Herr Antimicrobial Agents Chemother. 1965 801 222 A. D. Argoudelis and J. F. Ziesert Tetrahedron Lett. 1966 1969 223 S. Mizuba K. Lee and J. Jiu Can. J. Microbiol. 1975 21 1781 224 R. H. Evans Jr. G. A. Ellestad and M.P. Kunstmann Tetra-hedron Lett. 1969 1791 225 M. Tanabe T. Hamasaki D. Thomas and L. Johnson J. Am. Chem. Soc. 1971 93 273 226 S. P. Owen and B. K. Bhuyan Antimicrobial Agents Chemother. 1965 804 227 K. Arai T. Yoshimura Y. Hatani and Y. Yamamoto Chem. Pharm. Bull. 1983 31 925 228 T. Hamamoto H. Seto and T. Beppu J. Antibiot. 1983 36 646 229 S. Gunji K. Arima and T. Beppu Agric. Biol. Chem. 1983 47 2061 230 T. Hamamoto S. Gunji H. Tsuji and T. Beppu J. Antibiot. 1983 36 639 231 J. P. Schaumberg G. C. Hokanson and J. C. French J. Chem. Soc. Chem. Commun. 1984 1450 232 J. B. Tunac B. D. Graham W. E. Dobson and M. D. Lenzini J. Antibiot. 1985 38 460 233 K. Komiyama K. Okada H. Oka S. Tomisake T. Miyano S. Funayama and I. Umezawa J.Antibiot. 1984 38 220 234 I. Umezawa K. Komiyama H. Oka K. Okada S. Tomisaka T. Miyano and S. Takano J. Antibiot. 1984 37 706 235 K. Funaishi K. Kawamura Y. Sugiura N. Nakahori E. Yoshida M. Okanishi I. Umezawa S. Funayama and K. Komiyama. J. Antibiot. 1987 40 778 236 T. R. Hurley R. H. Bunge N. E. Willmer G. C. Hokanson and J. C. French J. Antibiot. 1986 39. 1651 237 Y. Hayakawa K. Adachi and N. Komeshima J. Antibior. 1987 40 1349 238 T. Hamamoto T. Uozumi and T. Beppu J. Antibior. 1985 38 533 239 B. J. Roberts K. L. Hamelehle J. S. Sebolt and W. R. Leopold Cancer Chemother. Pharmacol. 1986 16 95 (Chem. Abstr. 1986 104 218701s) 240 K. Komiyama K. Okada S. Tomisaka I. Umezawa T. Hamamoto and T. Beppu J. Antibiot. 1985 38 427 241 K.Komiyama K. Okada Y. Hirokawa K. Masuda S. Tomisaka and I. Umezawa J. Antibiot. 1985 38 224 242 J. B. Tunac B. D. Graham and W. E. Dobson J. Antibiot. 1983 36 1595 243 G. C. Hokanson and J. C. French J. Org. Chem. 1985 50. 462 244 S. Fushimi S. Nishikawa A. Shimazu and H. Seto J. Antibiot. 1989 42 1019 245 S. Fushimi K. Furihata and H. Seto J. Antibiot. 1989 42 1026 246 T. Ozasa K. Suzuki M. Sasamata K. Tanaka M. Kobori S. Kadota K. Nagai T. Saito S. Watanabe and M. Iwanami J. Antibiot. 1989 42 1331 247 T. Ozasa K. Tanaka M. Sasamata H. Kaniwa M. Shimizu H. Matsumoto and M. Iwanami J. Antibiot. 1989 42 1339 248 T. Tomiya M. Uramoto and K. Isono J. Antibiot. 1990,43 I18 249 M. Uramoto Y.-C. Shen N. Takizawa H. Kusakabe and K. Isono J.Antibiot. 1985 38 665 250 W. R. Leopold J. L. Shillis A. E. Mertus J. M. Nelson B. J. Roberts and R. C. Jackson Cancer Res. 1984 44 1928 251 P. W. Brian P. J. Curtis. H. G. Hemming C. H. Unwin. and J. M. Wright Nature (London) 1949 164 534 252 P. W. Brian P. J. Curtis H. G. Hemming E. G. Jefferys C. H. Unwin and J. M. Wright J. Gen. Microbiol. 1951 5 619 253 J. F. Grove J. Chem. Soc. 1952 4056 254 J. R. Bartels-Keith and J. F. Grove. Proc. Chem. Soc. 1959 398 255 J. R. Bartels-Keith J. Chem. Soc. 1960 860 256 J. R. Bartels-Keith J. Chem. Soc. 1960 1662 257 J. R. Bartels-Keith and W. B. Turner J. Chem. Soc. 1960 3413 258 W. B. Turner J. Chem. Soc. 1961 522 259 P. M. Newberne in ‘Mycotoxins’ ed. 1. F. H. Purchase Elsevier 1974 pp. 163-1 80 260 C.0.Emeh and E. H. Marth Trans. Br. Mycol. Soc. 1977 68 112 261 C. 0.Emeh and E. H. Marth Can. J. Microbiol. 1977 23 1695 262 C. 0.Emeh and E. H. Marth Arch. Microbiol. 1978 118 7 263 C. 0.Emeh and E. H. Marth Dev. Znd. Microbiol. 1976 18 517 (Chem. Abstr. 1979 91 189506n) 98 264 A. W. Hayes Antimicrob. Agents Chemother. 1973 4 80 265 J. Webber Nature 1981 292 449 266 J. F. Grove J. Chem. Soc. Perkin Trans. I 1985 865 267 N. Claydon J. F. Grove and M. Pople Phytochemistry 1985,24 937 268 J. A. Kepler M. E. Wall J. E. Mason C. Basset A. T. McPhail and G. A. Sim J. Am. Chem. SOC. 1967 89 1260 269 A. T. McPhail and G. A. Sim J. Chem. SOC. (B) 1968 1104 NATURAL PRODUCT REPORTS 1993 270 D. E. Cane R. B. Nachbar J. Clardy and J.Finer Tetrahedron Lett. 1977 4277 271 D. E. Cane and R. B. Nachbar Tetrahedron Lett. 1976 2097 272 D. E. Cane and R. B. Nachbar J. Am. Chem. Soc. 1978 100 3208 273 D. E. Cane and R. B. Nachbar Tetrahedron Lett. 1980 437 274 D. M. Green J. A. Edwards A. W. Barksdale and T. C. McMorris Tetrahedron 1971 27 I199

ISSN:0265-0568    

DOI:10.1039/NP9931000071

出版商:RSC    

年代:1993

数据来源: RSC